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Mechanical Regulation of Angiogenesis in a Biomimetic Model
Abstract
Collective cell migration is required for numerous developmental and pathological processes including
angiogenesis, branching morphogenesis, and cancer progression. Dynamic regulation of cell-cell adhesions,
transmission of long-range contractile forces across cells, and remodeling of the extracellular matrix (ECM)
are all required for successful multicellular invasion. While actomyosin contractility is well studied in single
cells on flat surfaces, less is understood about its regulation of collective cell migration, including during
angiogenesis whereby endothelial cells from existing vessels invade as multicellular sprouts to form new
vessels. Here, we have engineered a novel organotypic model of angiogenic sprouting and neovessel formation
that originates from pre-formed artificial vessels fully encapsulated within a 3D ECM. Using this model, we
screened the effects of angiogenic factors and identified two distinct cocktails that promoted robust
multicellular endothelial sprouting. The angiogenic sprouts in our system exhibited hallmark structural
features of in vivo angiogenesis, including directed invasion of leading cells that developed filopodia-like
protrusions characteristic of tip cells and following polarized stalk cells that line lumens connecting back to
parent vessels. Ultimately, sprouts bridged between pre-formed channels and formed perfusable neovessels.
Using this model, we investigated the effects of angiogenic inhibitors on sprouting morphogenesis using
quantitative evaluation metrics. Together, these results demonstrate an in vitro 3D biomimetic model that
reconstitutes the morphogenetic steps of angiogenic sprouting. We used this biomimetic model to
characterize the role of actomyosin contractility during multicellular sprout extension. We also described
differences in tip cell-stalk cell and stalk cell-stalk cell adhesions by evaluating vascular endothelial (VE)-
cadherin organization. Inhibition of actomyosin contractility through non-muscle myosin II caused a decrease
in VE-cadherin organization at cell-cell adhesions, and a loss of cell-cell contact between leading tip cell and
the following stalk during sprout extension. This effect is rescued when cells express a form of VE-cadherin
that stabilizes its interactions with the actin cytoskeleton. Our findings reveal contractility is required for
multicellular invasion during angiogenic sprout extension, and are validated using an in silico model
developed by Bentley et al. 2014 to simulate cell dynamics during sprouting, and recapitulated in an in vivo
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ABSTRACT 
 
MECHANICAL REGULATION OF ANGIOGENESIS IN A BIOMIMETIC MODEL 
Sarah C. Stapleton 
Christopher S. Chen  
Collective	  cell	  migration	  is	  required	  for	  numerous	  developmental	  and	  pathological	  processes	  
including	  angiogenesis,	  branching	  morphogenesis,	  and	  cancer	  progression.	  Dynamic	  regulation	  
of	  cell-­‐cell	  adhesions,	  transmission	  of	  long-­‐range	  contractile	  forces	  across	  cells,	  and	  remodeling	  
of	  the	  extracellular	  matrix	  (ECM)	  are	  all	  required	  for	  successful	  multicellular	  invasion.	  While	  
actomyosin	  contractility	  is	  well	  studied	  in	  single	  cells	  on	  flat	  surfaces,	  less	  is	  understood	  about	  
its	  regulation	  of	  collective	  cell	  migration,	  including	  during	  angiogenesis	  whereby	  endothelial	  
cells	  from	  existing	  vessels	  invade	  as	  multicellular	  sprouts	  to	  form	  new	  vessels.	  Here,	  we	  have	  
engineered	  a	  novel	  organotypic	  model	  of	  angiogenic	  sprouting	  and	  neovessel	  formation	  that	  
originates	  from	  pre-­‐formed	  artificial	  vessels	  fully	  encapsulated	  within	  a	  3D	  ECM.	  Using	  this	  
model,	  we	  screened	  the	  effects	  of	  angiogenic	  factors	  and	  identified	  two	  distinct	  cocktails	  that	  
promoted	  robust	  multicellular	  endothelial	  sprouting.	  The	  angiogenic	  sprouts	  in	  our	  system	  
exhibited	  hallmark	  structural	  features	  of	  in	  vivo	  angiogenesis,	  including	  directed	  invasion	  of	  
leading	  cells	  that	  developed	  filopodia-­‐like	  protrusions	  characteristic	  of	  tip	  cells	  and	  following	  
polarized	  stalk	  cells	  that	  line	  lumens	  connecting	  back	  to	  parent	  vessels.	  Ultimately,	  sprouts	  
bridged	  between	  pre-­‐formed	  channels	  and	  formed	  perfusable	  neovessels.	  Using	  this	  model,	  we	  
investigated	  the	  effects	  of	  angiogenic	  inhibitors	  on	  sprouting	  morphogenesis	  using	  quantitative	  
evaluation	  metrics.	  Together,	  these	  results	  demonstrate	  an	  in	  vitro	  3D	  biomimetic	  model	  that	  
reconstitutes	  the	  morphogenetic	  steps	  of	  angiogenic	  sprouting.	  We	  used	  this	  biomimetic	  model	  
to	  characterize	  the	  role	  of	  actomyosin	  contractility	  during	  multicellular	  sprout	  extension.	  We	  
	   vi	  
also	  described	  differences	  in	  tip	  cell-­‐stalk	  cell	  and	  stalk	  cell-­‐stalk	  cell	  adhesions	  by	  evaluating	  
vascular	  endothelial	  (VE)-­‐cadherin	  organization.	  Inhibition	  of	  actomyosin	  contractility	  through	  
non-­‐muscle	  myosin	  II	  caused	  a	  decrease	  in	  VE-­‐cadherin	  organization	  at	  cell-­‐cell	  adhesions,	  and	  a	  
loss	  of	  cell-­‐cell	  contact	  between	  leading	  tip	  cell	  and	  the	  following	  stalk	  during	  sprout	  extension.	  
This	  effect	  is	  rescued	  when	  cells	  express	  a	  form	  of	  VE-­‐cadherin	  that	  stabilizes	  its	  interactions	  
with	  the	  actin	  cytoskeleton.	  Our	  findings	  reveal	  contractility	  is	  required	  for	  multicellular	  invasion	  
during	  angiogenic	  sprout	  extension,	  and	  are	  validated	  using	  an	  in	  silico	  model	  developed	  by	  
Bentley	  et	  al.	  2014	  to	  simulate	  cell	  dynamics	  during	  sprouting,	  and	  recapitulated	  in	  an	  in	  vivo	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CHAPTER	  1:	  Introduction	  
Angiogenesis	  in	  development	  	  
The	  vascular	  system,	  or	  the	  branched	  network	  of	  channels	  that	  guide	  the	  circulation	  of	  blood	  
throughout	  the	  body,	  plays	  many	  key	  roles	  in	  physiologic	  maintenance,	  including	  the	  delivery	  of	  
nutrients	  and	  oxygen	  to	  the	  body’s	  tissues,	  removal	  of	  cellular	  metabolites,	  and	  a	  pathway	  for	  
patrolling	  immune	  cells.	  Development	  of	  the	  vasculature	  begins	  with	  the	  differentiation	  of	  
CD31+CD34+	  vascular	  endothelial	  growth	  factor	  receptor	  (VEGFR)-­‐2-­‐positive	  angioblasts	  into	  
endothelial	  cells	  (ECs)	  and	  the	  subsequent	  de	  novo	  formation	  of	  a	  small	  network	  of	  ECs	  (Jain	  
2003).	  As	  the	  network	  develops,	  ECs	  form	  connected	  lumens,	  or	  hollow	  spaces,	  and	  are	  pre-­‐
specified	  into	  arterial	  or	  venous	  phenotypes,	  which	  have	  unique	  molecular	  identities	  that	  
appear	  to	  drive	  their	  function	  (Potente,	  Gerhardt	  et	  al.	  2011).	  Arterial	  ECs	  are	  characterized	  by	  
ephrinB2,	  neuropilin-­‐1,	  and	  Notch	  signaling,	  while	  ephrinB4	  or	  neuropilin-­‐2	  are	  specifically	  
expressed	  by	  venous	  ECs	  (Wang,	  Chen	  et	  al.	  1998;	  Silvestre	  and	  Mallat	  2006).	  	  
Further	  growth	  of	  the	  vascular	  network	  relies	  on	  the	  sprouting	  of	  new	  vessels	  from	  
existing	  vasculature,	  or	  angiogenesis,	  and	  their	  eventual	  connection,	  or	  anastamosis,	  with	  the	  
network	  to	  establish	  flow.	  There	  is	  limited	  evidence	  from	  the	  zebrafish,	  some	  vascular	  networks	  
may	  form	  via	  segmentation	  of	  vessels	  from	  existing	  vessels,	  but	  this	  is	  yet	  to	  be	  demonstrated	  in	  
mammals	  (Herbert,	  Huisken	  et	  al.	  2009).	  In	  settings	  of	  postnatal	  EC	  growth,	  ECs	  either	  
proliferate	  from	  existing	  ECs,	  or	  differentiate	  from	  bone	  marrow-­‐derived	  cells	  (Rafii,	  Meeus	  et	  
al.	  2002;	  Reyes,	  Dudek	  et	  al.	  2002).	  Broad	  markers	  for	  ECs	  are	  numerous,	  but	  often	  non-­‐specific.	  
A	  progressive	  lineage	  analysis	  by	  cell	  sorting	  and	  culture	  found	  that	  expression	  of	  vascular	  
endothelial	  growth	  factor	  (VEGF)	  receptor	  (R)-­‐2	  and	  vascular	  endothelial	  (VE)-­‐cadherin	  signaled	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the	  point	  of	  divergence	  between	  hemopoeitic	  and	  endothelial	  cells.	  Platelet	  EC	  adhesion	  
molecule	  (PECAM-­‐1)	  while	  found	  in	  other	  cell	  types	  is	  expressed	  ubiquitously	  across	  all	  ECs	  
(Muller,	  Hermanns	  et	  al.	  2002).	  Lymphatic	  vessels	  form	  from	  pre-­‐existing	  veins	  during	  
embryonic	  development,	  in	  which	  ECs	  begin	  to	  express	  unique	  expression	  profiles	  (expression	  of	  
transcription	  factor	  Prox1	  and	  the	  lymphatic	  vessel	  hyaluronan	  receptor-­‐1	  (LYVE-­‐1)	  in	  mice)	  and	  
bud	  off	  and	  migrate	  dorsally	  to	  vessels	  to	  form	  new	  lymphatic	  networks	  (Wigle,	  Harvey	  et	  al.	  
2002;	  Karkkainen,	  Haiko	  et	  al.	  2004).	  Angiogenesis	  and	  anastamosis	  increase	  the	  density	  of	  the	  
vascular	  network	  by	  providing	  the	  route	  to	  a	  highly	  branched	  network	  of	  interconnected	  vessels	  
(Fantin,	  Vieira	  et	  al.	  2010).	  	  
The	  eventual	  maturation	  and	  stabilization	  of	  blood	  vessels	  is	  accompanied	  by	  the	  
deposition	  of	  a	  basement	  membrane	  matrix,	  the	  organ	  specification	  of	  ECs,	  and	  the	  recruitment	  
of	  vascular	  smooth	  muscle	  cells	  and	  pericytes	  that	  surround	  and	  layer	  the	  early	  vessels	  (Jain	  
2003).	  Recruitment	  and	  interactions	  with	  mural	  cells	  are	  largely	  regulated	  through	  EC	  
expression	  of	  platelet-­‐derived	  growth	  factor	  (PDGF)	  receptor-­‐β	  (PDGFR-­‐β)	  and	  transforming	  
growth	  factor	  β	  (TGF-­‐β)	  (Hellstrom,	  Gerhardt	  et	  al.	  2001).	  While	  pericytes	  maintain	  cell-­‐cell	  
contact	  with	  ECs	  in	  capillaries	  and	  early	  vessels,	  vascular	  smooth	  muscle	  cells	  layer	  arteries	  and	  
veins	  while	  remaining	  separated	  from	  the	  ECs	  monolayer	  by	  a	  the	  basement	  membrane.	  
Arteries	  are	  lined	  by	  layers	  of	  smooth	  muscle	  cells	  and	  dense	  extracellular	  matrix	  (ECM),	  which	  
support	  the	  high-­‐pressure	  gradients	  that	  drive	  blood	  flow	  to	  small-­‐diameter,	  highly	  branched	  
capillary	  vessels	  (Adams	  and	  Alitalo	  2007).	  Fewer	  smooth	  muscle	  cells	  associate	  with	  veins,	  
which	  act	  under	  low-­‐pressure	  flow	  gradients.	  Mural	  cells	  help	  to	  regulate	  vessel	  permeability,	  
elasticity,	  and	  stability	  of	  the	  vessels	  (Hellstrom,	  Kalen	  et	  al.	  1999;	  Jain	  2003).	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Vascular	  networks	  vary	  in	  structure,	  density,	  and	  molecular	  identities	  across	  niches	  of	  
the	  body	  to	  perform	  their	  organ-­‐specific	  function.	  Depending	  on	  location,	  EC	  organization	  within	  
vessels	  may	  be	  continuous,	  as	  in	  muscle,	  discontinuous,	  as	  in	  liver	  sinusoids,	  or	  fenestrated,	  as	  
in	  the	  kidney	  (Jain	  2003).	  Network	  structures	  may	  form	  a	  relatively	  2D	  plexus,	  as	  in	  the	  retina,	  or	  
a	  densely	  branched	  vascular	  tree,	  as	  in	  the	  lung.	  Vessels	  functions	  vary	  as	  well,	  for	  example,	  
allowing	  mass	  transport	  across	  their	  walls,	  as	  in	  the	  lung,	  or	  tightly	  restricting	  passage,	  as	  in	  the	  
brain	  (Dobbs,	  Gonzalez	  et	  al.	  1998;	  Rubin	  and	  Staddon	  1999).	  The	  ECs	  that	  comprise	  the	  
vasculature	  of	  different	  organs	  often	  express	  unique	  combinations	  of	  transcription	  factors,	  
angiogenic	  growth	  factors,	  adhesion	  molecules,	  and	  chemokines	  (Nolan,	  Ginsberg	  et	  al.	  2013).	  
Such	  differences	  allow	  ECs	  to	  support	  homeostasis	  and	  regeneration	  of	  organ-­‐specific	  
populations	  of	  stem	  and	  progenitor	  cells.	  For	  example,	  ECs	  in	  the	  lung	  express	  MMP14	  and	  EGF-­‐
like	  ligands	  that	  aid	  alveolar	  regeneration,	  while	  subsets	  of	  ECs	  in	  the	  liver	  express	  Wnt2	  and	  
hepatocyte	  growth	  factor	  (HGF)	  to	  promote	  liver	  regeneration	  following	  partial	  hepatectomy	  
(Bauer,	  Jackson	  et	  al.	  2010;	  Amend,	  Hennenlotter	  et	  al.	  2012).	  
	  
Angiogenesis	  in	  disease	  
Post	  development,	  vessels	  usually	  exist	  in	  a	  homeostatic	  environment,	  rarely	  undergoing	  large	  
morphogenic	  changes.	  With	  the	  exception	  of	  wound	  healing,	  angiogenesis	  in	  adulthood	  is	  often	  
the	  result	  or	  cause	  of	  a	  diseased	  state.	  An	  imbalance	  in	  angiogenic	  regulation	  often	  promotes	  
inflammatory	  and	  malignant	  pathologic	  situations,	  perhaps	  most	  notable,	  cancer	  growth	  and	  
metastasis	  whereby	  tumors	  promote	  the	  angiogenic	  morphology	  of	  existing	  vessels	  into	  new	  
tumor-­‐associated	  vessels	  (Folkman	  1995;	  Nussenbaum	  and	  Herman	  2010).	  Tumor	  angiogenesis	  
is	  mediated	  by	  the	  release	  of	  soluble	  pro-­‐angiogenic	  factors,	  including	  VEGF,	  from	  the	  tumor	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itself	  as	  well	  as	  tumor-­‐associated	  immune	  and	  stromal	  cells,	  such	  as	  tumor-­‐associated	  
monocytes	  and	  fibroblasts	  (Carmeliet	  and	  Jain	  2000).	  Tumor-­‐associated	  vasculature	  is	  poorly	  
supported	  by	  pericytes	  and	  smooth	  muscle	  cells	  and	  is	  characterized	  by	  tortuous,	  leaky	  vessels	  
of	  widely	  varying	  diameters	  that	  form	  networks	  of	  sparse	  to	  extremely	  dense	  networks	  (Nagy	  
and	  Dvorak	  2012).	  ECs	  in	  tumor	  vasculature,	  like	  organ-­‐specific	  ECs,	  also	  exhibit	  unique	  
expression	  profiles	  (Peters,	  St	  Croix	  et	  al.	  2007)	  (Jinnin,	  Medici	  et	  al.	  2008).	  
Attempts	  to	  block	  tumor	  angiogenesis	  through	  inhibition	  of	  pro-­‐angiogenic	  factor	  
signaling	  long	  dominated	  treatment	  approaches,	  with	  the	  belief	  blocking	  the	  tumor	  blood	  
supply	  would	  lead	  to	  cancer	  regression	  (Carmeliet	  and	  Jain	  2011).	  Unfortunately,	  therapies	  to	  
block	  or	  destroy	  the	  tumor	  vasculature	  have	  achieved	  only	  limited	  success	  (Saltz,	  Lenz	  et	  al.	  
2007;	  Shojaei	  and	  Ferrara	  2007;	  Bergers	  and	  Hanahan	  2008).	  Instead,	  studies	  now	  suggest	  that	  
evasion	  of	  anti-­‐VEGF	  therapy	  occurs	  through	  numerous	  mechanisms.	  These	  include	  1)	  tumor	  
upregulation	  of	  alternative	  angiogenic	  signaling	  pathways,	  2)	  recruitment	  of	  bone	  marrow-­‐
derived	  proangiogenic	  cells	  to	  further	  recruit	  new	  vessels,	  3)	  recruitment	  of	  pericytes	  to	  
improve	  function	  of	  the	  existing	  tumor	  vasculature,	  and	  4)	  a	  triggered	  switch	  toward	  an	  
aggressive	  metastatic	  tumor	  phenotype	  (Bergers	  and	  Hanahan	  2008).	  Over	  the	  past	  two	  
decades,	  the	  paradigm	  has	  begun	  to	  shift	  from	  one	  of	  complete	  inhibition	  or	  abrogation	  to	  one	  
of	  tumor	  vessel	  normalization	  through	  precisely-­‐regulated	  antivascular	  targeting	  strategies	  (Jain	  
2001).	  Recently	  it	  was	  found	  that	  inhibition	  of	  nitric	  oxide	  production	  by	  tumor	  cells	  resulted	  in	  
a	  normalized	  tumor	  vasculature	  that	  increased	  the	  efficiency	  of	  nutrient	  and	  drug	  delivery	  to	  the	  
tumor,	  improving	  the	  effectiveness	  of	  chemotherapy	  treatments	  and	  potentially	  avoiding	  
triggering	  a	  metastatic	  phenotype	  (Kashiwagi,	  Tsukada	  et	  al.	  2008).	  Tumor	  vasculature	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normalization	  may	  also	  decrease	  the	  ease	  through	  which	  tumors	  can	  enter	  the	  blood	  stream	  to	  
metastasize	  (Jain	  2001;	  Nagy	  and	  Dvorak	  2012).	  	  
	   While	  anti-­‐VEGF	  therapies	  have	  struggled	  to	  make	  significant	  impact	  in	  cancer	  
treatment,	  they’ve	  experienced	  greater	  success	  in	  the	  treatment	  of	  macular	  degeneration	  and	  
diabetic	  macular	  edema.	  Macular	  degeneration	  is	  characterized	  by	  excessive	  growth	  of	  highly	  
permeable	  blood	  vessel	  growth	  in	  the	  eye	  (Ng	  and	  Adamis	  2005).	  The	  formation	  of	  the	  aberrant	  
vascular	  network	  is	  largely	  driven	  by	  VEGF	  released	  by	  the	  retina	  and	  retinal	  pigment	  epithelium	  
(Tolentino,	  Miller	  et	  al.	  1996).	  In	  a	  clinical	  study	  of	  Pegaptanib,	  an	  FDA-­‐approved	  targeted	  anti-­‐
VEGF165	  aptamer,	  patients	  treated	  with	  the	  anti-­‐VEGF	  therapy	  for	  two	  years	  exhibited	  45%	  
improvement	  in	  visual	  acuity	  over	  traditional	  therapy	  control	  (Ng,	  Shima	  et	  al.	  2006).	  Preclinical	  
and	  clinical	  studies	  have	  confirmed	  that	  VEGF	  is	  also	  a	  key	  regulator	  of	  diabetic	  retinopathy,	  
including	  diabetic	  macular	  edema	  and	  proliferative	  diabetic	  retinopathy,	  and	  treatment	  with	  
anti-­‐VEGF	  therapy	  has	  had	  similarly	  positive	  outcomes	  to	  those	  in	  macular	  degeneration	  (Ishida,	  
Usui	  et	  al.	  2003;	  Cunningham,	  Adamis	  et	  al.	  2005).	  	  
Disregulation	  of	  angiogenesis	  is	  not	  only	  presented	  as	  excessive	  or	  dysfunctional	  vessels.	  
In	  the	  event	  of	  ischemic	  tissue,	  usually	  caused	  by	  the	  occlusion	  of	  a	  major	  vessel,	  an	  insufficient	  
or	  disregulated	  angiogenic	  response	  will	  fail	  to	  revascularize	  the	  tissue,	  leading	  to	  tissue	  death	  
or	  dysfunction	  including	  stroke,	  neurodegeneration,	  or	  myocardial	  infarctions	  (Oosthuyse,	  
Moons	  et	  al.	  2001;	  Carmeliet	  and	  Jain	  2011).	  In	  mouse	  models	  of	  neurodegeneration,	  treatment	  
with	  VEGF-­‐A	  has	  prolonged	  survival	  and	  stimulated	  motor	  neuron	  function	  through	  increased	  
circulation	  (Shibuya	  2011).	  With	  tumor	  resistance	  to	  anti-­‐VEGF	  therapies,	  and	  slow	  development	  
of	  pro-­‐angiogenic	  therapies,	  great	  therapeutic	  potential	  lies	  in	  further	  elucidation	  of	  molecular	  
regulators	  of	  angiogenesis.	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Multicellular	  organization	  and	  communication	  during	  angiogenesis	  	  
Angiogenesis	  is	  a	  highly	  coordinated,	  multicellular	  process	  by	  which	  ECs	  lining	  an	  existing	  vessel	  
are	   activated	   and	   begin	   to	   sprout	   and	   form	   new	   vessels	   within	   the	   surrounding	   tissue.	   This	  
vessel	  sprouting	  process	  is	  largely	  controlled	  by	  gradients	  of	  soluble	  factors	  released	  by	  hypoxic	  
or	  inflammatory	  tissue.	  Numerous	  factors	  have	  been	  shown	  to	  drive	  an	  angiogenic	  response	  by	  
binding	  EC	  surface	  receptors	  to	  induce	  migration,	  proliferation,	  and	  proteolytic	  activities.	  When	  
soluble	   angiogenic	   factors	   are	   present	   in	   a	   gradient,	   in	   addition	   to	   stimulation,	   they	   provide	  
directional	   guidance	   to	   the	   hypoxic	   or	   inflamed	   region.	   	   Perhaps	   the	   most	   well	   known	   and	  
characterized,	  vascular	  endothelial	  growth	  factor-­‐A	  (VEGF-­‐A)	   is	  a	  potent	  driver	  of	  angiogenesis	  
that	  binds	  receptor	  tyrosine	  kinase	  VEGF	  receptors	  (R)-­‐1	  and	  -­‐2.	  VEGF-­‐R2	  is	  associated	  with	  an	  
increased	  angiogenic	   response	   in	  ECs,	  while	   the	  VEGF-­‐R1	  receptor	  acts	  as	  a	  sink	   receptor	   that	  
effectively	   reduces	   cell	   response	   to	   soluble	   VEGF	   gradients	   (Fong,	   Rossant	   et	   al.	   1995).	   Thus,	  
differential	   expression	   of	   the	   VEGF	   receptors	   regulates	   individual	   cell	   responses	   to	   VEGF	  
stimulation.	  Interestingly,	  VEGF-­‐C	  signaling	  through	  VEGF-­‐R3	  has	  recently	  been	  linked	  to	  VEGF-­‐
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Table	  1.	  Soluble	  factors	  involved	  in	  new	  vasculature	  formation	  and	  stabilization	  
Initiation	  and	  support	  of	  early	  sprouting	  
Factor	   Function	   Refs	  
VEGF-­‐A	   Increases	  vessel	  permeability,	  stimulates	  EC	  differentiation	  
from	  precursor	  cells,	  chemotaxis,	  and	  proliferation;	  
Released	  by	  tumors,	  ECs,	  other	  pro-­‐angiogenic	  cells	  
(Ferrara,	  Gerber	  et	  al.	  




Stimulates	  mural	  cell	  detachment	  from	  vessel	  before	  
sprouting	  initiates;	  facilitates	  sprout	  formation	  in	  the	  
presence	  of	  VEGF;	  expressed	  by	  tumors;	  antagonizes	  
endothelial	  receptor	  tyrosine	  kinase	  TIE2	  	  
(Maisonpierre,	  Suri	  et	  
al.	  1997;	  Augustin,	  Koh	  
et	  al.	  2009;	  Huang,	  Bhat	  
et	  al.	  2010)	  
Hypoxia-­‐inducible	  
factors	  (HIFs)	  
Regulates	  adaptive	  responses	  of	  ECs	  to	  changes	  in	  oxygen	  
tension	  by	  controlling	  gene	  networks	  that	  govern	  survival,	  
metabolism,	  and	  angiogenesis	  
	  
(Fraisl,	  Aragones	  et	  al.	  
2009;	  Majmundar,	  
Wong	  et	  al.	  2010)	  
Hepatocyte	  growth	  
factor	  (HGF)	  
Stimulates	  EC	  proliferation	  and	  motility,	  and	  wound	  
healing	  in	  EC	  monolayers;	  promotes	  EC	  scattering	  on	  
three-­‐dimensional	  collagen	  gels;	  promotes	  
neovascularization	  of	  the	  rabbit	  cornea;	  signals	  through	  EC	  
tyrosine	  kinase	  receptor	  c-­‐MET	  receptor	  	  





Promotes	  VEGF-­‐A	  mediated	  sprouting;	  maintains	  vascular	  
integrity	  through	  regulation	  of	  adherens	  junctions;	  signals	  
through	  FGFR-­‐1	  	  	  




VEGF	  homolog	  that	  transmits	  angiogenic	  signals	  through	  
VEGFR1	  









(MMP2,	  MMP3	  and	  
MMP9)	  
Required	  for	  cell-­‐mediated	  matrix	  remodeling;	  cleaves	  
extracellular	  matrix	  proteins;	  Released	  by	  ECs	  
(Vu,	  Shipley	  et	  al.	  1998)	  
(Seo,	  Li	  et	  al.	  2003)	  
Stabilization	  of	  immature	  vasculature	  
Factor	   Function	   Refs	  
Transforming	  
growth	  factor	  β	  
(TGFβ)	  
Stimulates	  mural	  cell	  induction,	  differentiation,	  
proliferation,	  and	  migration	  and	  promotes	  production	  of	  
ECM;	  signals	  through	  multiple	  receptors,	  including	  TGF	  β	  
class	  I	  and	  II	  receptors	  





Released	  by	  ECs	  to	  stimulate	  migration	  and	  proliferation	  in	  
recruitment	  of	  mural	  cells;	  signals	  through	  PDGFR-­‐β	  




Stabilizes	  vessels,	  promotes	  pericyte	  adhesion,	  and	  makes	  
them	  leak	  resistant	  by	  tightening	  endothelial	  junctions;	  
controls	  survival	  and	  vessel	  quiescence;	  released	  by	  mural	  
cells,	  activates	  endothelial	  receptor	  tyrosine	  kinase	  TIE2	  
(Suri,	  Jones	  et	  al.	  
1996)(Maisonpierre,	  
Suri	  et	  al.	  1997)	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   A	  wide	  variety	  of	  other	  factors	  produced	  by	  hypoxic	  or	  inflammatory	  cells	  are	  also	  been	  
linked	  to	  angiogenesis	  and	  discussed	  in	  numerous	  comprehensive	  reviews	  (Carmeliet	  and	  Jain	  
2011)(Carmeliet	  and	  Jain	  2000).	  Key	  players	  in	  the	  formation	  and	  stabilization	  of	  new	  
vasculature	  are	  listed	  in	  Table	  1.	  These	  pro	  angiogenic	  factors	  include	  the	  first	  discovered	  pro-­‐
angiogenic	  factor,	  basic	  fibroblast	  growth	  factor	  (bFGF)	  shown	  to	  synergize	  with	  VEGF-­‐A	  
signaling	  through	  heparin-­‐dependent	  binding	  of	  FGF-­‐R1	  (Shing,	  Folkman	  et	  al.	  1984)	  
(Montesano,	  Vassalli	  et	  al.	  1986),	  and	  the	  mitogen	  hepatocyte	  growth	  factor	  (HGF)	  which	  
improves	  vascularization	  of	  ischemic	  tissues	  through	  promotion	  of	  migration	  and	  branching	  
(Bussolino,	  Di	  Renzo	  et	  al.	  1992)(Silvagno,	  Follenzi	  et	  al.	  1995).	  Additional	  proangiogenic	  factors	  
include	  the	  chemokine	  monocyte	  chemotactic	  protein-­‐1	  (MCP-­‐1)	  abundantly	  produced	  by	  
tumors	  (Salcedo,	  Ponce	  et	  al.	  2000),	  the	  bioactive	  lipid	  sphingosine-­‐1-­‐phosphate	  (S1P)	  that	  acts	  
through	  S1P/EDG	  receptors	  (Bayless	  and	  Davis	  2003;	  Kono,	  Mi	  et	  al.	  2004),	  and	  angiopoeitin	  
isoform,	  Ang-­‐1	  a	  legend	  for	  receptor	  tyrosine	  kinase	  TIE-­‐2,	  which	  when	  absent	  mice	  experience	  
severely	  disrupted	  angiogenesis	  resulting	  in	  lethality	  (Suri,	  Jones	  et	  al.	  1996).	  Phorbol	  12-­‐
myristate	  13-­‐acetate	  (PMA)	  is	  a	  small	  molecule	  regulator	  of	  in	  vitro	  angiogenesis	  that	  acts	  as	  an	  
analogue	  of	  diacylglycerol	  to	  activate	  protein	  kinase	  C	  signaling	  (Montesano	  and	  Orci	  1985).	  In	  
addition	  to	  the	  significant	  role	  of	  soluble	  factor	  induced	  signaling,	  recent	  studies	  suggest	  matrix-­‐
bound	  gradients,	  extracellular	  matrix	  (ECM)	  stiffness,	  endothelial	  cell	  mutations,	  shifts	  in	  shear	  
stress	  levels,	  and	  other	  factors	  can	  also	  lead	  to	  angiogenic	  endothelial	  cell	  responses(Potente,	  
Gerhardt	  et	  al.	  2011;	  Galie,	  Nguyen	  et	  al.	  2014).	  	  
It	  has	  been	  shown	  that	  in	  response	  to	  environmental	  factors,	  particular	  “tip”	  endothelial	  
cells	  (ECs)	  activate	  and	  invade	  into	  the	  matrix	  while	  maintaining	  cell-­‐cell	  contacts	  with	  trailing	  
“stalk”	  ECs	  (FIG	  1)	  (Gerhardt,	  Golding	  et	  al.	  2003).	  Tip	  cell	  stimulation	  is	  mediated	  via	  VEGF-­‐
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A/VEGFR-­‐2	  signaling.	  Rather	  than	  all	  cells	  activating	  in	  the	  presence	  of	  VEGF,	  the	  specific	  
selection	  of	  tip	  cells	  is	  mediated	  largely	  by	  Notch-­‐DLL4	  receptor-­‐ligand	  signaling.	  When	  Notch-­‐
DLL4	  signaling	  is	  inhibited,	  hyper	  sprouting	  does	  occur,	  with	  all	  cells	  appearing	  to	  gain	  a	  tip	  cell	  
phenotype.	  In	  the	  absence	  of	  outside	  manipulations,	  cells	  within	  a	  quiet	  monolayer	  often	  exhibit	  
a	  patchwork	  patterning	  of	  Notch-­‐expressing	  and	  DLL-­‐4	  expressing	  ECs.	  DLL4-­‐expressing	  ECs	  also	  
express	  high	  levels	  of	  VEGF-­‐R2,	  which	  drives	  increased	  DLL4	  expression	  upon	  VEGF-­‐A	  binding	  in	  
a	  positive	  feedback	  loop.	  Increases	  in	  DLL4	  expression	  drives	  activation	  of	  Notch	  signaling	  in	  
neighboring	  cells,	  which	  drives	  a	  decreased	  response	  to	  VEGF-­‐A	  and	  -­‐C	  through	  down	  regulation	  
of	  VEGFR2,	  VEGFR3	  and	  NRP1	  and	  an	  upregulation	  of	  VEGFR1.	  As	  such,	  DLL4-­‐Notch	  signaling	  
defines	  specific	  cells	  to	  a	  tip	  cell	  phenotype,	  and	  surrounding	  neighbor	  cells	  to	  a	  stalk	  cell	  
phenotype.	  The	  initial	  phase	  of	  tip	  cell	  selection	  and	  early	  invasion	  is	  marked	  by	  a	  remodeling	  
and	  loosening	  of	  VE-­‐cadherin	  adhesions	  between	  tip	  and	  stalk	  cells,	  matrix	  degradation,	  and	  
initial	  VEGF-­‐mediated	  actin	  protrusions	  by	  activated	  tip	  cells.	  As	  invasion	  advances,	  tip	  cells	  
remain	  characterized	  by	  high	  VEGF-­‐R2	  and	  delta-­‐like	  ligand	  4	  (DLL4)	  expression,	  tip	  cell-­‐stalk	  cell	  
adhesions	  at	  their	  posterior	  end,	  and	  actin-­‐rich	  protrusions	  at	  their	  anterior	  region	  directed	  
toward	  the	  gradient	  source.	  Genetic	  mosaic	  analyses	  demonstrated	  a	  vital	  role	  for	  NRP1	  in	  
endothelial	  tip	  rather	  than	  stalk	  cells	  during	  vessel	  sprouting,	  and	  selective	  targeting	  of	  NRP1	  in	  
ECs	  led	  to	  dysfunctional	  formation	  of	  vasculature	  in	  the	  brain	  (Fantin,	  Vieira	  et	  al.	  2013).	  In	  a	  
study	  of	  central	  nervous	  system	  vasculature	  formation	  in	  zebrafish,	  atypical	  signaling	  through	  
Wnt/β-­‐catenin	  was	  shown	  to	  selectively	  control	  tip	  cell	  function.	  Mosaic	  restoration	  of	  single	  
wild-­‐type	  tip	  cells	  in	  Wnt/β-­‐catenin-­‐deficient	  vessels	  was	  sufficient	  to	  initiate	  the	  formation	  of	  
new	  vessels(Vanhollebeke,	  Stone	  et	  al.	  2015).	  Stalk	  cells	  are	  generally	  not	  protrusive,	  exhibit	  
high	  VEGF-­‐R1	  and	  Notch	  expression,	  and	  line	  the	  lumen	  behind	  the	  invading	  tip	  cell	  (Carmeliet	  
and	  Jain	  2011).	  This	  structural	  isolation	  of	  high	  DLL4	  and	  high	  Notch	  cells	  is	  supported	  by	  JAG1,	  a	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second	  Notch	  ligand,	  which	  is	  largely	  expressed	  by	  stalk	  cells	  and	  antagonizes	  any	  DLL4	  activity	  
(Benedito,	  Roca	  et	  al.	  2009).	  	  
	  
Figure	  1.	  Endothelial	  multicellular	  invasion	  during	  angiogenesis	  
As	  sprouts	  extend	  tip	  cells	  and	  stalk	  cells	  dynamically	  shuffle	  phenotypes	  and	  positions	  
within	  the	  invading	  sprout	  (Jakobsson,	  Franco	  et	  al.	  2010).	  Increased	  DLL4	  signaling	  in	  stalk	  cells	  
is	  associated	  with	  decreased	  VE-­‐cadherin	  adhesion	  organization,	  the	  formation	  of	  protrusions,	  
and	  an	  increase	  in	  migration	  activity	  (Bentley,	  Franco	  et	  al.	  2014).	  Often,	  cells	  expressing	  high	  
levels	  of	  DLL4	  will	  overtake	  and	  replace	  the	  leading	  tip	  cell	  or	  will	  form	  a	  new	  branch	  in	  the	  
invading	  sprout	  (Bentley,	  Franco	  et	  al.	  2014).	  Eventually	  tip	  cells	  make	  contact	  with	  other	  
sprouts	  or	  existing	  vasculature	  and	  form	  a	  connection,	  establishing	  of	  flow	  through	  the	  newly	  
formed	  vessels.	  Tightening	  of	  cell	  junctions,	  deposition	  of	  a	  matrix	  membrane	  around	  the	  
vessels,	  and	  localization	  of	  other	  cell	  types	  to	  the	  vessel	  walls	  stabilize	  of	  the	  new	  network	  
(Senger	  and	  Davis	  2011).	  
	  
	  
	   11	  
Cell-­cell	  cadherin	  adhesions	  are	  vital	  to	  angiogenesis	  
ECs	  maintain	  connections	  with	  each	  other	  through	  adherens	  junctions	  (AJs)	  and	  tight	  junctions	  
(TJs)	  (Wallez	  and	  Huber	  2008).	  Such	  EC-­‐EC	  adhesions	  are	  responsible	  for	  regulating	  the	  barrier	  
between	  blood	  and	  tissue	  and	  EC-­‐EC	  communication	  (Pappenheimer,	  Renkin	  et	  al.	  1951).	  Some	  
junctional	  proteins	  such	  as	  PECAM1	  and	  CD146	  exist	  outside	  classical	  AJs	  and	  TJs.	  Tight	  adhesion	  
between	  ECs	  is	  promoted	  by	  claudins,	  junctional	  adhesion	  molecule	  (JAM)	  family,	  occludin,	  
endothelial-­‐cell-­‐selective	  adhesion	  molecule	  (ESAM)	  and	  nectins	  at	  TJs	  (Furuse,	  Hirase	  et	  al.	  
1993;	  Furuse,	  Fujita	  et	  al.	  1998;	  Wallez	  and	  Huber	  2008;	  Dejana	  and	  Orsenigo	  2013).	  Such	  
adhesions	  are	  vital	  to	  maintenance	  of	  tight	  barrier	  function,	  as	  in	  the	  blood-­‐brain	  barrier,	  that	  
inhibit	  the	  diffusion	  of	  ions,	  proteins,	  and	  other	  solutes	  across	  the	  EC	  monolayer	  (Janzer	  and	  
Raff	  1987;	  Hirase,	  Staddon	  et	  al.	  1997).	  Tight	  junctions	  are	  also	  believed	  to	  regulate	  apical	  basal	  
polarity	  by	  providing	  a	  barrier	  between	  the	  two	  membranes	  of	  each	  EC	  (Hartsock	  and	  Nelson	  
2008).	  	  
AJs,	  which	  regulate	  EC	  permeability,	  dynamic	  adhesions,	  and	  transcellular	  signaling,	  are	  
mediated	  by	  cadherins	  (Mehta	  and	  Malik	  2006).	  In	  ECs	  vascular	  endothelial	  (VE)-­‐cadherin	  is	  the	  
dominant	  cadherin	  junctional	  protein	  with	  AJs	  (Lampugnani,	  Resnati	  et	  al.	  1992).	  Classical	  
cadherins	  are	  Ca2+-­‐dependent	  transmembrane	  adhesion	  proteins	  that	  mediate	  the	  formation	  of	  
adherens	  junctions	  through	  homophilic	  binding	  of	  their	  extracellular	  domains,	  and	  are	  
exemplified	  by	  N	  (neural)-­‐,	  E	  (epithelial)-­‐	  and	  VE	  (vascular	  endothelial)-­‐	  cadherins.	  Cadherin-­‐
based	  adherens	  junctions	  are	  not	  only	  critical	  for	  the	  formation	  of	  cell-­‐cell	  contacts	  but	  are	  also	  
crucial	  for	  initiating	  and	  dynamically	  regulating	  the	  formation	  of	  other	  cell	  junctional	  complexes	  
such	  as	  tight	  and	  gap	  junctions,	  and	  desmosomes	  (absent	  in	  ECs)	  (Rutten,	  Hoover	  et	  al.	  1987;	  
Gumbiner,	  Stevenson	  et	  al.	  1988;	  Lewis,	  Jensen	  et	  al.	  1994;	  Frenzel	  and	  Johnson	  1996;	  Tunggal,	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Helfrich	  et	  al.	  2005;	  Capaldo	  and	  Macara	  2007).	  It	  has	  recently	  it	  has	  come	  to	  light	  VE-­‐cadherin	  
specifically	  controls	  TJs	  by	  regulating	  expression	  of	  claudin-­‐5	  (Taddei,	  Giampietro	  et	  al.	  2008).	  
While	  junctional	  proteins	  VE-­‐cadherin	  and	  claudin	  5	  are	  uniquely	  expressed	  by	  ECs,	  others	  such	  
as	  JAM,	  occluding,	  and	  nectins	  are	  common	  to	  other	  cells.	  Cadherins	  have	  been	  shown	  to	  be	  
linked	  intracellularly	  to	  the	  actin	  cytoskeleton	  by	  the	  dynamic,	  phosphorylation-­‐mediated	  
binding	  of	  the	  intracellular	  cadherin	  domain	  to	  the	  actin	  cytoskeleton	  via	  molecular	  complexes	  
consisting	  of	  α-­‐catenins	  (Aberle,	  Butz	  et	  al.	  1994),	  β-­‐catenins	  (Jou,	  Stewart	  et	  al.	  1995),	  p120-­‐
catenin	  (Reynolds,	  Daniel	  et	  al.	  1994),	  and	  other	  molecular	  partners	  (FIG	  2).	  	  
 
	  
Figure	   2:	   Classical-­‐cadherin-­‐mediated	   adhesions	   mechanically	   connect	   cells	   in	   tissues.	   A)	   Schematic	   depicting	  
homophilic	   cadherin	   adhesion	   between	   two	   cells	   and	   their	   cytoskeleton.	   Cadherin-­‐mediated	  mechanotransduction	  
drives	   many	   biological-­‐signaling	   events.	   B)	   Schematic	   of	   cytoskeletal	   organization	   and	   its	   coupling	   with	   cadherin-­‐
mediated	  adhesions	  in	  an	  endothelial	  monolayer	  layer	  of	  a	  blood	  vessel	  wall.	  
	  
During	  adhesion	  strengthening,	  trans-­‐	  homophilic	  cadherin	  complexes	  cluster	  together	  
to	  form	  large	  adhesions	  linked	  to	  actin	  structures.	  The	  local	  organization	  of	  actin	  and	  cadherin	  
turnover	  vary	  between	  stable	  and	  dynamic	  AJs.	  Inactive	  inhesions,	  usually	  found	  between	  non-­‐
migrating	  cells	  in	  a	  stable	  monolayer,	  are	  characterized	  by	  linear	  tightly	  localized	  junctions	  that	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undergo	  relatively	  little	  cadherin	  turnover	  (Kametani	  and	  Takeichi	  2007;	  Taguchi,	  Ishiuchi	  et	  al.	  
2011).	  These	  adhesions	  are	  often	  lined	  by	  parallel	  actin	  bundles	  thought	  to	  play	  a	  role	  in	  
junction	  stabilization.	  Alternatively,	  punctate,	  non-­‐uniform	  cadherin	  clusters	  that	  co-­‐localize	  
with	  actin	  filaments	  perpendicular	  to	  the	  adhesion	  are	  characteristic	  of	  active	  VE-­‐cadherin	  
adhesions.	  Work	  has	  suggested	  such	  active	  adhesions	  undergo	  rapid	  cadherin	  turnover,	  with	  
clusters	  of	  cadherins	  complexes	  flowing	  from	  the	  basal	  to	  apical	  surface	  of	  the	  adhesion	  as	  well	  
as	  treadmilling	  from	  cell	  front	  to	  rear	  during	  migration	  (Kametani	  and	  Takeichi	  2007;	  Peglion,	  
Llense	  et	  al.	  2014).	  
Regulation	  of	  VE-­‐cadherin	  via	  Rho	  GTPases	  	  
Small	  Rho	  GTPases	  previously	  linked	  to	  actin	  dynamics	  and	  integrin-­‐adhesion	  regulation,	  are	  
also	  regulators	  of	  cadherin	  adhesion	  permeability	  and	  stabilization	  (Braga,	  Machesky	  et	  al.	  1997;	  
Takaishi,	  Sasaki	  et	  al.	  1997;	  Kooistra,	  Dube	  et	  al.	  2007;	  Yamada	  and	  Nelson	  2007).	  Rho	  GTPases	  
are	  members	  of	  the	  larger	  Ras	  signaling	  family,	  known	  for	  regulating	  actin	  cytoskeleton,	  
microtubule	  dynamics,	  and	  cell	  polarity,	  and	  exist	  in	  one	  of	  two	  conformational	  states,	  active	  
(bound	  to	  guanosine-­‐5’-­‐triphosphate)	  or	  inactive	  (bound	  to	  guanosine-­‐5’-­‐diphosphate)(Etienne-­‐
Manneville	  and	  Hall	  2002).	  When	  active,	  Rho	  GTPases	  signal	  to	  their	  multiple	  downstream	  
effector	  proteins.	  Activity	  of	  the	  Rho	  GTPases	  is	  regulated	  by	  the	  activating	  guanine	  nucleotide	  
exchange	  factors	  (GEFs),	  which	  initiate	  nucleotide	  exchange,	  the	  inactivating	  GTPase-­‐activating	  
proteins	  (GAPs),	  which	  drive	  GTP	  hydrolysis,	  and	  guanine	  nucleotide	  exchange	  inhibitors	  (GDIs),	  
which	  remove	  inactive	  Rho	  GTPases	  from	  membranes.	  	  
Rac-­‐1,	  which	  drives	  protrusions	  at	  the	  front	  of	  cells	  through	  stimulation	  of	  actin	  
polymerization	  and	  integrin	  adhesion	  complexes,	  is	  also	  necessary	  for	  cadherin	  cluster	  
formation,	  junction	  stability	  and	  barrier	  function	  (Waschke,	  Baumgartner	  et	  al.	  2004;	  Perez-­‐
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Moreno	  and	  Fuchs	  2006).	  Surprisingly,	  other	  studies	  have	  shown	  that	  expression	  of	  
constitutively	  active	  (CA)	  Rac-­‐1	  in	  ECs	  leads	  to	  reactive-­‐oxygen-­‐species-­‐mediated	  junction	  
disruption	  through	  β-­‐catenin	  phosphorylation	  by	  tyrosine	  kinase	  Protein	  Proline-­‐rich	  tyrosine	  
kinase	  2	  (Pyk2)(van	  Wetering,	  van	  Buul	  et	  al.	  2002).	  Both	  Rac-­‐1	  and	  Cdc42,	  which	  regulates	  cell	  
polarization,	  are	  required	  for	  cadherin	  endocytosis	  and	  control	  cadherin-­‐mediated	  adhesion	  via	  
IQGAP1	  	  (Kuroda,	  Fukata	  et	  al.	  1998;	  Izumi,	  Sakisaka	  et	  al.	  2004;	  Gavard	  and	  Gutkind	  2006).	  
When	  cells	  are	  treated	  with	  the	  enzyme	  thrombin,	  AJs	  disassemble	  before	  recovery	  of	  barrier	  
function	  within	  2	  hours	  (Rabiet,	  Plantier	  et	  al.	  1996).	  Dominant	  negative	  forms	  of	  Cdc42	  
significantly	  delayed	  junction	  recovery	  following	  thrombin	  treatment	  in	  vitro,	  and	  recovery	  of	  
barrier	  function	  in	  vivo	  (Kouklis,	  Konstantoulaki	  et	  al.	  2004).	  Cdc42	  has	  since	  been	  identified	  to	  
regulate	  binding	  of	  α-­‐catenin	  to	  the	  VE-­‐cadherin	  complex	  (Broman,	  Kouklis	  et	  al.	  2006).	  Finally,	  
RhoA	  signaling,	  which	  drives	  actin	  crosslinking	  and	  actomyosin	  contraction	  through	  MLC	  
phosphorylation,	  is	  necessary	  for	  adhesion	  stabilization	  and	  formation	  of	  actin	  bundles	  at	  
cadherin	  adhesions	  (Braga,	  Machesky	  et	  al.	  1997;	  Abraham,	  Yeo	  et	  al.	  2009).	  Not	  surprisingly,	  
other	  studies	  have	  shown	  Rac	  and	  RhoA	  play	  opposing	  roles	  in	  adhesion	  regulation,	  in	  which	  
Rac-­‐1	  inhibition	  leading	  to	  RhoA	  activation	  causes	  EC	  barrier	  function	  to	  decrease	  (Seebach,	  
Madler	  et	  al.	  2005).	  	  
Numerous	  other	  signaling	  pathways	  that	  play	  a	  role	  in	  angiogenesis	  and	  activate	  GTPase	  
signaling	  regulate	  cadherin	  adhesions.	  For	  instance,	  VEGF	  signaling	  which	  modulates	  both	  RhoA	  
and	  Rac	  signaling	  has	  multiple	  effects	  on	  cadherins,	  including	  increased	  adhesion	  permeability	  
via	  Src	  kinase	  phosphorylation	  of	  VE-­‐cadherin	  and	  increased	  β-­‐arrestin-­‐mediated	  endocytosis	  of	  
VE-­‐cadherin	  (Gavard	  and	  Gutkind	  2006;	  Wallez,	  Cand	  et	  al.	  2007).	  S1P,	  which	  activates	  Rac-­‐1,	  
drives	  cadherin	  adhesion	  tightening	  (Herbert,	  Huisken	  et	  al.	  2009).	  Additionally,	  β-­‐1	  integrin,	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which	  increases	  Rac-­‐1	  signaling,	  is	  vital	  to	  the	  maintenance	  of	  barrier	  function	  in	  stable	  
monolayers	  (Miao,	  Li	  et	  al.	  2002)	  (Yamamoto,	  Ehling	  et	  al.	  2015).	  These	  findings	  importantly	  
demonstrate	  how	  closely	  regulation	  of	  the	  actin	  cytoskeleton	  is	  linked	  to	  modulation	  of	  
cadherin	  adhesions.	  
VE-­‐cadherin	  regulation	  of	  angiogenesis	  
Several	  studies	  have	  pointed	  to	  the	  absolutely	  vital	  role	  for	  VE-­‐cadherin	  in	  angiogenesis,	  where	  
migration,	  dynamic	  adhesions,	  actin	  remodeling,	  and	  finally	  tuned	  transcellular	  communication	  
occur.	  Mice	  lacking	  VE-­‐cadherin	  (VE-­‐/-­‐)	  exhibited	  severely	  impaired	  angiogenesis,	  leading	  to	  
lethality	  at	  9.5	  days	  of	  gestation	  (Carmeliet,	  Lampugnani	  et	  al.	  1999).	  In	  a	  separate	  study,	  
researchers	  found	  targeting	  different	  regions	  of	  the	  extracellular	  domain	  of	  VE-­‐cadherin	  with	  
blocking	  antibodies,	  which	  antagonize	  the	  bound	  site	  of	  the	  cadherin,	  differentially	  affected	  
static	  vessels	  and	  active	  angiogenesis.	  When	  a	  BV14	  blocking	  antibody	  was	  used,	  for	  example,	  
angiogenesis	  was	  inhibited,	  while	  vascular	  permeability	  was	  unaffected,	  highlighting	  that	  
differing	  roles	  and	  actions	  of	  VE-­‐cadherin	  exist	  within	  dynamic	  versus	  static	  settings	  (Corada,	  
Zanetta	  et	  al.	  2002).	  
VE-­‐cadherin’s	  broad	  effects	  on	  angiogenesis	  can	  be	  viewed	  through	  cadherin	  regulation	  
of	  numerous	  more	  basic	  cellular	  activities.	  During	  homeostasis	  VE-­‐cadherin	  is	  thought	  to	  signal	  
through	  multiple	  pathways	  to	  drive	  contact-­‐mediated	  growth	  inhibition.	  These	  include	  VE-­‐
cadherin	  inhibition	  of	  VEGF-­‐induced	  proliferation	  through	  increased	  phosphorylation	  and	  
internalization	  of	  VEGFR-­‐2,	  and	  dephosphorylation	  of	  a	  MAPK	  pathway	  activator	  (Pelicci,	  
Lanfrancone	  et	  al.	  1992;	  Lampugnani,	  Orsenigo	  et	  al.	  2006).	  VE-­‐cadherin	  also	  sequesters	  β-­‐
catenin	  likely	  preventing	  β-­‐catenin	  transcriptional	  activities	  leading	  to	  cell	  death,	  inhibits	  
	   16	  
proliferation	  by	  restricting	  cell	  spreading	  via	  ECM	  adhesions,	  and	  directly	  binds	  and	  activates	  a	  
Src	  inactivator	  (Nelson	  and	  Chen	  2003;	  Pierce,	  Wang	  et	  al.	  2003;	  Baumeister,	  Funke	  et	  al.	  2005).	  
Interestingly,	  while	  VE-­‐cadherin	  is	  vital	  to	  suppressing	  cell	  growth	  during	  homeostasis,	  it	  
also	  plays	  a	  role	  in	  promoting	  proliferation	  in	  settings	  of	  EC	  activity,	  e.g.	  angiogenesis.	  
Surprisingly,	  when	  micropatterning	  techniques	  were	  used	  to	  restrict	  cell	  spreading,	  Nelson	  and	  
Chen	  found	  that	  VE-­‐cadherin	  surprisingly	  drives	  proliferation	  in	  cells	  via	  RhoA-­‐mediated	  changes	  
in	  the	  cytoskeleton(Nelson	  and	  Chen	  2003).	  VE-­‐cadherin	  signaling	  is	  often	  mediated	  by	  the	  
direct	  binding	  of	  proteins	  in	  the	  phospholipid	  membrane	  vicinity.	  The	  complexing	  of	  VE-­‐cadherin	  
to	  VEGFR-­‐2	  enhances	  VEGF-­‐mediated	  activation	  of	  the	  AKT	  pathway	  through	  phosphorylation	  of	  
phosphoinositide	  3	  (PI3)-­‐kinase	  (Carmeliet,	  Lampugnani	  et	  al.	  1999).	  VE-­‐cadherin,	  VEGFR-­‐2,	  and	  
PECAM-­‐1	  also	  function	  as	  a	  mechano-­‐sensitive	  complex	  that	  allows	  cells	  to	  sense	  and	  respond	  
to	  changes	  in	  blood	  flow	  (Tzima,	  Irani-­‐Tehrani	  et	  al.	  2005).	  Both	  VE-­‐cadherin	  and	  VEGF	  augment	  
expression	  of	  apoptosis	  inhibitor	  growth	  arrest-­‐specific	  1	  (Gas1),	  and	  when	  VE-­‐cadherin	  activity	  
is	  blocked	  via	  blocking	  antibodies,	  VEGF-­‐induced	  Gas1	  expression	  is	  reduced	  (Spagnuolo,	  Corada	  
et	  al.	  2004).	  	  
Cadherin	  signaling	  modulates	  cytoskeletal	  organization	  through	  activation	  of	  Rho	  family	  
GTPases,	  Rac-­‐1,	  Cdc42,	  and	  RhoA.	  In	  epithelial	  cells,	  increased	  E-­‐cadherin	  (via	  a	  calcium	  switch)	  
led	  to	  a	  rapid	  increase	  in	  Rac-­‐1,	  followed	  by	  a	  delayed	  increase	  hours	  later	  in	  RhoA	  (Noren,	  
Niessen	  et	  al.	  2001).	  When	  VE-­‐cadherin	  was	  expressed	  in	  VE-­‐cadherin-­‐deficient	  ECs,	  Rac-­‐1	  
signaling	  was	  augmented	  via	  increased	  expression	  of	  the	  Rac-­‐specific	  GEF,	  Tiam1	  (Corada,	  
Zanetta	  et	  al.	  2002).	  This	  increased	  Rac-­‐1	  signaling	  was	  abrogated	  when	  the	  expressed	  VE-­‐
cadherin	  lacked	  p120	  or	  β-­‐catenin	  binding	  domain,	  suggesting	  VE-­‐cadherin	  complexing	  with	  the	  
actin	  cytoskeleton	  is	  likely	  required	  for	  its	  signaling.	  Expression	  of	  VE-­‐cadherin	  also	  increases	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Cdc42	  activation	  and	  the	  formation	  of	  large	  plasma-­‐membrane	  protrusion.	  While	  Cdc42	  
activation	  was	  independent	  of	  β-­‐catenin	  binding,	  when	  VE-­‐cadherins	  lacking	  the	  β-­‐catenin	  
binding	  domains	  were	  expressed,	  cells	  no	  longer	  formed	  large	  protrusions.	  VE-­‐cadherin	  in	  
complex	  with	  β-­‐catenin	  also	  drives	  cytoskeletal	  changes	  in	  cells	  via	  RhoA	  signaling	  to	  modulate	  
cytoskeletal	  tension	  and	  cell-­‐ECM	  adhesion	  (Nelson,	  Pirone	  et	  al.	  2004).	  Thus,	  VE-­‐cadherin	  can	  
drive	  numerous	  survival	  and	  mechanical	  cell	  responses	  regulating	  angiogenic	  responses.	  
Interestingly,	  it	  appears	  VE-­‐cadherin	  uses	  separate	  methods	  to	  signal	  individual	  Rho	  GTPases,	  
some	  of	  which	  are	  dependent	  on	  cadherin	  engagement,	  others	  of	  which	  are	  not,	  leading	  
differential	  cytoskeletal	  responses	  depending	  on	  cadherin	  activity.	  
Cadherin	  dynamics	  during	  angiogenesis	  
Recent	  work	  has	  explored	  the	  dynamic	  variability	  of	  VE-­‐cadherin	  during	  angiogenesis	  using	  in	  
vivo,	  in	  vitro	  and	  simulation	  modeling	  (Bentley,	  Franco	  et	  al.	  2014).	  Importantly,	  this	  study	  
reported	  variable	  types	  of	  cadherin	  adhesions	  ranging	  from	  inactive	  or	  inhibited	  to	  active	  are	  
present	  and	  regulated	  by	  Notch	  signaling	  during	  angiogenesis.	  Junction	  dynamics	  and	  strength	  
are	  intimately	  linked	  to	  interactions	  between	  cadherins	  and	  the	  actin	  cytoskeleton.	  Importantly,	  
Carmeliet	  and	  colleagues	  found	  VEδC/δC	  mice,	  which	  expressed	  a	  truncated	  form	  of	  VE-­‐cadherin	  
incapable	  of	  binding	  the	  actin	  cytoskeleton	  through	  the	  catenin	  complex,	  in	  addition	  to	  VE-­‐/-­‐	  
mice,	  experienced	  severely	  impaired	  angiogenesis	  (Carmeliet,	  Lampugnani	  et	  al.	  1999).	  This	  
important	  finding	  suggests	  it	  wasn’t	  simply	  the	  presence	  of	  the	  VE-­‐cadherin	  molecule	  that	  was	  
necessary	  in	  the	  dynamic	  setting	  of	  angiogenesis,	  but	  also	  its	  ability	  to	  complex	  with	  the	  
mechanical	  cytoskeleton	  of	  the	  cell.	  The	  understanding	  of	  such	  mechanical	  and	  molecular	  
interactions	  is	  discussed	  in	  detail	  in	  the	  following	  section,	  with	  a	  parallel	  focus	  on	  the	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engineering	  novelties	  that	  allowed	  cadherin	  mechanotransduction	  studies	  to	  advance	  from	  
single	  cell	  studies	  to	  multidimensional,	  multicellular	  investigations.	  
	  
Mechanical	  regulation	  of	  cell-­‐cell	  adhesions	  
Understanding	  the	  mechanical	  regulation	  of	  the	  multicellular	  morphogenesis	  during	  
angiogenesis	  is	  key	  to	  exploring	  new	  avenues	  to	  control	  the	  development	  of	  new	  blood	  vessels.	  
Our	  appreciation	  of	  force	  propagation	  through	  cell-­‐cell	  adhesions	  as	  a	  complex	  and	  vital	  aspect	  
of	  multicellular	  interactions	  has	  developed	  over	  the	  last	  fifteen	  years	  with	  the	  advancements	  of	  
study	  techniques.	  
It	  is	  well	  established	  that	  mechanical	  forces	  generated	  by	  contractile	  activity	  within	  the	  
actomyosin	  cytoskeleton	  of	  individual	  cells	  are	  critical	  not	  only	  for	  driving	  structural	  changes	  
inside	  those	  cells,	  but	  also	  for	  propagating	  forces	  outside	  those	  cells	  to	  control	  tissue-­‐level	  
organization(Wozniak	  and	  Chen	  2009;	  DuFort,	  Paszek	  et	  al.	  2011).	  Through	  the	  coupling	  of	  the	  
contractile	  cytoskeleton	  to	  adhesion	  molecules	  at	  the	  cell	  surface,	  cellular	  forces	  can	  transmit	  
long	  distances	  across	  multiple	  cells	  via	  cell-­‐cell	  adhesion	  receptors,	  and	  to	  extracellular	  matrix	  
(ECM)	  via	  integrins,	  to	  drive	  large-­‐scale	  physical	  movements	  during	  morphogenetic	  events	  such	  
as	  folding,	  twisting,	  and	  tissue	  compaction.	  In	  adult	  life	  such	  long-­‐range	  forces	  are	  critical	  for	  
functionality	  of	  muscles,	  blood	  vessels,	  integument,	  amongst	  others.	  With	  the	  advent	  several	  
decades	  ago	  of	  substrates	  to	  measure	  the	  traction	  forces	  cells	  apply	  against	  their	  integrin-­‐
mediated	  cell-­‐matrix	  adhesions,	  early	  efforts	  in	  mechanobiology	  primarily	  focused	  on	  defining	  
mechanical	  characteristics	  of	  integrin-­‐mediated	  binding.	  	  More	  recently,	  several	  studies	  have	  
highlighted	  the	  importance	  of	  mechanical	  coupling	  across	  cell-­‐cell	  adhesion	  receptors	  and	  the	  
actin	  cytoskeleton	  for	  successful	  tissue	  development	  and	  morphogenesis	  (Rauzi,	  Verant	  et	  al.	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2008;	  Sawyer,	  Harris	  et	  al.	  2009;	  Martin,	  Gelbart	  et	  al.	  2010;	  Rauzi,	  Lenne	  et	  al.	  2010;	  Maitre,	  
Berthoumieux	  et	  al.	  2012).	  
Of	  the	  many	  cell-­‐cell	  adhesion	  molecules	  coupled	  to	  the	  cytoskeleton,	  including	  
desmosomes,	  claudins	  and	  occludins,	  classical	  cadherins	  are	  perhaps	  the	  most	  important	  for	  
dynamically	  regulating	  the	  transmission	  of	  forces	  between	  cells.	  While	  the	  molecular	  basis	  for	  
the	  connections	  between	  the	  complex	  (including	  α-­‐catenin,	  β-­‐catenin	  and	  p120	  catenin)	  and	  the	  
actin	  cytoskeleton	  are	  still	  being	  defined	  (Yamada,	  Pokutta	  et	  al.	  2005;	  Dufour,	  Mege	  et	  al.	  
2013),	  these	  complexes	  mechanically	  couple	  cadherins	  with	  the	  cytoskeleton,	  and	  such	  coupling	  
is	  necessary	  for	  force	  transmission	  through	  these	  complexes	  and	  across	  numerous	  cells.	  	  
Interestingly,	  cytoskeletal	  contractility	  has	  been	  shown	  to	  differentially	  regulate	  adhesion	  
strengthening	  and	  disruption,	  highlighting	  the	  importance	  of	  this	  coupling	  in	  the	  dynamic	  
adhesions	  required	  for	  tissue	  morphogenesis	  (Conti,	  Even-­‐Ram	  et	  al.	  2004;	  Shewan,	  Maddugoda	  
et	  al.	  2005;	  Miyake,	  Inoue	  et	  al.	  2006;	  Maddugoda,	  Crampton	  et	  al.	  2007;	  Yamada	  and	  Nelson	  
2007;	  Krieg,	  Arboleda-­‐Estudillo	  et	  al.	  2008;	  Smutny,	  Cox	  et	  al.	  2010;	  Krishnan,	  Klumpers	  et	  al.	  
2011).	  
The	  severe	  morphogenetic	  and	  functional	  defects	  caused	  by	  disruption	  of	  cadherin-­‐
mediated	  junctions	  are	  highlighted	  by	  a	  brief	  look	  at	  in	  vivo	  studies	  of	  the	  skin	  and	  heart.	  In	  the	  
heart,	  N-­‐cadherin	  junctions	  form	  a	  part	  of	  the	  intercalated	  disc	  that	  mechanically	  links	  myocytes	  
together	  end-­‐to-­‐end	  and	  serves	  as	  an	  attachment	  site	  for	  myofibrils	  spanning	  adjacent	  cells	  
(Goncharova,	  Kam	  et	  al.	  1992;	  Geisler,	  Green	  et	  al.	  2010).	  Conditional	  knockout	  of	  the	  N-­‐
cadherin	  gene	  in	  the	  adult	  mouse	  heart	  leads	  to	  disruption	  of	  the	  intercalated	  discs	  and	  
distorted	  myofibrils;	  reduction	  in	  the	  gap	  junction	  protein	  connexin	  43;	  impaired	  mechanical	  
function;	  and	  arrhythmia-­‐induced	  sudden	  death	  (Kostetskii,	  Li	  et	  al.	  2005;	  Li,	  Levin	  et	  al.	  2008).	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Studies	  have	  conversely	  demonstrated	  the	  importance	  of	  N-­‐cadherin	  to	  cytoskeletal	  maturation	  
of	  cardiomyocytes,	  multicellular	  assembly	  and	  tissue	  structure	  in	  the	  heart	  (Radice,	  Rayburn	  et	  
al.	  1997;	  Piven,	  Kostetskii	  et	  al.	  2011).	  Cadherins	  are	  critical	  to	  the	  assembly	  and	  structure	  of	  
many	  tissues,	  including	  the	  skin,	  in	  which	  E-­‐cadherin	  regulates	  cell-­‐cell	  adhesions	  in	  the	  
epithelial	  cell	  sheets	  (Fig	  1c)	  (Hirai,	  Nose	  et	  al.	  1989;	  Fujita,	  Furukawa	  et	  al.	  1992).	  Functionally	  
blocking	  cadherins	  causes	  severe	  defects	  in	  skin	  tissue	  morphogenesis	  and	  organization	  during	  
development	  (Hirai,	  Nose	  et	  al.	  1989)	  and	  disrupts	  actin	  filament	  cables	  and	  coordinated	  cell	  
migration	  necessary	  for	  wound	  healing	  (Danjo	  and	  Gipson	  1998).	  These	  studies	  illustrate	  the	  
importance	  of	  cadherin	  adhesions	  in	  regulating	  mechanical	  and	  structural	  function	  of	  the	  heart	  
and	  skin.	  	  
Although	  the	  requirement	  of	  cadherins	  for	  tissue	  formation	  and	  maintenance	  has	  clearly	  
been	  demonstrated,	  it	  has	  until	  recently	  been	  difficult	  to	  characterize	  how	  mechanical	  forces	  
and	  their	  propagation	  through	  cell-­‐cell	  junctions	  contribute	  to	  these	  biological	  processes.	  
Recent	  progress	  in	  the	  development	  of	  methods	  to	  apply	  and	  measure	  forces	  across	  cell-­‐cell	  
junctions	  have	  highlighted	  the	  truly	  enabling	  nature	  of	  biophysical	  tools	  in	  the	  investigation	  of	  
mechanotransduction	  by	  cadherin	  complexes.	  
Given	  the	  close	  co-­‐dependency	  between	  new	  biophysical	  tools	  and	  our	  ability	  to	  further	  
understand	  mechanical	  regulation	  of	  cell-­‐cell	  junctions,	  this	  review	  is	  structured	  around	  the	  
different	  approaches	  that	  have	  been	  developed	  to	  measure	  and	  apply	  forces	  to	  junctions.	  The	  
following	  subsections	  will	  discuss	  our	  developing	  understanding	  of	  cadherin-­‐based	  junctions	  as	  
both	  force	  transmission	  and	  transduction	  structures	  in	  the	  context	  of	  the	  advancing	  engineering	  
techniques.	  The	  discussion	  will	  begin	  with	  methods	  involving	  coating	  cadherins	  onto	  surfaces	  in	  
order	  to	  drive	  single	  cells	  to	  form	  AJ-­‐like	  structures	  across	  which	  forces	  can	  be	  measured	  or	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applied,	  then	  examine	  methods	  to	  measure	  cell-­‐cell	  forces	  on	  cells	  cultured	  on	  a	  planar	  surface,	  
and	  end	  with	  methods	  with	  the	  potential	  for	  extending	  force	  measurements	  to	  3D	  in	  vitro	  
culture	  models.	  
Forces	  between	  immobilized	  cadherins	  and	  single	  cells	  
The	  large	  variety	  and	  dynamic	  nature	  of	  adhesions	  paired	  with	  their	  general	  inaccessibility	  to	  
mechanical	  characterization	  in	  vivo	  make	  it	  difficult	  to	  isolate	  the	  effects	  of	  forces	  on	  specific	  
junctions,	  and	  consequently	  methods	  to	  investigate	  the	  mechanics	  of	  specific	  cell-­‐cell	  adhesion	  
receptors	  have	  been	  slow	  to	  develop.	  An	  important	  early	  approach	  for	  isolating	  cadherin	  
binding	  involved	  immobilization	  of	  dimers	  of	  an	  N-­‐cadherin-­‐Fc	  chimera	  (extracellular	  domain	  of	  
N-­‐cadherin	  coupled	  to	  IgG	  Fc	  fragment)	  on	  rigid	  surfaces	  (FIG	  3A),	  which	  at	  the	  time	  allowed	  the	  
exploration	  of	  the	  effects	  of	  cadherin	  engagement	  in	  cells	  (Lambert,	  Padilla	  et	  al.	  2000).	  A	  
natural	  extension	  of	  immobilizing	  cadherins	  on	  a	  deformable	  substrate	  provided	  the	  first	  direct	  
evidence	  of	  significant	  forces	  transmitted	  across	  cadherins	  (Ganz,	  Lambert	  et	  al.	  2006).	  
Previously,	  researchers	  had	  developed	  culture	  substrates	  of	  microfabricated	  arrays	  of	  flexible,	  
vertical	  polydimethylsiloxane	  (PDMS)	  microneedles	  on	  which	  cells	  would	  attach	  and	  spread	  
across	  multiple	  microneedle	  tips	  (FIG	  3B)	  (Tan,	  Tien	  et	  al.	  2003).	  Forces	  across	  these	  cell-­‐
substrate	  attachments	  could	  then	  be	  measured	  by	  the	  cell-­‐mediated	  deflections	  in	  these	  spring-­‐
like	  needles.	  Although	  the	  technique	  was	  originally	  used	  to	  characterize	  forces	  at	  cell-­‐matrix	  
adhesions,	  culturing	  cells	  on	  such	  substrates	  coated	  with	  the	  N-­‐cadherin-­‐Fc	  chimera	  allowed	  one	  
to	  demonstrate	  forces	  exerted	  at	  homophilic	  cadherin	  adhesions.	  In	  this	  case,	  C2	  myogenic	  cells	  
were	  shown	  to	  spread	  and	  generate	  forces	  through	  cadherin	  binding	  comparable	  in	  magnitude	  
to	  cell-­‐ECM	  adhesions,	  suggesting	  that	  cells	  are	  able	  to	  transmit	  forces	  through	  these	  junctions	  
(Fig	  3C)	  (Ganz,	  Lambert	  et	  al.	  2006).	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Figure	  3.	  Cadherin-­‐coated	  tools	  to	  apply	  and	  measure	  force	  in	  a	  single	  cell	  in	  vitro.	  A)	  Cadherin-­‐Fc	  chimera	  (cadherin	  
extracellular	   domain	   (C-­‐ECD)	   coupled	   to	   IgG	   Fc	   fragment	   (purple))	   is	   immobilized	   on	   rigid	   surface.	   Binding	   occurs	  
between	  the	  C-­‐ECD	  of	  the	  chimera	  and	  the	  C-­‐ECD	  of	  the	  cell.	  B)	  A	  cell	  seeded	  on	  microneedles	  coated	  with	  cadherin-­‐
FC	   chimera	   applies	   traction	   forces	   through	   cadherin-­‐mediated	   adhesions	   that	   cause	  measurable	   deflections	   of	   the	  
microneedles.	  C)	  Single	  C2	  myogenic	  cells	  on	  microneedle	  substrate	  spread	  and	  exert	  mapable	  traction	  forces	  through	  
cadherin-­‐mediated	   binding.	   Arrows	   indicate	  magnitude	   and	   direction	   of	   traction	   forces	   exerted	   by	   the	   cell	   (Ganz,	  
Lambert	  et	  al.	  2006).	  D)	  Deformable	  polyacrylamide	  gels	  with	  immobilized	  cadherin-­‐Fc	  chimera	  on	  their	  surface	  allow	  
cells	   to	   bind	   and	   exert	   traction	   forces	   through	   cadherin-­‐mediated	   adhesions.	   E)	   Single	   myocyte	   cells	   plated	   on	  
cadherin-­‐coated	  substrates	  (polyacrylamide	  gels	  or	  glass)	  of	  varying	  rigidity	  exhibit	  stiffness-­‐dependent	  cell	  spreading.	  
F-­‐actin	   (red);	   α-­‐actinin	   (green).	   Scale	   bars	   =	   10	   μm	   (Chopra,	   Tabdanov	   et	   al.	   2011).	   F)	   Magnetic	   beads	   with	  
immobilized	   cadherin-­‐FC	   chimera	   bind	   to	   cell	   surface	   and	   exert	   a	   shear	   force	   through	   cadherin	   adhesions	   when	  
rotated.	  G)	  (i)	  The	  measured	  displacement	  of	  an	  E-­‐cadherin(E-­‐cad)-­‐	  or	  poly-­‐L-­‐lysine(PL)-­‐coated	  bead	  on	  the	  surface	  of	  
an	  F9	  cell	  under	  a	  0.3	  Hz	  oscillatory	  magnetic	   field	   for	  one	  minute.	   (ii)	  Stiffening	  of	  the	  cell	  as	  a	  result	  of	  cadherin-­‐
coated	  bead-­‐applied	  shear	  relative	  to	  unperturbed	  cadherin-­‐coated	  bead-­‐cell	  adhesion	  was	  modulated	  by	  treatment	  
with	   blebbistatin,	   to	   inhibit	   actin	   contractility,	   or	   Latrunculin	   B	   (LatB)	   or	   Cytochalasin	   D	   (CytoD)	   to	   disrupt	   actin	  
polymerization	  (le	  Duc,	  Shi	  et	  al.	  2010).	  
	  
Two	  additional	  studies	  addressed	  whether	  the	  forces	  that	  are	  transmitted	  through	  
cadherin	  adhesions	  could	  modulate	  cellular	  responses,	  by	  examining	  cells	  cultured	  on	  N-­‐
Cadherin-­‐coated	  polyacrylamide	  substrates	  of	  varying	  stiffnesses	  (FIG	  3D)	  (Ladoux,	  Anon	  et	  al.	  
2010;	  Chopra,	  Tabdanov	  et	  al.	  2011).	  By	  varying	  substrate	  rigidity,	  one	  could	  modulate	  the	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mechanical	  resistance	  to	  deformation	  by	  cellular	  forces	  applied	  through	  adherens	  junctions,	  
testing	  the	  ability	  of	  the	  cells	  to	  sense	  and	  respond	  to	  these	  forces.	  Measuring	  displacement	  of	  
fluorescent	  beads	  embedded	  near	  the	  surface	  of	  the	  gel	  before	  and	  after	  lysing	  of	  the	  cell	  allows	  
for	  calculation	  of	  the	  traction	  forces	  exerted	  on	  the	  substrate	  surface.	  In	  both	  studies	  the	  cells	  
(C2	  mouse	  myogenic	  cells	  and	  primary	  cardiac	  myocytes)	  responded	  to	  changes	  in	  substrate	  
rigidity	  by	  changing	  their	  morphology	  and	  cytoskeleton	  assembly.	  Both	  cell	  types	  on	  stiff	  
substrates	  displayed	  a	  highly	  spread	  morphology	  with	  the	  formation	  of	  large	  cadherin	  adhesion	  
complexes	  and	  robust	  stress	  fiber	  assembly.	  On	  soft	  substrates	  cells	  appeared	  rounded	  with	  
disorganized	  and	  poor	  actin	  stress	  fiber	  bundling	  (FIG	  3E).	  Myocytes	  have	  been	  shown	  to	  
elongate	  and	  assemble	  contractile	  units	  (sarcomeres)	  on	  ECM-­‐coated	  flexible	  substrates	  that	  
match	  in	  vivo	  cardiac	  tissue	  elasticity	  (Jacot,	  McCulloch	  et	  al.	  2008;	  Chopra,	  Lin	  et	  al.	  2012).	  A	  
similar	  change	  in	  shape	  and	  enhancement	  of	  sarcomere	  assembly	  was	  observed	  on	  cadherin-­‐
coated	  substrates	  that	  matched	  cardiac	  tissue	  elasticity	  (Chopra,	  Lin	  et	  al.	  2012),	  suggesting	  that	  
myocytes	  are	  able	  to	  sense	  and	  adapt	  their	  cytoskeleton	  to	  forces	  via	  cell-­‐cell	  or	  cell-­‐ECM	  
adhesions.	  Such	  responses	  were	  lost	  when	  cells	  were	  treated	  with	  blebbistatin,	  a	  non-­‐muscle	  
myosin	  II	  (here	  forth	  referred	  to	  as	  myosin)	  inhibitor	  (Ladoux,	  Anon	  et	  al.	  2010),	  further	  
supporting	  the	  notion	  that	  mechanical	  stresses	  were	  responsible	  for	  the	  observed	  changes.	  
These	  studies	  provided	  some	  of	  the	  first	  evidence	  that	  cadherins	  were	  not	  only	  force	  
transmitters,	  but	  were	  also	  part	  of	  an	  actomyosin-­‐machinery-­‐reliant	  mechanotransductive	  
complex	  through	  which	  cells	  respond	  to	  mechanical	  stimuli.	  
Both	  studies	  discussed	  above	  utilized	  polyacrylamide	  gel	  substrates	  for	  which	  stiffness	  
can	  be	  varied	  by	  degree	  of	  crosslinking.	  Of	  note,	  recent	  studies	  have	  raised	  important	  concerns	  
about	  whether	  polyacrylamide	  gels	  are	  in	  fact	  a	  good	  model	  for	  varying	  mechanical	  interactions	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with	  cells.	  The	  change	  in	  degree	  of	  crosslinking	  used	  to	  vary	  gel	  stiffness	  also	  modulates	  the	  
nanoscale	  pore	  structure	  of	  these	  gels	  such	  that	  less	  stiff	  gels	  also	  present	  fewer	  sites	  for	  
immobilizing	  proteins	  (Trappmann,	  Gautrot	  et	  al.	  2012).	  This	  decreased	  density	  of	  
immobilization	  sites	  appears	  to	  affect	  how	  proteins	  are	  coupled	  to	  the	  substrate,	  and	  in	  the	  case	  
of	  cell-­‐matrix	  adhesions,	  the	  authors	  found	  that	  this	  decreased	  density	  alone	  can	  cause	  changes	  
in	  cell	  spreading	  and	  adhesions	  assembly.	  In	  Ladoux	  et	  al.’s	  study,	  they	  recapitulated	  the	  
stiffness	  effects	  using	  PDMS	  microneedle	  substrates	  in	  place	  of	  polyacrylamide	  gels.	  Unlike	  in	  
gels,	  stiffness	  of	  the	  microneedle	  substrate	  is	  varied	  by	  changing	  pillar	  height,	  reducing	  the	  
flexibility	  of	  each	  individual	  needle.	  As	  such,	  ligand	  density	  has	  no	  potential	  dependence	  on	  
substrate	  stiffness.	  
Rather	  than	  relying	  on	  cell-­‐generated	  forces	  on	  substrates	  to	  study	  
mechanotransduction,	  others	  have	  taken	  a	  more	  direct	  approach	  by	  applying	  forces	  at	  junctions	  
using	  magnetic	  beads	  (Wang,	  Butler	  et	  al.	  1993).	  Of	  note,	  optical	  tweezers	  and	  atomic	  force	  
microscopy	  have	  been	  used	  to	  measure	  and	  apply	  forces	  as	  well	  but	  the	  range	  of	  forces	  is	  
significantly	  lower	  (0.1-­‐100pN	  and	  10pN-­‐10nN,	  respectively),	  making	  this	  approach	  generally	  
more	  attractive	  for	  single	  molecule	  studies	  (Baumgartner,	  Hinterdorfer	  et	  al.	  2000;	  Neuman	  and	  
Nagy	  2008).	  In	  a	  formative	  study	  Le	  Duc	  et	  al.	  covalently	  bound	  E-­‐cadherin-­‐Fc	  chimeras	  to	  the	  
surface	  of	  magnetic	  beads,	  and	  subsequently	  incubated	  these	  beads	  with	  a	  confluent	  monolayer	  
of	  embryonic	  carcinoma	  F9	  cells	  (le	  Duc,	  Shi	  et	  al.	  2010).	  Applying	  an	  oscillatory	  magnetic	  field	  
perpendicular	  to	  the	  beads’	  magnetic	  moment	  rotated	  the	  beads	  on	  the	  cell	  surface	  to	  apply	  a	  
shear	  force	  (FIG	  3F).	  By	  measuring	  the	  displacement	  of	  the	  beads	  in	  response	  to	  this	  imposed	  
force,	  they	  were	  able	  to	  measure	  the	  local	  stiffness	  of	  the	  cell	  and	  reported	  that	  cell	  
cytoskeleton	  stiffened	  in	  response	  to	  a	  cyclic	  (0.3	  Hz)	  force	  within	  a	  minute	  of	  force	  application	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through	  cadherin-­‐coated	  beads.	  This	  stiffening	  response	  was	  abrogated	  in	  cells	  treated	  with	  
blebbistatin	  to	  block	  myosin-­‐mediated	  contractility,	  Latrunculin	  B,	  or	  Cytochalasin	  D,	  to	  disrupt	  
actin	  depolymerization	  and/or	  polymerization	  (FIG	  3G).	  Cells	  also	  did	  not	  stiffen	  when	  treated	  
with	  calcium	  chelating	  reagent	  ethylene	  glycol	  tetraacetic	  acid	  (EGTA)	  to	  disrupt	  cadherin	  
binding.	  When	  cells	  were	  treated	  with	  hepatocyte	  growth	  factor	  (HGF)	  to	  increase	  cell	  
contractility,	  immunofluorescence	  staining	  revealed	  vinculin	  recruitment	  to	  actin-­‐anchored	  
cadherin	  adhesions	  (while	  localization	  of	  the	  adhesion	  complex	  proteins	  E-­‐cadherin,	  α-­‐catenin,	  
β-­‐catenin	  and	  p120-­‐catenin	  did	  not	  appear	  to	  change	  with	  increased	  contractility).	  Vinculin	  
recruitment	  was	  blocked	  when	  cells	  were	  treated	  with	  blebbistatin,	  but	  returned	  upon	  rinsing	  
away	  of	  the	  contractility	  inhibitor.	  Although	  cell-­‐cell	  adhesions	  and	  matrix	  adhesions	  exhibit	  a	  
similar	  stiffening	  and	  vinculin-­‐recruitment	  response	  to	  forces,	  some	  of	  the	  molecular	  players	  
that	  mediate	  these	  responses	  are	  likely	  different.	  For	  example,	  Le	  Duc	  et	  al.	  showed	  cadherin-­‐
induced	  stiffening	  was	  only	  partially	  inhibited	  in	  vinculin	  knockout	  cells	  and	  did	  not	  involve	  the	  
localization	  of	  paxillin	  at	  cell-­‐cell	  contacts,	  which	  is	  important	  for	  vinculin	  recruitment	  at	  
integrin-­‐mediated	  focal	  adhesions	  (Humphries,	  Wang	  et	  al.	  2007;	  Pasapera,	  Schneider	  et	  al.	  
2010).	  The	  consequences	  of	  such	  differences	  are	  not	  yet	  clear,	  but	  these	  early	  studies	  suggest	  
that	  mechanotransduction	  at	  adherens	  junctions	  may	  have	  different	  functions	  than	  at	  cell-­‐ECM	  
adhesions.	  
Such	  applied	  forces	  at	  cadherins	  not	  only	  appear	  to	  locally	  stiffen	  the	  cell,	  but	  also	  
impact	  broader	  cell	  polarization.	  Weber	  et	  al.,	  coated	  beads	  with	  C-­‐cadherin-­‐Fc	  and	  let	  these	  
beads	  bind	  to	  individual	  Xenopus	  mesendoderm	  cells	  (Weber,	  Bjerke	  et	  al.	  2012).	  Binding	  itself	  
had	  no	  effect	  on	  cell	  phenotype,	  but	  upon	  application	  of	  tensile	  force	  to	  the	  adhesions	  through	  
magnetic	  tweezers,	  cells	  polarized	  and	  migrated	  directionally,	  with	  protrusions	  extending	  away	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from	  the	  direction	  of	  bead	  pulling.	  Interestingly,	  plakoglobin,	  a	  member	  of	  the	  catenin	  family	  
that	  associates	  classical	  cadherins	  with	  the	  intermediate	  filament	  network,	  was	  required	  for	  the	  
mechanotransductive	  effects	  seen	  in	  this	  study.	  Tension	  across	  the	  cell-­‐cell	  adhesions	  resulted	  
in	  localization	  of	  plakoglobin	  to	  the	  adhesion	  site	  and	  reorganization	  of	  the	  intermediate	  
filament	  network,	  suggesting	  the	  classical	  cadherin-­‐actin	  cytoskeleton	  connection	  of	  adherens	  
junctions	  is	  just	  one	  of	  many	  junctional	  complexes	  that	  may	  play	  a	  role	  in	  force	  sensing.	  	  
In	  addition	  to	  force	  transmission	  and	  transduction	  findings	  discussed	  above,	  studies	  of	  single	  
cells	  with	  cadherin-­‐coated	  force-­‐sensing	  substrates	  may	  actually	  provide	  some	  insight	  into	  how	  
cells	  interact	  with	  each	  other.	  The	  developmental	  process	  of	  cell	  sorting	  that	  enables	  tissue	  
morphogenesis	  has	  been	  historically	  attributed	  to	  differential	  adhesion	  affinity,	  in	  which	  cells	  
expressing	  similar	  cadherins	  tend	  to	  segregate	  together	  (Friedlander,	  Mege	  et	  al.	  1989).	  
Explanations	  for	  why	  this	  segregation	  occurred	  however,	  remained	  unclear	  for	  some	  time	  as	  it	  
was	  shown	  that	  heterophilic	  cadherin	  extracellular	  domain	  binding	  can	  occur	  in	  vitro	  (Prakasam,	  
Maruthamuthu	  et	  al.	  2006)	  and	  that	  binding	  affinity	  alone	  could	  not	  always	  account	  for	  the	  
segregation.	  Using	  magnetic	  twisting	  cytometry	  to	  apply	  forces	  across	  cadherins,	  Tabdili	  et	  al.	  
examined	  binding	  affinity	  as	  well	  as	  cell	  cytoskeletal	  stiffening	  responses	  to	  homophilic	  and	  
heterophilic	  cadherin	  binding	  (Tabdili,	  Langer	  et	  al.	  2012).	  This	  study	  tested	  cadherin	  binding	  in	  
four	  different	  cell	  types	  against	  N-­‐,	  E-­‐,	  C-­‐cadherin	  coated	  beads.	  Endogenous	  N-­‐cadherin	  
expressing	  C2C12	  mouse	  myoblast	  cells	  and	  MDA-­‐MB-­‐435	  cells,	  and	  E-­‐cadherin	  expressing	  
MCF7	  human	  breast	  epithelial	  cells	  and	  Madin-­‐Darby	  canine	  kidney	  (MDCK)	  cells	  were	  tested.	  In	  
all	  cell	  types	  binding	  affinity	  appeared	  relatively	  indifferent	  to	  the	  binding	  event	  (homophilic	  or	  
heterophilic),	  whereas	  cell	  stiffening	  only	  occurred	  when	  cells	  were	  bound	  to	  beads	  through	  
homophilic	  cadherin	  binding	  (e.g.	  E-­‐cadherin	  expressing	  cells	  only	  stiffened	  in	  response	  to	  beads	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coated	  with	  E-­‐cadherin-­‐Fc).	  Thus,	  it	  is	  possible	  that	  mechanotransduction	  initiated	  by	  
homophilic	  and	  not	  heterophilic	  cadherin	  binding	  drives	  a	  necessary	  reinforcement	  for	  cells	  to	  
maintain	  and	  stabilize	  their	  adheren	  junctions,	  and	  could	  explain	  the	  sorting	  behavior	  of	  cell	  
types.	  	  
Spatial	  micropatterning	  of	  cadherin	  and	  integrin	  surfaces	  	  
While	  cells	  actively	  bind	  to	  each	  other,	  they	  are	  also	  in	  contact	  with	  the	  extracellular	  matrix.	  	  A	  
number	  of	  studies	  have	  explored	  the	  possible	  interplay	  between	  integrin	  and	  cadherin	  binding,	  
but	  only	  recently	  have	  such	  studies	  focused	  on	  how	  forces	  impact	  that	  interaction.	  To	  test	  
whether	  rigidity	  regulates	  cell	  binding	  to	  substrates	  coated	  with	  either	  cadherins	  or	  fibronectin,	  
Tsai	  et	  al.	  patterned	  islands	  of	  fibronectin	  surrounded	  by	  immobilized	  E-­‐cadherin-­‐Fc	  on	  PDMS	  
surfaces	  of	  varying	  mechanical	  properties	  (Tsai	  and	  Kam	  2009).	  While	  MDCK-­‐epithelial	  cells	  
were	  able	  to	  form	  both	  cadherin	  and	  integrin-­‐mediated	  adhesions,	  on	  stiff	  surfaces,	  integrin	  
engagement	  blocked	  cadherin	  binding	  of	  MCF-­‐7	  (adenocarcinoma	  cell	  line)	  cells.	  This	  study	  
suggests	  a	  cross-­‐talk	  between	  cadherin	  and	  integrin	  adhesions	  that	  appears	  to	  be	  mechanically	  
regulated.	  In	  another	  study	  of	  epithelial	  cells	  plated	  on	  alternating	  patterned	  lines	  of	  E-­‐cadherin-­‐
Fc	  and	  collagen	  type	  IV,	  Borghi	  et	  al.	  found	  that	  the	  presence	  of	  E-­‐cadherin-­‐Fc	  decreased,	  in	  a	  
concentration	  dependent	  manner,	  lamellipodia	  formation	  throughout	  the	  cell	  as	  well	  as	  biased	  
cell	  migration	  (Borghi,	  Lowndes	  et	  al.	  2010).	  Cells	  preferentially	  applied	  traction	  forces	  on	  the	  
ECM	  stripes,	  and	  in	  the	  presence	  of	  E-­‐cadherin	  the	  traction	  stresses	  on	  the	  ECM	  were	  
anisotropic.	  Interestingly,	  concentration	  and	  presence	  of	  cadherin	  binding	  did	  not	  affect	  
migration	  rate	  of	  the	  cells	  but	  did	  influence	  directional	  bias,	  and	  without	  ECM	  presence	  cell	  
migration	  was	  absent.	  A	  similar	  rearrangement	  of	  ECM-­‐applied	  traction	  force	  directionality	  was	  
observed	  in	  keratinocyte	  colonies	  when	  cell-­‐cell	  adhesion	  formation	  was	  initiated	  in	  the	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presence	  of	  calcium	  (Mertz,	  Che	  et	  al.	  2013).	  	  Such	  force-­‐dependent	  cross-­‐talk	  between	  cell-­‐cell	  
and	  cell-­‐ECM	  adhesion	  molecules	  seems	  to	  suggest	  both	  physical	  and	  biochemical	  regulatory	  
pathways	  play	  a	  role	  in	  coordinating	  these	  two	  systems.	  
Studies	  of	  immobilized	  cadherin-­‐Fc	  and,	  in	  some	  cases	  ECM,	  on	  surfaces	  provided	  
insight	  into	  the	  ability	  of	  these	  adhesions	  to	  transmit	  and	  transduce	  force	  under	  tightly	  
controlled	  conditions,	  but	  they	  are	  limited	  in	  capturing	  the	  active	  cell-­‐to-­‐cell	  aspects	  of	  cell-­‐cell	  
adhesions,	  such	  as	  allowing	  cadherins	  to	  move	  laterally	  on	  both	  cell	  surfaces,	  or	  the	  mechanics	  
of	  two	  cells	  pulling	  on	  each	  other.	  To	  model	  lateral	  mobility	  of	  cadherins	  using	  a	  substrate,	  Perez	  
et	  al.	  tethered	  E-­‐cadherin-­‐Fc	  molecules	  through	  glycosylphosphatidyl	  inositol	  to	  supported	  lipid	  
bilayers	  (Perez,	  Nelson	  et	  al.	  2005).	  Islands	  of	  anchored	  fibronectin	  were	  patterned	  into	  the	  
bilayer.	  While	  only	  30-­‐60%	  of	  the	  E-­‐cadherin-­‐Fc	  proteins	  were	  diffusively	  mobile,	  without	  the	  
fibronectin	  islands	  cells	  could	  not	  spread	  and	  their	  ability	  to	  cluster	  the	  cadherins	  was	  
diminished.	  This	  approach	  may	  eventually	  provide	  additional	  insights	  into	  the	  clustering	  
behavior	  of	  cadherins,	  but	  studies	  of	  the	  forces	  involved	  have	  not	  yet	  been	  reported.	  As	  such,	  
much	  of	  our	  most	  recent	  understanding	  of	  junctional	  forces	  is	  derived	  from	  measurements	  
between	  two	  attached	  cells.	  
Forces	  between	  cells	  in	  2D	  culture	  
Often	  building	  off	  insights	  from	  cadherin-­‐coated	  substrate	  studies,	  groups	  have	  recently	  
employed	  cell-­‐cell	  doublets	  to	  capture	  the	  dynamic	  complexities	  of	  cell-­‐cell	  adhesions.	  The	  dual	  
pipette	  assay	  was	  an	  early	  method	  developed	  to	  explore	  the	  strength	  of	  adhesions	  formed	  
between	  two	  cells.	  In	  such	  an	  assay,	  two	  cells	  at	  the	  end	  of	  pipette	  tips	  are	  brought	  into	  contact	  
and	  then	  the	  separation	  force,	  or	  force	  required	  to	  break	  the	  junction,	  is	  measured	  (FIG	  4A).	  
Using	  this	  assay,	  Chu	  et	  al.	  measured	  the	  force	  to	  separate	  two	  E-­‐cadherin	  transfected	  murine	  
	   29	  
sarcoma	  S180	  cells,	  which	  do	  not	  express	  any	  endogenous	  cadherins	  (Chu,	  Thomas	  et	  al.	  2004).	  
After	  cadherin	  transfection,	  cells	  adhered	  to	  each	  other	  and	  E-­‐cadherin	  and	  β-­‐catenin	  localized	  
to	  adhesion	  sites.	  When	  two	  E-­‐cadherin	  expressing	  S180	  cells	  were	  brought	  into	  contact,	  the	  
force	  required	  to	  break	  the	  cell-­‐cell	  adhesion	  increased	  rapidly	  with	  time	  over	  approximately	  30	  
minutes	  and	  then	  stabilized	  (around	  200nN	  max	  separation	  force).	  Similar	  results	  were	  obtained	  
using	  two	  N-­‐cadherin	  expressing	  S180	  cells.	  However,	  when	  one	  E-­‐cadherin	  cell	  was	  paired	  with	  
one	  N-­‐cadherin	  cell	  while	  cells	  would	  maintain	  contact	  for	  up	  to	  30	  minutes,	  the	  force	  to	  
separate	  the	  cells	  was	  undetectable,	  again	  supporting	  Tabdili	  et	  al.’s	  conclusion	  that	  only	  
homophilic	  binding	  appears	  to	  lead	  to	  adhesion	  strengthening	  and	  stabilization.	  





Figure	  4.	  Tools	  to	  study	  mechanotransduction	  in	  cell-­‐to-­‐cell	  adhesions	  in	  vitro.	  A)	  In	  the	  dual	  pipette	  assay	  two	  cells	  
held	  by	  suction	  at	  the	  end	  of	  separate	  pipettes	  are	  brought	  into	  contact.	  After	  adhesions	  have	  formed	  between	  the	  
cells	   the	  force	  required	  to	  separate	  the	  cells	   is	  measured.	  B)	  The	  force	  required	  to	  break	  the	  cell-­‐cell	  adhesion	  (SF)	  
between	  two	  S180	  cells	  expressing	  E-­‐cadherin	  increased	  over	  30	  minutes.	  Adhesions	  between	  S180	  cells	  transfected	  
with	  an	  E-­‐cadherin	  lacking	  the	  cytoplasmic	  domain	  (Ecad-­‐Δcyto)	  did	  not	  demonstrate	  such	  time-­‐dependent	  adhesion	  
strengthening	   (Chu,	   Thomas	   et	   al.	   2004).	   C)	   Cells	   on	  microneedles	   are	   constrained	   to	   patterned	   ECM	   to	   create	   a	  
repeatable,	  straight	  cell-­‐cell	  adhesion.	  Cells	  exert	  forces	  through	  cell-­‐ECM	  and	  cell-­‐cell	  adhesions.	  D)	  “Tugging”	  forces	  
across	   the	   cell-­‐cell	   adhesion	  as	  well	   as	   adhesion	   size	  were	   reduced	  when	  endothelial	   cells	  were	   treated	  with	  actin	  
contractility	  inhibitors,	  Blebbistatin	  (Blebbi)	  or	  Y27632	  (Y27)	  (Liu,	  Tan	  et	  al.	  2010).	  E)	  A	  monolayer	  of	  cells	  suspended	  
between	   two	   rods	   is	   stretched	  until	   cell-­‐cell	   adhesions	  are	  disrupted	  causing	  a	   fissure	   in	   the	  monolayer.	   The	   force	  
required	  to	  cause	  the	  monolayer	  failure	  is	  measured.	  F)	  Fluorescent	  images	  of	  a	  monolayer	  of	  MDCK	  II	  epithelial	  cells	  
pre-­‐stretch	  and	  during	  stretch.	  Top	  row:	  Cells	  expressing	  E-­‐cadherin	  GFP.	  Bottom	  row:	  Cells	  expressing	  Life-­‐act	  GFP,	  
an	  F-­‐actin	  marker	  (Harris,	  Peter	  et	  al.	  2012).	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To	  examine	  the	  role	  of	  the	  cytoplasmic	  cadherin	  complex	  in	  this	  adhesion	  strengthening	  
Chu	  et	  al.	  transfected	  cells	  with	  either	  E-­‐cadherin	  constructs	  that	  lacked	  the	  cytoplasmic	  
domain,	  and	  thus	  the	  β-­‐catenin	  binding	  domain,	  (Ecad-­‐Δcyto)	  or	  with	  chimeric	  E-­‐cadherin-­‐α-­‐
catenin	  (EαMC)	  also	  lacking	  β-­‐catenin	  binding	  site.	  It	  appears	  all	  cells	  were	  able	  to	  form	  
adhesions,	  but	  that	  adhesion	  strengthening	  occurred	  in	  the	  EαMC	  and	  E-­‐cadherin	  expressing	  cell	  
doublets,	  while	  not	  in	  the	  Ecad-­‐Δcyto	  expressing	  cells	  (FIG	  4B).	  This	  finding	  suggests	  that	  
connection	  to	  the	  actin	  cytoskeleton	  is	  required	  for	  adhesion	  strengthening,	  but	  not	  for	  initial	  
adhesion	  formation	  (characterized	  as	  having	  an	  approximate	  20nN	  separation	  force	  and	  forming	  
within	  the	  first	  30	  seconds).	  Additionally,	  it	  appears	  that	  the	  cadherin	  domain	  is	  required	  for	  β-­‐
catenin	  coexpression	  as	  no	  such	  expression	  was	  found	  in	  either	  of	  the	  cells	  expressing	  E-­‐
cadherins	  with	  cytoplasmic	  edits.	  Treatment	  of	  cells	  with	  actin-­‐dysregulation	  drugs	  Latrunculin	  B	  
or	  Jasplakinolide	  also	  blocked	  adhesion	  strengthening,	  but	  not	  initial	  adhesion	  formation,	  again	  
providing	  evidence	  for	  the	  link	  between	  the	  cell	  cytoskeleton	  and	  cadherin	  adhesion	  dynamics.	  
This	  study	  aligns	  with	  the	  important	  finding	  that	  α-­‐catenin	  undergoes	  a	  conformational	  change	  
allowing	  for	  vinculin	  binding	  and	  consequently	  adherens	  junction	  stability	  and	  force	  
transmission	  (Yonemura,	  Wada	  et	  al.	  2010).	  In	  a	  related	  dual	  pipette	  study,	  Thomas	  et	  al.	  found	  
that	  over	  expression	  of	  mutant	  forms	  of	  the	  α-­‐catenin	  vinculin-­‐binding	  domain	  or	  depletion	  of	  
vinculin	  significantly	  reduced	  adhesion	  strength	  of	  S180	  cells	  and	  that	  localization	  of	  vinculin	  
was	  dependent	  on	  the	  stretching	  of,	  or	  increasing	  the	  force	  between	  cells	  in	  the	  assay	  (Thomas,	  
Boscher	  et	  al.	  2013).	  Such	  findings	  provide	  evidence	  that	  the	  mechanotransductive	  properties	  of	  
cadherin	  adhesions	  may	  be	  modulated	  by	  the	  cytoplasmic	  complex	  through	  which	  cadherins	  are	  
linked	  to	  the	  actin	  cytoskeleton.	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As	  the	  dual	  pipette	  assay	  uses	  cell	  doublets	  that	  are	  suspended	  between	  two	  
micropipettes,	  it	  is	  difficult	  to	  study	  the	  influence	  of	  cell	  shape	  and	  cell-­‐ECM	  generated	  forces	  on	  
cadherin-­‐mediated	  mechanotransduction	  and	  the	  separation	  force	  reported	  by	  this	  assay	  does	  
not	  indicate	  what	  levels	  of	  force	  cells	  normally	  exert	  across	  these	  junctions.	  To	  overcome	  these	  
issues,	  Liu	  et	  al.	  developed	  a	  method	  for	  calculating	  the	  endogenous	  forces	  between	  two	  cells	  
plated	  on	  ECM-­‐coated	  microneedles	  (FIG	  4C)	  (Liu,	  Tan	  et	  al.	  2010).	  They	  reasoned	  that	  the	  force	  
across	  the	  cell-­‐cell	  adhesion	  in	  a	  cell	  doublet	  is	  equal	  to	  the	  vector	  sum	  of	  cell-­‐matrix	  traction	  
forces	  experienced	  in	  either	  of	  the	  two	  cells	  (which	  are	  equal	  and	  opposite),	  described	  as	  the	  
cell-­‐cell	  “tugging	  force.”	  This	  insight	  allowed	  them	  to	  examine	  the	  relationship	  between	  cell-­‐cell	  
forces	  and	  cell-­‐ECM	  forces.	  They	  found	  that	  this	  tugging	  force	  was	  approximately	  perpendicular	  
to	  the	  plane	  of	  endothelial	  cell-­‐cell	  adhesion.	  Importantly,	  they	  reported	  that	  as	  tugging	  forces	  
increased,	  the	  size	  of	  the	  cell-­‐cell	  junction	  grew,	  while	  inhibiting	  these	  forces	  led	  to	  AJ	  
disassembly.	  Using	  approaches	  to	  modulate	  myosin-­‐mediated	  contractile	  forces	  or	  by	  directly	  
pulling	  on	  junctions,	  the	  authors	  showed	  changes	  in	  junction	  size	  (FIG	  4D).	  Further,	  the	  dynamic	  
response	  to	  forces	  appeared	  to	  require	  Rac-­‐mediated	  signaling,	  with	  Rac	  being	  a	  well	  known	  
regulator	  of	  actin	  cytoskeleton	  organization	  (Nobes	  and	  Hall	  1995).	  
Employing	  a	  similar	  approach	  of	  deriving	  tugging	  forces	  from	  traction	  force	  
measurements,	  Maruthamuthu	  et	  al.	  studied	  randomly	  coupled	  epithelial	  cells	  on	  collagen-­‐
coated	  polyacrylamide	  gels	  (Maruthamuthu,	  Sabass	  et	  al.	  2011).	  By	  separately	  increasing	  
substrate	  stiffness	  and	  ligand	  density	  they	  found	  cell-­‐ECM	  forces	  increased	  and	  the	  calculated	  
cell-­‐cell	  forces	  were	  a	  constant	  fraction	  of	  cell-­‐ECM	  forces.	  This	  finding	  suggested	  a	  direct	  link	  
between	  integrin	  binding	  and	  cadherin	  binding,	  providing	  further	  support	  for	  the	  notion	  that	  
both	  adhesion	  molecules	  are	  mechanically	  connected	  via	  the	  same	  actin	  cytoskeletal	  networks.	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Interestingly,	  in	  this	  study,	  increased	  junction	  size	  was	  not	  observed	  with	  increased	  cell-­‐cell	  
forces.	  A	  number	  of	  differences	  between	  the	  two	  studies	  could	  explain	  these	  contrasting	  
responses,	  including	  a	  difference	  in	  cell	  type	  (endothelial	  versus	  epithelial),	  cadherin	  (VE-­‐
cadherin	  versus	  E-­‐cadherin),	  the	  geometry	  of	  the	  junctions	  (endothelial	  junctions	  were	  small	  
compared	  to	  the	  cell	  diameter	  whereas	  epithelial	  junctions	  already	  reached	  the	  same	  width	  of	  
the	  cells),	  and	  structure	  of	  the	  underlying	  actin	  (stress	  fibers	  in	  endothelial	  cells	  versus	  cortical	  
actin	  in	  epithelia).	  Using	  the	  same	  approach	  to	  study	  cardiac	  myocytes,	  McCain	  et	  al.	  also	  
observed	  that	  forces	  between	  myocytes	  increased	  with	  substrate	  stiffness,	  though	  at	  the	  
highest	  forces	  cell-­‐ECM	  adhesions	  began	  to	  form	  under	  the	  cell-­‐cell	  contacts	  and	  were	  
hypothesized	  to	  de-­‐stabilize	  the	  cell-­‐cell	  adhesions	  (McCain,	  Lee	  et	  al.	  2012).	  Across	  all	  of	  these	  
studies,	  the	  endogenous	  cell-­‐generated	  magnitude	  of	  forces	  and	  stresses	  across	  AJs	  are	  of	  the	  
same	  nanonewton	  order	  as	  those	  experienced	  at	  cell-­‐matrix	  adhesions.	  Thus,	  while	  these	  forces	  
are	  significantly	  lower	  than	  the	  fracture	  forces	  reported	  using	  dual	  pipettes,	  they	  suggest	  that	  
AJs	  nonetheless	  experience	  substantial	  physiological	  forces	  in	  their	  homeostatic	  settings.	  
Studies	  of	  single	  cells	  on	  patterned	  ECM	  and	  cadherin	  substrates	  provided	  important	  
first	  evidence	  of	  a	  force-­‐dependent	  cross	  talk	  between	  integrin	  and	  cadherin-­‐mediated	  
adhesions.	  However,	  these	  studies	  were	  unable	  to	  explore	  the	  dynamic	  feedback	  between	  cell-­‐
cell	  adhesions.	  Tseng	  et	  al.	  examined	  mammary	  epithelial	  cell	  doublet	  adhesions	  when	  seeded	  
on	  ECM-­‐patterned	  polyacrylamide	  gels	  to	  explore	  cell-­‐cell	  adhesions	  in	  the	  context	  of	  
anisotropic	  ECM-­‐patterned	  substrates	  (Tseng,	  Duchemin-­‐Pelletier	  et	  al.	  2012).	  They	  found	  that	  
cell-­‐cell	  adhesions	  remain	  stable	  and	  spatially	  confined	  to	  regions	  that	  are	  ECM	  deprived.	  Cell-­‐
cell	  junctions	  positioned	  close	  to	  ECM	  regions	  experienced	  large	  perpendicular	  tensional	  forces	  
that	  led	  to	  destabilization	  of	  the	  cadherin	  junctions.	  Interestingly,	  the	  relative	  localization	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pattern	  of	  the	  two	  adhesion	  types	  was	  perturbed	  when	  cells	  were	  exposed	  to	  blebbistatin.	  In	  
support	  of	  the	  single	  cell	  findings,	  this	  study	  suggests	  a	  role	  for	  the	  mechanical	  linkage	  between	  
integrin	  and	  cadherin	  binding	  that	  drives	  cell	  function,	  and	  eventual	  tissue	  morphogenesis.	  	  
Other	  studies	  have	  attempted	  to	  examine	  cell	  forces	  under	  a	  more	  complex	  
environment	  employing	  multiple	  cells.	  It	  has	  been	  shown	  that	  forces	  across	  cells	  within	  a	  
monolayer	  differ	  greatly	  from	  those	  across	  single	  pairs	  of	  cells	  (Trepat,	  Wasserman	  et	  al.	  2009).	  
In	  their	  study,	  Trepat	  et	  al.	  computed	  cell-­‐ECM	  traction	  forces	  as	  well	  as	  cell-­‐cell	  stresses	  in	  a	  
migrating	  sheet	  of	  MDCK	  (strain	  II)	  cells	  on	  polyacrylamide	  gels.	  The	  authors	  suggest	  that	  
collective	  cell	  migration	  is	  not	  driven	  purely	  by	  a	  dragging	  front	  of	  leading	  cell,	  nor	  by	  
individually	  propelled	  cells.	  Instead	  they	  find	  forces	  through	  cell-­‐ECM	  and	  cell-­‐cell	  adhesions	  
engage	  in	  a	  tug-­‐of-­‐war	  type	  relationship	  to	  create	  collective	  motion.	  In	  a	  separate	  study	  
employing	  a	  suspended	  2D	  sheet	  of	  epithelial	  cells	  (FIG	  4E),	  Harris	  et	  al.	  was	  able	  to	  examine	  the	  
effects	  of	  stretch	  on	  monolayer	  integrity,	  cell-­‐cell	  adhesions	  and	  cytoskeletal	  tension	  (FIG	  4F)	  
(Harris,	  Peter	  et	  al.	  2012).	  Surprisingly	  the	  average	  force	  needed	  to	  separate	  a	  pair	  of	  cells	  
within	  monolayers	  was	  near	  ninefold	  larger	  than	  measured	  in	  pairs	  of	  isolated	  cells.	  These	  
studies	  have	  just	  begun	  to	  reveal	  the	  potential	  differences	  in	  cell-­‐cell	  interactions	  as	  a	  result	  of	  
culture	  methods.	  Thus,	  we	  see	  the	  continued	  extension	  of	  our	  ability	  to	  study	  force	  in	  
progressively	  more	  complex	  settings	  is	  key	  to	  improved	  understanding	  of	  force	  transmission	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FRET	  studies	  for	  cadherin	  mechanics	  	  
While	  studies	  have	  provided	  valuable	  insight	  into	  the	  potential	  molecular	  regulation	  and	  
makeup	  of	  the	  cadherin-­‐actin	  complex,	  much	  is	  not	  understood	  about	  how	  this	  complex	  is	  
mechanically	  regulated.	  While	  the	  engineering	  techniques	  above	  have	  begun	  to	  shed	  light	  on	  
cadherins	  for	  mechanotransduction,	  they	  lack	  the	  ability	  to	  characterize	  the	  force	  that	  is	  actually	  
experienced	  within	  the	  cadherin	  complex	  versus	  other	  cell-­‐cell	  receptors.	  
To	  address	  this,	  investigators	  have	  begun	  to	  develop	  single	  molecule	  force	  sensors.	  
Insertion	  of	  a	  random	  coiled-­‐coil	  spring-­‐like	  sequence	  separating	  a	  Förster	  Resonance	  Energy	  
Transfer	  (FRET)	  pair	  into	  a	  molecule	  can	  reveal	  whether	  and	  when	  that	  molecule	  is	  under	  
tension.	  This	  FRET	  method	  was	  applied	  in	  integrin	  force	  studies	  (Grashoff,	  Hoffman	  et	  al.	  2010)	  
and	  later	  adapted	  for	  cadherin	  studies.	  To	  explore	  the	  cadherin	  complex	  under	  tension	  in	  
epithelial	  cell	  doublets	  in	  vitro,	  Borghi	  et	  al.	  employed	  a	  FRET	  sensor	  inserted	  into	  the	  
cytoplasmic	  domain	  of	  E-­‐cadherin	  between	  the	  transmembrane	  domain	  and	  the	  β-­‐catenin	  
binding	  domain	  (FIG	  5A)	  (Borghi,	  Sorokina	  et	  al.	  2012).	  Thus,	  when	  the	  cadherin	  was	  under	  
tension	  the	  FRET	  signal	  would	  be	  undetectable.	  Borghi,	  et	  al.	  found	  that	  E-­‐cadherin	  is	  under	  
constant	  tension	  by	  the	  actomyosin	  cytoskeleton	  both	  at	  cell-­‐cell	  junctions	  as	  well	  as	  
throughout	  the	  free	  plasma	  membrane.	  Treatment	  of	  cells	  with	  Cytochalasin	  B	  or	  ML-­‐7	  (a	  
myosin	  II	  inhibitor)	  resulted	  in	  a	  detectable	  FRET	  signal	  (FIG	  5B).	  They	  were	  also	  able	  to	  show	  α-­‐
E-­‐catenin	  (and	  the	  α-­‐catenin	  binding	  domain	  of	  the	  cadherin)	  is	  required	  for	  E-­‐cadherin	  to	  carry	  
this	  tension,	  supporting	  the	  theory	  that	  α-­‐catenin	  provides	  a	  mechanical	  link	  between	  the	  
cadherin	  and	  the	  actin	  cytoskeleton	  (direct	  or	  otherwise	  e.g.	  through	  vinculin).	  This	  study	  
provides	  powerful	  support	  for	  the	  physical	  link	  between	  the	  cadherins	  and	  the	  actin	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cytoskeleton	  and	  shows	  that	  the	  cadherin	  catenin	  complex	  is	  upstream	  of	  the	  
mechanotransduction	  process	  similar	  to	  that	  observed	  for	  integrins.	  
	  
	  
Figure	  5.	  Emerging	  force	  measurement	  FRET	  tool	  may	  allow	  mechanotransduction	  studies	  in	  3D	  in	  vitro	  cell	  culture	  
models.	  A)	  FRET	  complexes	  are	  inserted	  between	  the	  transmembrane	  domain	  and	  the	  cytoplasmic	  β-­‐catenin	  binding	  
domain	  of	   the	   cadherin	  molecule.	   The	   FRET	   signal	   is	   observable	  when	   the	  molecule	   is	   not	  under	   tension.	   Signal	   is	  
absent	  when	   the	   FRET-­‐containing	   cadherin	   is	   under	   tension.	   B)	   FRET	   index	  of	  MDCK	  epithelial	   cells	   expressing	   the	  
tension	   sensitive	   FRET-­‐cadherin	   (EcadTSMod)	   indicates	   cadherin	   molecules	   are	   under	   tension	   both	   at	   cell-­‐cell	  
junctions	   and	   in	   the	   free	   plasma	  membrane.	   This	   tension	   is	   lost	  when	   cells	   are	   treated	  with	   actin	   polymerization	  
inhibitor,	  Cytochalasin	  B	  (Borghi,	  Sorokina	  et	  al.	  2012).	  
	  
FRET	  sensors	  open	  up	  a	  window	  of	  opportunity	  for	  studying	  adhesion	  tension	  under	  a	  variety	  of	  
settings.	  Recently,	  Conway	  et	  al.	  employed	  a	  FRET	  VE-­‐cadherin	  in	  2D	  endothelial	  sheets,	  and	  
found	  that	  VE-­‐cadherin	  was	  under	  myosin-­‐dependent	  tension	  in	  static	  culture(Conway,	  
Breckenridge	  et	  al.	  2013).	  Surprisingly,	  when	  shear	  stress	  was	  applied	  to	  these	  cells,	  tension	  
across	  VE-­‐cadherin	  was	  reduced	  as	  was	  total	  cell-­‐cell	  and	  cell-­‐matrix	  adhesion	  tension.	  Their	  
measurements	  of	  tension	  on	  non-­‐engaged	  VE-­‐cadherin	  were	  approximately	  zero,	  suggesting	  
that	  perhaps	  unbound	  cadherins	  are	  disconnected	  from	  the	  actin	  cytoskeleton,	  and	  that	  only	  
their	  engagement	  leads	  to	  this	  connection.	  This	  finding	  differs	  partially	  from	  the	  FRET	  study	  by	  
Borghi	  et	  al.,	  and	  it	  raises	  questions	  as	  to	  the	  differences	  between	  endothelial	  and	  epithelial	  
cadherin	  signaling,	  2D	  sheets	  of	  cells	  versus	  cell	  pairs,	  and	  study-­‐specific	  analysis	  techniques.	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FRET	  technology	  provides	  us	  the	  potential	  to	  study	  mechanotransduction	  in	  cadherins	  in	  a	  more	  
complex	  setting	  as	  the	  technology	  is	  widely	  adoptable	  and	  adaptable	  to	  different	  settings	  (e.g.	  in	  
vitro	  single	  cells,	  monolayers	  or	  3D	  models,	  or	  in	  vivo)	  and	  molecules	  (cadherin,	  β-­‐catenin,	  α-­‐
catenin,	  etc.).	  Thus,	  advances	  in	  FRET	  application	  may	  allow	  us	  to	  understand	  piece-­‐by-­‐piece	  
how	  mechanical	  forces	  are	  transmitted	  within	  the	  cell	  and	  eventually	  converted	  to	  a	  
biochemical	  signal.	  Of	  note,	  a	  limitation	  of	  current	  FRET	  technology	  is	  the	  inability	  to	  determine	  
directionality	  of	  the	  force,	  as	  the	  optical	  signal	  only	  provides	  evidence	  of	  strain	  within	  an	  
adhesion	  complex.	  
Future	  studies:	  Advancing	  current	  technologies	  to	  three	  dimensional	  culture	  systems	  
We	  now	  know	  that	  cells	  plated	  on	  planar	  substrates	  behave	  differently	  than	  those	  cultured	  
within	  3D	  hydrogels	  (Cukierman,	  Pankov	  et	  al.	  2001;	  Baker	  and	  Chen	  2012).	  Cell	  shape	  (Beningo,	  
Dembo	  et	  al.	  2004),	  focal	  adhesion	  assembly	  (Beningo,	  Dembo	  et	  al.	  2004),	  migration	  modes	  
(Friedl	  2004),	  and	  differentiation	  (Benya	  and	  Shaffer	  1982;	  Huebsch,	  Arany	  et	  al.	  2010;	  Khetan,	  
Guvendiren	  et	  al.	  2013)	  can	  all	  be	  affected	  by	  the	  dimensionality	  of	  their	  extracellular	  
environment.	  Not	  surprisingly,	  cell-­‐cell	  interactions	  are	  also	  greatly	  altered	  depending	  on	  
environment.	  For	  example,	  epithelial	  cells	  on	  2D	  surfaces	  form	  a	  sheet-­‐like	  monolayer	  while	  
those	  cultured	  in	  3D	  arrange	  into	  polarized	  spheroids	  with	  a	  central	  lumen,	  similar	  to	  the	  acini	  
structures	  seen	  in	  vivo	  (Emerman	  and	  Pitelka	  1977;	  Weigelt	  and	  Bissell	  2008).	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Figure	   6.	   In	   vitro	   models	   and	   tools	   for	   the	   study	   cells	   in	   3D	   environments.	   A)	   In	   vitro	   3D	   cardiac	   microtissues.	  
Immunofluorescence	   stainings	   of	   cytoskeletal	   and	   ECM	   proteins	   demonstrate	   cell	   alignment	   and	   cell-­‐cell	   and	   cell-­‐
ECM	  adhesions	  (i)	  F-­‐actin	  (green),	  Fibronectin	  (Red),	  Tenascin-­‐C	  (Yellow)	  (Legant,	  Pathak	  et	  al.	  2009).	  (ii)	  Troponin-­‐T	  
(red)	   and	   nuclei	   (blue).	   Scale	   bar:	   10μm	   (Boudou,	   Legant	   et	   al.	   2012).	   (iii)	   N-­‐cadherin	   (red),	   α-­‐actinin	   (green)	   and	  
nuclei	  (blue).	  Scale	  bar:	  20μm.	  B)	  (i)	  Histochemistry	  and	  (ii)	  immunofluorescence	  staining	  of	  a	  3D	   in	  vitro	  skin	  model	  
adapted	   to	   explore	   tumor	   cells	   migration.	   β-­‐Gal	   expressing	   tumor	   cells	   line	   the	   top	   of	   an	   epithelium	   of	   human	  
epidermal	   keratinocytes,	  which	   lies	   above	  a	   collagen	  matrix	   that	   contains	  dermal	   fibroblasts.	  β-­‐catenin	   (red),	  β-­‐gal	  
(green)	   and	   nuclei	   (blue).	   C)	   (i)	   Bead	   displacement	   trajectories	   around	   a	   volume	   rendering	   of	   a	   3T3	   fibroblast	  
spreading	   in	   a	  3D	  hydrogel	   are	   color-­‐coded	  by	  magnitude.	   Scale	  bar:	   50	  μm.	   (ii)	   Contour	  plot	  of	   the	  magnitude	  of	  
traction	   forces	   exerted	   by	   the	   cell	   in	   one	   protrusion.	   Range	   of	   approximately	   0	   kPa	   (blue)	   to	   2	   kPa	   (red)	   of	   force	  
(Legant,	  Miller	  et	  al.	  2010).	  
	  
To	  create	  a	  more	  relevant	  setting	  in	  which	  to	  study	  cell-­‐cell	  interactions,	  many	  3D	  in	  
vitro	  model	  systems	  have	  been	  developed	  with	  tunable	  ECM,	  high	  structural	  control,	  and	  
accessibility	  for	  imaging.	  Microtissues	  of	  aligned	  cardiac	  cells	  suspended	  in	  ECM	  between	  
flexible	  cantilevers	  allow	  whole	  tissue	  force	  measurements	  while	  cells	  engage	  in	  cell-­‐cell	  and	  
cell-­‐ECM	  adhesions	  in	  3D	  (Fig	  6A)(Legant,	  Pathak	  et	  al.	  2009;	  Boudou,	  Legant	  et	  al.	  2012).	  Three	  
dimensional	  in	  vitro	  angiogenesis	  models	  including	  the	  bead	  sprouting	  assay	  (Nakatsu,	  Sainson	  
et	  al.	  2003),	  lumen	  formation	  assay	  (Koh,	  Stratman	  et	  al.	  2008)	  and	  more	  complex	  models	  such	  
as	  those	  recently	  developed	  by	  Zheng	  et	  al.	  and	  Nguyen	  et	  al.	  are	  currently	  limited	  in	  their	  
ability	  to	  examine	  mechanical	  regulation	  of	  vessel	  homeostasis	  and	  the	  angiogenic	  process	  
(Zheng,	  Chen	  et	  al.	  2012;	  Nguyen,	  Stapleton	  et	  al.	  2013).	  Another	  widely	  used	  3D	  model,	  the	  in	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vitro	  skin	  model,	  has	  provided	  an	  excellent	  platform	  to	  study	  homophilic	  and	  heterophilic	  cell	  
interactions	  within	  a	  multi-­‐layer,	  structured	  3D	  environment	  that	  recapitulates	  the	  native	  
setting	  (FIG	  6B)	  (Boelsma,	  Gibbs	  et	  al.	  2000;	  Alt-­‐Holland,	  Shamis	  et	  al.	  2008).	  
While	  these	  systems	  all	  provide	  a	  setting	  to	  explore	  the	  importance	  of	  cell-­‐cell	  
adhesions	  in	  a	  more-­‐native	  3D	  environment,	  they	  lack	  the	  ability	  to	  measure	  or	  apply	  force	  at	  
the	  cellular	  level.	  Such	  systems	  today	  are	  generally	  confined	  to	  immunofluorescence	  staining	  or	  
dosing	  with	  inhibitors	  to	  investigate	  cell-­‐cell	  interactions.	  It	  is	  possible	  that	  the	  combination	  of	  
3D	  in	  vitro	  models	  with	  emerging	  force	  sensing	  technologies	  could	  allow	  for	  cadherin	  
mechanotransduction	  studies	  in	  3D,	  providing	  novel	  insight	  into	  the	  relationship	  between	  
individual	  cell-­‐cell	  adhesions	  and	  larger	  scale	  tissue	  force	  transmission.	  As	  we	  discussed	  above,	  
FRET	  technology	  holds	  great	  potential	  for	  application	  in	  a	  variety	  of	  systems	  and	  cells,	  and	  could	  
potentially	  provide	  insight	  into	  cell-­‐cell	  force	  transmission	  in	  previously	  inaccessible	  3D	  in	  vitro	  
models.	  Alternatively,	  traction	  force	  microscopy,	  which	  provided	  great	  early	  insight	  into	  
directionality	  and	  magnitude	  of	  cell-­‐ECM	  and	  cell-­‐cell	  force	  transmission	  in	  2D,	  has	  recently	  
advanced	  to	  single	  cell	  studies	  in	  3D	  (FIG	  6C)	  (Legant,	  Miller	  et	  al.	  2010;	  Franck,	  Maskarinec	  et	  
al.	  2011).	  This	  approach	  involves	  the	  seeding	  of	  individual	  cells	  in	  defined	  and	  degradable	  
hydrogels	  that	  contain	  fluorescent	  beads.	  Measurement	  of	  the	  beads’	  displacement	  before	  and	  
after	  lysing	  the	  encapsulated	  cell	  allows	  for	  the	  determination	  of	  cellular	  traction	  forces	  exerted	  
on	  the	  surrounding	  matrix.	  While	  the	  method	  has	  thus	  far	  been	  established	  for	  measuring	  cell-­‐
matrix	  traction	  forces,	  deriving	  cell-­‐cell	  tugging	  forces	  is	  likely	  not	  far	  off.	  Force	  measurements	  
at	  cell-­‐cell	  adhesions	  in	  3D	  could	  provide	  new	  appreciation	  of	  the	  multicellular	  mechanics	  
behind	  tissue	  morphogenesis.	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Developmental	  models	  provided	  early	  insight	  into	  the	  role	  of	  force	  propagation	  in	  tissue	  
morphogenesis.	  More	  recently,	  in	  vitro	  cell	  culture	  paired	  with	  force	  sensing	  technologies	  have	  
shown	  that	  both	  cell-­‐ECM	  and	  cell-­‐cell	  adhesions	  can	  serve	  as	  mechanotransductive	  complexes.	  
As	  previous	  studies	  have	  clearly	  linked	  mechanical	  stimulus	  through	  ECM	  adhesions	  to	  cell	  
activities	  including	  differentiation	  (Engler,	  Sen	  et	  al.	  2006),	  proliferation	  (Paszek,	  Zahir	  et	  al.	  
2005;	  Klein,	  Yin	  et	  al.	  2009)	  and	  death	  (Chen,	  Mrksich	  et	  al.	  1997),	  it	  seems	  likely	  such	  stimulus	  
through	  adherens	  junctions	  (or	  other	  potentially	  mechanotransductive	  cell-­‐cell	  adhesion	  
complexes	  such	  as	  desmosomes	  or	  tight	  junctions)	  could	  drive	  similar	  cell	  responses.	  	  
Advancements	  and	  collaborations	  in	  force	  measurement	  technology	  will	  open	  doors	  to	  
the	  many	  remaining	  questions	  surrounding	  the	  cadherin	  complex.	  Particularly,	  of	  interest	  is	  
understanding	  how	  tension	  across	  cadherins	  is	  converted	  into	  biochemical	  signals	  and	  how	  such	  
biochemical	  signaling	  in	  turn	  leads	  to	  changes	  at	  the	  adhesion	  site	  itself.	  The	  cues	  behind	  
dynamic	  remodeling	  and	  differential	  strengthening	  and	  destabilization	  of	  cell-­‐cell	  adhesions	  as	  
required	  by	  processes	  such	  as	  cell	  sorting	  and	  tissue	  morphogenesis	  remain	  somewhat	  a	  
mystery.	  Finally,	  crosstalk	  between	  cadherins	  and	  integrins	  has	  only	  begun	  to	  be	  appreciated	  be	  
it	  through	  their	  attachment	  to	  same	  actin	  cytoskeleton	  or	  force	  driven	  biochemical	  signaling.	  It	  
is	  quite	  possible	  that	  as	  we	  advance	  toward	  force	  application	  and	  measurement	  in	  3D	  models	  
new	  insights	  into	  cadherin	  adhesion	  remodeling	  and	  cross-­‐adhesion	  signaling	  will	  arise.	  We	  look	  
forward	  to	  the	  continued	  progress	  of	  a	  field	  that	  in	  only	  the	  last	  few	  years	  has	  covered	  so	  much	  
territory	  in	  defining	  cadherins	  as	  an	  important	  player	  in	  mechanotransduction	  and	  tissue	  
function.	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Engineered	  efforts	  to	  study	  angiogenesis	  	  
Similar	  to	  tools	  for	  evaluating	  cell-­‐cell	  forces,	  angiogenesis	  assays	  have	  advanced	  from	  simple	  2D	  
platforms	  to	  complex	  3D	  dynamic	  systems.	  Such	  tools	  are	  used	  to	  understand	  the	  elements	  
driving	  the	  process,	  be	  it	  for	  promoting	  angiogenesis	  in	  cases	  of	  hypoxic,	  diseased	  tissues	  and	  
tissue	  engineering,	  or	  stabilizing	  or	  blocking	  angiogenesis	  in	  cases	  of	  cancer.	  Thus,	  many	  models	  
of	  angiogenesis	  ranging	  have	  been	  developed	  (Staton,	  Reed	  et	  al.	  2009)(Jain,	  Schlenger	  et	  al.	  
1997)	  (Bentley,	  Franco	  et	  al.	  2014).	  
In	  vivo	  angiogenesis	  models	  
In	  vivo	  models	  that	  allow	  for	  the	  visualization	  of	  the	  angiogenic	  process	  have	  provided	  great	  
insight	  into	  the	  physical	  invasion	  process	  and	  the	  overall	  consequences	  of	  probing	  angiogenic	  
factors.	  Perhaps	  the	  most	  widely	  used	  in	  vivo	  model	  of	  angiogenesis	  is	  the	  mouse	  retina	  model	  
(Dorrell	  and	  Friedlander	  2006)(Stahl,	  Connor	  et	  al.	  2010).	  Mouse	  pups,	  unlike	  humans,	  are	  born	  
with	  an	  immature	  vasculature	  in	  the	  retina	  that	  develops	  postnatally.	  Radial	  outgrowth	  of	  the	  
superficial	  vascular	  plexus	  from	  the	  optic	  nerve	  occurs	  over	  approximately	  one	  week	  postnatal	  
and	  is	  followed	  by	  vessel	  branching	  and	  formation	  of	  the	  deep	  and	  intermediate	  vascular	  
plexuses.	  The	  spatial	  and	  temporal	  patterning	  of	  retinal	  vascular	  outgrowth	  is	  highly	  conserved,	  
allowing	  for	  easy	  comparison	  across	  genetic	  manipulations	  and	  pharmacologic	  studies.	  This	  
model	  has	  also	  been	  extensively	  used	  to	  explore	  expression	  patterning	  during	  angiogenesis,	  
leading	  to	  important	  discoveries	  of	  notch-­‐DLL4	  and	  VEGF-­‐R2	  patterning	  (Benedito,	  Roca	  et	  al.	  
2009)(Gerhardt,	  Golding	  et	  al.	  2003).	  Despite	  its	  utility,	  many	  of	  the	  characteristics	  of	  retinal	  
angiogenesis	  are	  inherent	  to	  the	  retina	  only.	  For	  example,	  retinal	  angiogenesis	  is	  largely	  2D	  and	  
ECs	  co-­‐localize	  with	  a	  pre-­‐existing	  network	  of	  retinal	  astrocytes	  while	  forming	  the	  vascular	  
plexus.	  As	  an	  additional	  limitation,	  this	  model	  does	  not	  allow	  for	  real	  time	  evaluations.	  Instead,	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samples	  must	  be	  removed,	  fixed,	  and	  stained	  for	  analysis.	  Other	  commonly	  used	  in	  vivo	  models	  
such	  as	  the	  mouse	  dorsal	  window	  chamber,	  chick	  chorioallantoic	  membrane,	  and	  mouse	  corneal	  
micropocket	  assays	  provide	  alternative	  important	  validation	  platforms	  (Staton,	  Reed	  et	  al.	  
2009)(Jain,	  Schlenger	  et	  al.	  1997).	  Unfortunately,	  in	  vivo	  animal	  models	  occasionally	  fail	  to	  
reproduce	  aspects	  of	  human	  disease,	  are	  generally	  low-­‐throughput,	  and	  are	  hindered	  by	  system	  
complexity	  making	  new	  molecular	  mechanisms	  difficult	  to	  obtain	  (Knight	  and	  Shokat	  2007;	  
Yamada	  and	  Cukierman	  2007).	  	  
In	  vitro	  angiogenesis	  models	  
Consequently,	   in	   vitro	   models	   have	   been	   developed	   to	   study	   angiogenesis	   under	   highly	  
controlled	  and	  manipulatable	  conditions.	  Simple	  in	  vitro	  models	  simply	  capture	  endothelial	  cell	  
processes	  that	  play	  a	  role	   in	  angiogenesis	  such	  as	  proliferation,	  migration,	  and	  tube	  formation	  
capabilities	  (Vailhe,	  Vittet	  et	  al.	  2001).	  Other	  models	  have	   looked	  at	  network	  formations	   in	  3D	  
gels	   and	   invasion	   from	   mouse	   explants	   or	   endothelialized	   surfaces	   (Aplin,	   Fogel	   et	   al.	  
2008)(Nakatsu,	   Sainson	  et	  al.	   2003)(Koh,	   Stratman	  et	  al.	   2008).	  While	   these	  assays	  have	  been	  
key	  in	  identifying	  many	  molecular	  mechanism	  of	  sprouting,	  they	  lack	  some	  important	  aspects	  of	  
the	   in	   vivo	   environment	   such	   as	   directed	   invasion	   into	   a	   3D	   ECM,	   proper	   polarization	   of	   the	  
luminal	  and	  abluminal	  sides	  of	  ECs,	  lumen	  formation,	  and	  support	  of	  fluid	  flow	  (Donovan,	  Brown	  
et	   al.	   2001).	  As	  exposure	   to	   flow	  has	  been	   show	   to	  have	  a	  major	   role	   in	   cell	   polarization	  and	  
sprouting	  activity,	  recent	  groups	  have	  aimed	  to	  develop	  novel	  in	  vitro	  microfluidic	  angiogenesis	  
assays	  (Kang,	  Bayless	  et	  al.	  2008)(Beningo,	  Dembo	  et	  al.	  2004).	  Such	  devices	  cells	  are	  plated	  on	  a	  
matrix	  surface	  and	  a	  gradient	  of	  soluble	  factors	  or	  a	  support	  cell	  type	  (e.g.	  fibroblasts)	  promotes	  
invasion	  of	  the	  ECs	  into	  the	  matrix	  under	  flow(Chung,	  Sudo	  et	  al.	  2009)(Song	  and	  Munn	  2011).	  
In	  these	  models	  cells	  are	  constrained	  to	  small	  areas	  of	  matrix	  and	  are	  partially	   in	  contact	  with	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glass	   and	   PDMS	   (polydimethylsiloxane;	   a	   non-­‐toxic	   elastomer	   used	   in	   many	   device	   molds)	  
supports	   and	   surfaces.	   While	   these	   non-­‐in-­‐vivo	   like	   surfaces	   likely	   affect	   cells	   activity	  
(extracellular	  stiffness	  is	  known	  to	  impact	  to	  cell	  activity),	  they	  also	  constrain	  the	  cells	  sprouting	  
and	   network	   formation,	   not	   allowing	   for	   true	   gradient-­‐directed,	   multicellular	   sprouting	   and	  
network	  formation	  in	  a	  3D	  matrix	  (Even-­‐Ram	  and	  Yamada	  2005).	  
In	  silico	  angiogenesis	  models	  
In	  efforts	  to	  understand	  complex	  signaling	  pathways	  within	  angiogenesis	  numerous	  simulation-­‐
based	   models	   have	   been	   proposed.	   The	   many	   approaches	   to	   modeling	   biological	   systems	  
include	   non-­‐spatial	  models	   of	   signaling	   networks	   as	  well	   as	  more	   complex	  models	   of	   cell-­‐cell	  
rearrangements	   (using	  Potts	  model	  or	  spring-­‐based	  models)	  or	  cells	  within	  a	  3D	  space	   (Bauer,	  
Jackson	   et	   al.	   2010)(Sandersius	   and	   Newman	   2008)(Graner	   and	   Glazier	   1992).	   Models	   have	  
predicted	   the	   effects	   of	   3D	   scaffold	   mechanics,	   network	   patterning,	   and	   Notch	   signaling	  
pathways	  (Bentley,	  Mariggi	  et	  al.	  2009)(Mehdizadeh,	  Sumo	  et	  al.	  2013)(Peirce,	  Van	  Gieson	  et	  al.	  
2004).	  
Recently,	   Bentley	   et	   al.	   built	   on	   cell-­‐cell	   adhesion	   and	   signaling	   network	   models	   to	   include	  
receptor	  level	  dynamics,	  particle	  diffusion,	  and	  multicellular	  remodeling	  in	  a	  model	  of	  sprouting	  
angiogenesis(Bentley,	  Franco	  et	  al.	  2014).	  This	  hybrid	  model	   included	  a	  3D	  multicellular	  spatial	  
model	  simulating	  a	  sprout	  comprised	  of	  cells	  with	  Notch/VEGF	  signaling	  and	  filopodia	  dynamics.	  
This	   component	  was	   a	   previously	   validated	  Notch	   tip	   cell	   selection	   spring	  model	   from	   earlier	  
work	   by	   the	   same	   group	   (Bentley,	   Gerhardt	   et	   al.	   2008)(Bentley,	   Mariggi	   et	   al.	   2009).	   A	  
junctional	   remodeling	   component	   of	   the	   2014	   model,	   which	   allowed	   cell	   movement	   and	  
junctional	  dynamics,	  was	  based	  on	  a	  cellular	  Potts	  model.	  Combinations	  of	  the	  spring	  and	  Potts	  
models	  allowed	  investigation	  of	  force-­‐mediated	  junctional	  dynamics.	  Model	  simulations	  paired	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with	  in	  vitro	  and	  in	  vivo	  experiments	  revealed	  a	  regulatory	  role	  for	  Notch	  and	  cell	  contractility	  in	  
junction	  dynamics	  during	  sprouting	  angiogenesis	  and	  cell-­‐cell	  rearrangements.	  	  
	  
Engineering	  a	  novel	  3D	  angiogenesis	  model	  for	  studies	  of	  collective	  
migration	  
We	  aimed	   to	  engineer	  a	   truly	   three-­‐dimensional	  model	  of	  angiogenesis	   that	   captured	   the	  key	  
environmental	   aspects	   of	   completely	   unconstrained	   gradient-­‐driven	   sprouting	   and	   vessel	  
network	   formation	   from	   a	   flow-­‐carrying	   vessel.	   The	   establishment	   of	   a	   biomimetic	   model	   of	  
angiogenesis	  allowed	  for	  the	  isolation	  of	  single	  molecules’	  effect	  on	  the	  endothelium,	  while	  also	  
providing	  a	  close	  approximation	  of	  the	  in	  vivo	  environment.	  Using	  this	  model,	  we	  were	  able	  to	  
systematically	  quantify	  morphological	   features	  of	  angiogenesis	   to	   further	  define	   the	   sprouting	  
process,	  as	  well	  as	  the	  specific	  effects	  of	  inhibitors.	  
Following	  engineering	  and	  characterization	  of	  the	  platform,	  we	  applied	  the	  biomimetic	  
model	   to	   study	   the	   mechanical	   regulation	   of	   gradient-­‐driven	   angiogenic	   sprouting.	   We	  
quantitatively	   characterized	   cadherin-­‐based	   adhesions	   in	   normal	   sprouting	   as	   well	   as	   in	  
contractility-­‐deficient	  sprouting.	  Using	  our	  model	  we	  were	  able	  to	  develop	  novel	  conclusions	  as	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CHAPTER	  2:	  A	  biomimetic	  model	  to	  reconstitute	  angiogenic	  
sprouting	  morphogenesis	  in	  vitro	  
Introduction	  
Examining	   the	   physical	   process	   of	   angiogenesis	   requires	   experimental	   systems	   in	   which	   the	  
formation	  of	  new	  capillary	  vessels	  can	  be	  easily	  observed	  and	  manipulated.	  Discussed	  above,	  in	  
vivo	   and	   in	   vitro	   systems	   are	   limited	   by	   their	   complexity	   or	   simplicity,	   respectively.	   The	  
advancement	  of	   in	  vitro	  models	   to	  organotypic	  models	   that	  have	   faithfully	  captured	  biological	  
structure	   and	   the	   biophysical	   environment	   has	   proven	   to	   be	   transformative	   for	   a	   field,	   as	  
exemplified	  by	  studies	  of	  engineered	  skin	  or	  mammary	  epithelial	  morphogenesis	  (Meier,	  Nesbit	  
et	  al.	  2000;	  Schmeichel	  and	  Bissell	  2003;	  Debnath	  and	  Brugge	  2005).	  	  Here,	  we	  demonstrate	  the	  
use	  of	   endothelium-­‐lined	   channels	   as	   a	  platform	   to	   recapitulate	   angiogenic	   sprouting	   in	   vitro.	  
The	  system	  allowed	  us	  to	  screen	  combinations	  of	  angiogenic	  factors	  and	  identify	  cocktails	  that	  
induced	  highly	  organized,	  directed	  multicellular	  sprouting	  into	  a	  surrounding	  ECM	  that	  appears	  
to	  mimic	  key	  morphological	  aspects	  of	   in	  vivo	  angiogenesis	  not	  yet	  described	  by	  other	   in	  vitro	  
models.	  Furthermore,	  we	  demonstrate	  the	  utility	  of	  this	  model	  by	  illustrating	  how	  pro-­‐	  and	  anti-­‐
angiogenic	  agents	  impact	  the	  complex	  multicellular	  process	  of	  angiogenesis.	  
Results	  
A	  microengineered	  platform	  that	  supports	  angiogenic	  sprouting	  and	  neovessel	  
formation	  in	  vitro	  
To	   study	   the	   process	   of	   angiogenic	   invasion	   and	   sprouting	   from	   an	   existing	   vessel,	   we	  
engineered	  a	  device	   in	  which	  an	  endothelium	  lining	  a	  cylindrical	  channel	  was	  fully	  surrounded	  
by	  matrix	   and	   exposed	   to	   a	   gradient	   of	   angiogenic	   factors	   emanating	   from	   a	   parallel	   source	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channel	   (FIG	   8A).	   Microfabrication	   was	   used	   to	   create	   bi-­‐layer	   PDMS	  molds.	   The	   device	   was	  
assembled	  by	  casting	  Type	   I	   collagen	   into	  a	  PDMS	  mold/gasket	  with	   two	  parallel	  needles	  held	  
across	  the	  casting	  chamber.	  Upon	  collagen	  polymerization,	  the	  needles	  were	  extracted	  to	  create	  
hollow	   cylindrical	   channels	   in	   the	   collagen	   matrix	   (FIG	   7).	   Endothelial	   cells	   (ECs)	   were	   then	  
injected	   into	   one	   of	   the	   channels,	   allowing	   them	   to	   attach	   on	   the	   interior	   wall	   and	   form	   a	  
confluent	  endothelium	  or	  “parent	  vessel”	  (FIG	  8B).	  	  
	  
	  
Figure	  7:	  Schematic	  of	   the	  device	  manufacturing	  process.	  Top	   row:	  A	  silicon	   template	   (blue	  and	  white)	  containing	  
four	  rectangular	  features	  for	  the	  top	  layer	  of	  the	  device	  was	  made	  using	  UV	  lithography.	  Uncured	  PDMS	  (beige)	  was	  
cast	  onto	  silicon	   template.	  After	  curing	  at	  80	  °C,	  PDMS	  top	   layer	   (beige)	  was	  cast	  off	   the	   template.	  Middle	  Row:	  A	  
silicon	  template	  containing	  four	  linked	  rectangular	  features	  was	  used	  to	  make	  a	  bottom	  positive	  PDMS	  mold	  (grey).	  
Uncured	  PDMS	  (green)	  was	  cast	  onto	  positive	  PDMS	  mold	  and	  a	  glass	  slide	  was	  applied	  to	  trap	  the	  PDMS	  between	  the	  
mold	  and	  glass.	  System	  was	  inverted.	  After	  curing	  at	  110	  °C,	  PDMS	  bottom	  layer	  (green)	  was	  cast	  off	  the	  PDMS	  mold	  
and	  adhered	  to	  a	  glass	  coverslip.	  Following	  oxygen	  plasma	  treatment,	  top	  and	  bottom	  PDMS	  layers	  were	  aligned	  and	  
sealed	  and	  placed	  in	  a	  110	  °C	  oven	  overnight.	  Bottom	  Row:	  Two	  needles	  were	  inserted	  in	  parallel	  into	  the	  device	  and	  
collagen	   was	   subsequently	   polymerized	   around	   the	   needles.	   Needles	   were	   extracted	   leaving	   two	   cylindrical	   voids	  
running	   through	   the	   central	   reservoir.	   A	   suspension	   of	   cells	   was	   seeded	   into	   one	   channel,	   creating	   a	   monolayer	  
around	  the	  void.	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Manufacturing	   complete,	  our	  device	  was	  approximately	  1”x1”	   and	   supported	  ECs	   in	   a	  
monolayer	  around	  a	  cylindrical	  void	  of	  400	  μm	  diameter.	  Total	  manufacture	   time	  prior	   to	  cell	  
seeding	   is	   two	  days	   and	  devices	   can	  be	  manufactured	   at	   a	   rate	   of	   approximately	   30	  per	   day.	  
Following	  seeding	  of	  the	  cells	  into	  the	  device,	  devices	  were	  maintained	  on	  the	  rocker.	  
	  
Flow	  was	  maintained	  through	  both	  channels	   for	   the	  duration	  of	   the	  experiments.	  Two	  
days	   after	   ECs	   were	   seeded	   into	   the	   channel,	   media	   containing	   angiogenic	   factors	   was	  
subsequently	  added	  to	  the	  second	  channel	  to	  establish	  a	  gradient	  across	  the	  collagen	  matrix	  to	  
the	   endothelium	   (FIG	   9).	   Thus,	   the	   device	   design	   provided	   a	  means	   to	   promote	   and	   visualize	  
endothelial	  sprouting	  that	  might	  emulate	  early	  angiogenic	  processes.	  
Figure	   8.	   The	   3D	   angiogenesis	   device	   (A)	   Device	  
schematic.	  Parallel	  cylindrical	  channels	  are	  encased	  in	  3D	  
collagen	   matrix	   within	   a	   microfabricated	   PDMS	   gasket	  
and	  connected	  to	  fluid	  reservoirs.	  One	  channel	  is	  coated	  
with	   ECs	   and	   perfused	   with	   medium	   while	   the	   other	  
channel	   is	   perfused	   with	   medium	   enriched	   with	  
angiogenic	   factors.	   (B)	  Photograph	  of	   the	  device.	   	   Zoom	  
shows	  phase	  (top)	  and	  fluorescent	  (bottom)	  micrographs	  
of	   an	   endothelialized	   channel.	   F-­‐actin	   and	   nuclei	   are	  
labeled	   with	   phalloidin	   (green)	   and	   DAPI	   (blue),	  
respectively.	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Using	   this	   device,	  we	   first	   examined	  how	  various	  pro-­‐angiogenic	   factors	  might	   impact	  
directed	   invasion	   and	   sprouting	   from	   the	   parent	   vessel.	   Six	   common	   factors	   associated	   with	  
angiogenesis	  in	  the	  literature	  were	  selected:	  basic	  fibroblast	  growth	  factor	  (bFGF)	  (Montesano,	  
Vassalli	   et	   al.	   1986),	   hepatocyte	   growth	   factor	   (HGF)	   (Silvagno,	   Follenzi	   et	   al.	   1995),	   vascular	  
endothelial	   growth	   factor	   (VEGF)(Fong,	   Rossant	   et	   al.	   1995;	   Carmeliet,	   Ferreira	   et	   al.	   1996),	  
monocyte	  chemotactic	  protein-­‐1	  (MCP-­‐1)	  (Salcedo,	  Ponce	  et	  al.	  2000),	  sphingosine-­‐1-­‐phosphate	  
(S1P)	  (Bayless	  and	  Davis	  2003;	  Kono,	  Mi	  et	  al.	  2004),	  and	  phorbol	  12-­‐myristate	  13-­‐acetate	  (PMA)	  
(Montesano	   and	   Orci	   1985).	   After	   these	   factors	   were	   added	   individually	   to	   the	   non-­‐
endothelialized	   source	   channel,	   phase-­‐contrast	   and	   confocal	  microscopy	  were	   used	   to	   assess	  
the	  organization	  and	  development	  of	  EC	  invasion	  over	  four	  days	  (FIG	  10).	  	  
Figure	   9.	   Characterization	   of	  
gradient	   between	   parent	   vessel	  
and	   source	   channel.	   Relative	  
intensity	   profiles	   at	   2,	   5,	   and	   60	  
min	   after	   addition	   of	   20kDa	  
fluorescently-­‐tagged	   dextran.	  
Diffusion	   coefficient	   was	  
estimated	   from	   the	   data	   to	   be	  
1.80x10-­‐6	   cm2/s.	   	   A	   pure	   diffusion	  
model	  with	  this	  value	  for	  diffusion	  
coefficient	   matched	   the	  
experimental	  data.	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Figure	  10.	  Representative	  phase	  images	  of	  each	  condition	  after	  4	  days	  of	  exposure	  to	  indicated	  factor(s).	  Scale	  bars	  
are	  200	  µm.	  Abbreviations:	  F=bFGF,	  H=HGF,	  M=MCP-­‐1,	  P=PMA,	  S=S1P,	  V=VEGF.	  
	  
We	   found	   that	   simple	   metrics	   of	   sprout	   length	   and	   number	   of	   detached	   cells	   in	   the	  
matrix	  were	   easily	   evaluated	   using	   10X	   phase	   contrast	   images	   of	   live	   of	   fixed	   samples.	   These	  
metrics	  are	   illustrated	   in	  Figure	  11.	  These	  were	  reasonable	  metrics	  to	  allow	  a	  high	  throughput	  
evaluation	   of	   the	   ability	   of	   growth	   factors	   to	   induce	   angiogenesis-­‐like	   behavior	   from	   our	  
monolayer.	  	  
	  
Figure	  11.	  Quantification	  of	  angiogenic	  response	  to	  growth	  factors.	  Leading	  cells	  are	  categorized	  as	  sprout	  tip	  cells	  
(black	  arrowheads)	  when	  in	  contact	  with	  stalk	  cells	  that	  are	  connected	  to	  the	  parent	  vessel	  (dashed	  white	  line),	  or	  as	  
isolated,	  single	  cells	  (white	  arrowheads).	  Sprout	  length	  was	  measured	  as	  the	  distance	  between	  leading	  protrusions	  of	  
sprout	  tip	  cells	  and	  the	  nearest	  point	  along	  the	  parent	  vessel.	  Scale	  bars	  are	  100	  µm.	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We	  found	  that	  VEGF,	  MCP-­‐1,	  HGF	  or	  bFGF	  alone	  did	  not	  induce	  significant	  invasion	  into	  
the	  matrix,	  while	  S1P	  and	  PMA	  resulted	  in	  substantial	  directed	  invasion	  (FIG	  12A).	  This	  invasion	  
was	  oriented	  directly	   toward	  the	  source	  channel,	  despite	   the	   fact	   that	  cell	  migration	   from	  the	  
endothelium	  was	  not	  artificially	  constrained	  in	  any	  direction	  by	  our	  system	  design	  (FIG	  12Bi,	  ii,	  
iii).	  	  
	  
Figure	  12	  Angiogenic	  response	  of	  ECs	  to	  angiogenic	  factors	  in	  the	  device.	  A)	  Plot	  of	  sprout	  length	  and	  the	  number	  of	  
sprout	  tip	  cells	  and	  single	  cells	  after	  4	  days	  of	  exposure	  to	  indicated	  factor(s).	  N	  =	  2	  samples	  per	  condition.	  B)	  
Representative	  confocal	  immunofluorescence	  images	  of	  sprouting	  and	  migrating	  ECs	  in	  response	  to	  gradients	  of	  
different	  pro-­‐angiogenic	  factors:	  S	  (i),	  P	  (ii),	  HFMVS	  cocktail	  (iv),	  and	  MVPS	  cocktail	  (v).	  Panel	  iii	  shows	  a	  phase	  image	  
of	  directed	  sprouting	  induced	  by	  HFMVS.	  F-­‐actin	  and	  nuclei	  are	  labeled	  green	  and	  blue,	  respectively.	  Scale	  bars	  of	  2x	  
zoom-­‐in	  insets	  in	  (C)	  are	  50	  µm.	  	  All	  other	  scale	  bars	  are	  200	  µm.	  Abbreviations:	  F=bFGF,	  H=HGF,	  M=MCP-­‐1,	  P=PMA,	  
S=S1P,	  V=VEGF.	  
	  
Interestingly,	  S1P	  and	  PMA	  stimulated	  markedly	  different	  modes	  of	  cell	  migration.	  S1P	  
drove	  chemotactic	  migration	  primarily	  of	  single	  cells	  from	  the	  endothelialized	  channel,	  whereas	  
PMA	  triggered	  collective	  cell	  migration	  that	  manifested	  itself	  in	  the	  form	  of	  sparse,	  long,	  multi-­‐
cellular	   sprouts	   into	   the	  matrix	   (FIG	  12B)	   Progressively	  more	   complex	   combinations	  of	   the	   six	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factors	  yielded	  more	  substantial	  multicellular	  sprout-­‐like	  structures,	  especially	  in	  the	  case	  of	  two	  
distinct	  combinations	  that	  drove	  robust	  sprouting	  –	  HGF,	  bFGF,	  MCP-­‐1,	  VEGF,	  and	  S1P	  (HFMVS)	  
and	  MCP-­‐1,	  VEGF,	  PMA,	  and	  S1P	  (MVPS)	  (FIG	  12A).	  HFMVS-­‐guided	  invasion	  exhibited	  numerous	  
sprout-­‐like	  structures	  that	  extended	  hundreds	  of	  micrometers	  from	  the	  endothelialized	  parent	  
vessel	   as	   well	   as	   large	   numbers	   of	   solitary	   cells	  migrating	   into	   the	  matrix	   (FIG	   12Biii,iv).	   The	  
MVPS	   cocktail	   induced	   an	   even	   greater	   multicellular	   sprouting	   response	   with	   less	   single	   cell	  
migration	  (Fig.	  12Bv).	  In	  both	  cases,	  the	  sprouts	  continued	  to	  invade	  toward	  the	  source	  channel	  
as	  long	  as	  the	  gradient	  was	  maintained.	  
	  
Figure	  13.	  New	  vessel	  networks	  span	  the	  two	  original	  channels	  of	  the	  device.	  Neovessels	  in	  the	  device	  are	  shown	  at	  
the	  left	  in	  a	  merged	  image	  of	  a	  time-­‐lapse	  movie	  tracking	  the	  position	  of	  3µm	  red	  fluorescent	  beads	  perfused	  through	  
the	  large	  channels	  and	  neovessels.	  Beads	  were	  added	  to	  left	  side	  of	  parent	  vessel	  and	  flowed	  through	  neovessels	  to	  
the	  factor	  source	  channel.	  The	  right	  image	  is	  a	  z-­‐projection	  confocal	   image	  of	  the	  same	  neovessels.	   	   In	  both	  images	  
HUVECs	  (green)	  are	  stained	  with	  DiI.	  Scale	  bars	  are	  200	  µm.	  
	  
Remarkably,	  when	  the	  tips	  of	  these	  sprouts	  reached	  the	  source	  channel	  (typically	  after	  
one	   week),	   they	   breached	   into	   the	   source	   channel,	   forming	   what	   appeared	   to	   be	   new	  
microvessels	  connecting	  the	  two	  parallel	  channels	  (FIG	  13).	  To	  test	  whether	  these	  “neovessels”	  
possessed	   functional,	   perfusable	   lumens,	   3	   μm	   fluorescent	   beads	   were	   added	   to	   the	   media	  
flowing	   into	  the	  endothelialized	  parent	  channel.	  Beads	  traveled	  through	  the	  neovessels	   to	   the	  
source	   channel	   with	   no	   leakage	   into	   the	   interstitial	   space,	   indicating	   fully	   developed	   lumens	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lined	  by	  a	  continuous	  endothelium.	  Overlaying	   frames	  of	   the	  time-­‐lapse	   images	  demonstrated	  
the	  path	  of	  the	  beads	  through	  these	  occasionally	  branching	  neovessels	  (FIG	  13).	  	  	  
Sprouts	  exhibit	  morphologic	  features	  of	  in	  vivo	  angiogenesis	  
Because	   this	   experimental	   model	   allows	   us	   to	   monitor	   the	   detailed	   structural	   events	   of	  
sprouting,	   we	   next	   proceeded	   to	   examine	   the	   changes	   in	   cellular	   organization	   during	   early	  
stages	   of	   invasion.	   For	   this	   purpose,	   we	   focused	   on	   the	  MVPS	   cocktail,	   which	   promoted	   the	  
greatest	  sprouting	  response	  with	  minimal	  single	  cell	  migration.	  Prior	  to	  stimulation,	  cells	  in	  the	  
endothelialized	   channel	   exhibited	   the	   expected	   apical-­‐basal	   polarity	   as	   demonstrated	   by	   the	  
localization	  of	  CD34	  apical	  marker	  podocalyxin	  to	  the	  luminal	  face	  (Lampugnani,	  Orsenigo	  et	  al.	  
2010).	  On	   the	   basolateral	   side	   of	   the	   endothelium	  we	  observed	   both	   laminin	   and	   collagen	   IV	  
deposition,	  suggestive	  of	  a	  cell-­‐deposited	  matrix	  layer	  enveloping	  the	  parent	  vessel	  (FIG	  14).	  	  
	  
Figure	   14.	   Characterization	   of	   cell-­‐deposited	   extracellular	   matrices	   by	   the	   endothelium.	   (A)	   Laminin	  
immunofluorescence	   (red)	   is	   shown	   in	   a	   z-­‐resolved	   confocal	   stack	   en	   face	   projection	   of	   a	   parent	   vessel	   (i),	   with	  
zoomed	   in	   view	   (ii).	   Radial	   slice	   (iii)	   indicating	   localization	   of	   laminin	   at	   the	   basal	   side.	   (B)	   Collagen	   IV	  
immunofluorescence	   (red)	   is	   shown	   in	  a	   z-­‐resolved	  confocal	   stack	  projection	  of	  a	  parent	  vessel	   (i),	  with	   zoomed	   in	  
view	   (ii).	   Radial	   slice	   (iii)	   indicating	   localization	  of	   collagen	   IV	   at	   the	  basal	   side.	   F-­‐actin	   and	  nuclei	   are	   labeled	  with	  
phalloidin	  (green)	  and	  DAPI	  (blue).	  
	  
Upon	   stimulation,	   occasional	   single	   ECs	   began	   invading	   into	   the	  matrix	   and	   extending	  
filopodia-­‐like	   protrusions	   in	   the	   direction	   of	   the	   angiogenic	   gradient	   (FIG	   15A).	   During	   initial	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invasion,	   we	   observed	   interruptions	   in	   laminin	   immunofluorescence,	   consistent	   with	   focal	  
degradation	   of	   the	   cell-­‐deposited	   ECM	   reminiscent	   of	   basement	  membrane	   (FIG	   15B).	   These	  
leading	   tip	   cells	  were	   replete	  with	   filopodia-­‐like	   protrusions,	  morphologically	   recapitulating	   in	  
vivo	   sprout	   tips	   (Gerhardt,	   Golding	   et	   al.	   2003).	   As	   these	   tip	   cells	   migrated	   deeper	   into	   the	  
matrix,	   neighboring	   cells	   followed	  while	  maintaining	   cell-­‐cell	   contacts	   along	   the	   length	   of	   the	  
sprout,	  as	  shown	  by	  PECAM-­‐1	  staining	   (FIG	  15C).	  Thus,	   the	  sprouting	  process	   from	  the	  parent	  
endothelium	   into	   the	   matrix	   involved	   collective	   cell	   migration	   that	   supported	   a	   contiguous	  
structure	  between	  the	  sprout	  and	  parent	  vessel.	  Even	  at	  this	  early	  stage	  of	  2-­‐3	  cells	  per	  sprout,	  
evidence	  of	  lumen	  formation	  was	  detected	  in	  3D	  reconstructions	  of	  confocal	  images	  (FIG	  15D).	  
Moreover,	  apical-­‐basal	  polarity	  appeared	  intact	  in	  the	  sprouts	  as	  evidenced	  by	  apically	  targeted	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Figure	  15.	  Characterization	  of	  early	  and	   late	  stage	  sprouts.	   Immunofluorescent	  confocal	   images	  of	  early	   (A-­‐D)	  and	  
late	  (E-­‐G)	  sprouts.	  For	  all	  images	  F-­‐actin	  and	  nuclei	  are	  labeled	  with	  phalloidin	  (green)	  and	  DAPI	  (blue),	  respectively.	  
Staining	  for	   laminin	  (B,	  F,	   I),	  PECAM-­‐1	  (C,	  G,	  K),	  and	  Podocalyxin	  (D,	  E,	  and	  J)	  are	  shown	  in	  red.	  (A)	  Micrograph	  of	  a	  
HUVEC	  extending	  processes	  into	  the	  matrix	  towards	  the	  source	  channel.	  (B)	  Laminin	  immunofluorescence	  is	  marked	  
by	  white	  arrowheads	  at	  outside	  of	  parent	  vessel.	  Fluorescence	  is	  interrupted	  by	  early	  sprout	  invasion.	  (C)	  Image	  of	  an	  
early	  multicellular	  sprout	  stained	  for	  F-­‐actin	  and	  PECAM-­‐1.	  White	  arrowheads	  point	  to	  PECAM-­‐1	  staining	  at	  cell-­‐cell	  
junctions	  in	  early	  multicellular	  sprout.	  Inset:	  z-­‐projection	  of	  back	  half	  of	  sprout	  with	  PECAM-­‐1	  staining	  only.	  (D)	  Early	  
sprout	   stained	   for	   podocalyxin	   (Podoxyl)	   shown	   in	   (i)	   Z-­‐projection.	  White	   arrowheads	  mark	   Podocalyxin	   at	   luminal	  
side	  of	  sprout	  shown	  by	  transverse	  cross-­‐sections	  (inset,	  i)	  and	  longitudinal	  slice	  showing	  podocalyxin	  (ii)	  and	  f-­‐actin	  
(iii).	   (E)	   Podocalyxin	   immunofluorescence	   in	   later	   sprout	   shown	   in	   (i)	   z-­‐projection	   where	   blue	   arrow	   marks	   cell	  
invading	  out	  from	  sprout	  stalk,	  and	  in	  cross-­‐sections	  of	  (ii)	  	  tip	  cell	  where	  no	  lumen	  or	  spatial	  podocalyxin	  localization	  
is	  shown	  in	  the	  tip	  cell,	  and	  (iii)	  stalk	  where	  white	  arrowheads	  mark	  Podocalyxin	  staining	  at	  apical	  side	  of	  lumenized	  
stalk	  cells.	  	  (F)	  Laminin	  immunofluorescence	  in	  later	  sprout	  shown	  in	  (i)	  z-­‐projection	  where	  blue	  arrow	  marks	  stalk	  cell	  
filopodia,	  and	  in	  cross-­‐sections	  of	  (ii)	  sprout	  tip	  cell	  that	  contains	  no	  lumen	  and	  shows	  presence	  of	  laminin	  staining,	  
(iii)	   in	   lumen	   containing	   stalk	   cell	   where	   white	   arrowheads	   point	   to	   laminin	   immunofluorescence	   at	   basal	   side	   of	  
lumen-­‐containing	  stalk	  cell	  and	  (iv)	  stalk	  cell	  that	  contains	  no	  lumen	  shows	  laminin	  immunofluorescence	  .	  (G)	  PECAM-­‐
1	  staining	   in	   later	  sprout	  shown	  in	  (i)	  z-­‐projection	  and	  (ii)	  z-­‐projection	  of	  back	  half	  of	  sprout	  with	  PECAM-­‐1	  staining	  
only	  where	  white	   arrowheads	  mark	   PECAM-­‐1	   staining	   at	   cell	   junctions.	   Scale	   bars	   are	   25μm.	   Yellow,	   pink,	   orange	  
boxes	  indicate	  longitudinal	  slice	  or	  partial	  stack,	  transverse	  cross-­‐section,	  and	  zoom-­‐in	  respectively.	  	  
	  
As	   the	   sprouts	   continued	   to	   invade	   and	   extend	   into	   the	  matrix,	   they	   became	   longer,	  
contained	   progressively	   more	   cells,	   and	   began	   to	   branch	   (Fig.	   2E-­‐G).	   Stereotypical	   sprouting	  
morphology	   was	   evident	   in	   these	   mature	   sprouts,	   with	   cells	   at	   the	   sprout	   tip	   developing	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numerous	  thin	  filopodia-­‐like	  protrusions,	  in	  contrast	  to	  cells	  in	  the	  stalk	  containing	  few	  filopodia	  
protrusions	   (Fig.	   2E-­‐G).	   Lumens	  developed	   in	  both	  early	   and	   late	   sprouts	   that	  often	  extended	  
from	   the	   parent	   vessel	   up	   to,	   but	   never	   within,	   the	   tip	   cell	   (FIG	   15D,E).	   Partial	   lumens	  
occasionally	   were	   evident	   behind	   the	   tip	   cell	   and	   were	   not	   connected	   to	   the	   parent	   vessel,	  
suggestive	  of	  spontaneous,	  focal	  cord-­‐hollowing	  or	  lumenization	  (FIG	  15Fiv).	  Staining	  confirmed	  
that	   the	   sprout	   tip	   cells	   lacked	   specific	   localization	   of	   podocalyxin,	   while	   stalk	   cells	  
demonstrated	   localization	  of	  podocalyxin	  to	  the	   luminal	  space	  (FIG	  15E).	  We	  observed	  laminin	  
deposition	   in	  the	  mature	  sprouts	  (FIG	  15F)	  and	  found	  that	  PECAM-­‐1-­‐positive	  cell-­‐cell	   junctions	  
were	   generally	   intact	   throughout	   the	   sprouts	   (FIG	   15G).	   In	   addition	   to	   primary	   sprouts,	  
maturation	   of	   secondary	   branches	   also	   occurred	   in	   our	   system.	  Different	   stages	   of	   secondary	  
branching	  were	  evidenced	  by	  stalk	  cells	  occasionally	  marked	  by	  direct	  filopodia-­‐like	  protrusions	  
suggesting	  early	  branch	  initiation	  (Blue	  arrow,	  FIG	  15F),	  whole	  cells	  extending	  out	  from	  the	  stalk	  
of	  the	  sprout	  (Blue	  arrow,	  FIG	  15E),	  and	  finally	  as	  full	  multicellular	  branches	  with	  their	  own	  new	  
tip	  cells	  extending	  toward	  the	  angiogenic	  gradient	  (FIG	  15G).	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Upon	   formation	   of	   neovessels	   spanning	   the	   two	   channels,	   non-­‐perfused	   filopodial	  
protrusions	   notably	   disappeared	   (FIG	   16Ai).	   The	   neovessels	   were	   lumenized	   end-­‐to-­‐end	   (FIG	  
16Aii,	  iii),	  and	  cells	  were	  aligned	  with	  flow	  as	  in	  the	  parent	  vessel,	  demonstrated	  by	  actin	  stress	  
fiber	  alignment	  (FIG	  16Aiv).	  Further	  examination	  revealed	  the	  deposition	  of	  laminin	  around	  the	  
neovessels	  (FIG	  16B),	  localization	  of	  podocalyxin	  to	  the	  luminal	  domains	  (FIG	  16C),	  and	  PECAM-­‐
1	  staining	  reflective	  of	  intact	  cell-­‐cell	  junctions	  (FIG	  16D).	  
	  
VEGF	  drives	  directed	  filopodia	  formation	  and	  sprout	  extension	  in	  a	  context	  
dependent	  manner	  
While	  the	  structural	  similarities	  between	  angiogenic	  sprouts	  observed	  in	  our	  system	  and	  those	  
found	   in	   vivo	   were	   broadly	   encouraging,	   it	   was	   also	   important	   to	   explore	   whether	   our	  
angiogenic	   sprouts	   responded	   physiologically	   to	   agents	   known	   to	   perturb	   the	   angiogenic	  
Figure	   16.	   Characterization	   of	   early	   and	   late	  
sprouts	   and	   neovessels.	   Immunofluorescent	  
confocal	   images	   of	   neovessels.	   (A)	   Neovessel,	  
shown	   in	   (i)	   z-­‐projection,	   (ii)	   longitudinal	   slice	   and	  
(iii)	  cross-­‐section,	  displays	  (iv)	  actin	  fiber	  alignment	  
with	   direction	   of	   flow	   indicated	   by	   double-­‐arrow	  
line.	   (B)	   White	   arrowheads	   point	   to	   laminin	  
immunofluorescence	  at	  basal	  side	  of	  neovessel.	  (C)	  
White	  arrowheads	  point	  to	  Podocalyxin	  staining	  at	  
luminal	   of	   neovessel.	   (D)	  White	   arrowheads	  mark	  
PECAM-­‐1	   at	   cell	   junctions	   in	   neovessel.	   Yellow,	  
pink,	   orange	   boxes	   indicate	   longitudinal	   slice	   or	  
partial	  stack,	  transverse	  cross-­‐section,	  and	  zoom-­‐in	  
respectively.	  Scale	  bars	  are	  25μm.	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process.	  To	  address	  this	  question,	  we	  investigated	  whether	  anti-­‐angiogenic	  agents	  could	  impact	  
sprouting	  in	  our	  system.	  First,	  a	  VEGF	  receptor	  2	  (VEGFR2)	  inhibitor	  Semaxanib	  (Mendel,	  Laird	  et	  
al.	  2000)	  was	  added	  with	  the	  HFMVS	  angiogenic	  cocktail.	  If	  added	  from	  the	  outset,	  the	  inhibitor	  
abrogated	  sprout	  initiation	  (FIG	  17A).	  Because	  angiogenic	  inhibitors	  are	  also	  thought	  to	  lead	  to	  
regression	   of	   pre-­‐existing	   sprouts	   (Inai,	   Mancuso	   et	   al.	   2004),	   we	   also	   tested	   the	   effects	   of	  
adding	  Semaxanib	   to	   the	  source	  channel	  after	  3	  days	  of	  uninhibited	  sprouting.	  We	  found	  that	  
further	  progression	  of	  sprouts	  was	  arrested,	  but	  obvious	  regression	  of	  the	  sprouts	  did	  not	  occur	  
(FIG	  17A).	  	  
	  
Figure	  17.	  Effects	  of	  VEGFR2	  inhibition	  on	  angiogenic	  sprouting.	  (A,	  D)	  Plot	  of	  sprout	  length	  driven	  by	  (A)	  HFMVS	  or	  
(B)	  MVPS	  (D)	  in	  response	  to	  Semaxanib	  treatment	  over	  time.	  Arrowheads	  indicate	  initiation	  of	  Semaxanib	  treatment	  
at	  either	  Day	  0	  (Day	  0	  Sem)	  or	  Day	  3	  (Day	  3	  Sem).	  (B,E)	  Quantification	  of	  filopodia	  length	  and	  number	  in	  sprouting	  for	  
same	  inhibitor	  conditions	  versus	  no-­‐inhibitor	  control.	  (C,F)	  Representative	  confocal	  immunofluorescence	  images	  of	  
indicated	  conditions	  at	  Day	  6.	  .	  F-­‐actin	  and	  nuclei	  are	  labeled	  with	  phalloidin	  (green)	  and	  DAPI	  (blue),	  respectively.	  
Grid	  indicates	  no	  data	  acquired.	  Scale	  bars	  are	  50	  µm	  	  Error	  bars	  are	  S.E.M.	  *	  represents	  significant	  difference	  from	  
control	  (p	  <	  0.05).	  ns	  represents	  no	  significant	  difference	  from	  control.	  In	  all	  cases	  (inhibitor	  and	  no-­‐inhibitor	  control)	  
pro-­‐angiogenic	  cocktail	  treatment	  is	  started	  at	  Day	  0.	  n	  =	  5	  samples	  for	  sprout	  length	  quantification,	  n=3	  samples	  for	  
filopodia	  quantification.	  All	  filopodia	  quantifications	  performed	  on	  data	  from	  Day	  6	  of	  experiment.	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Closer	   inspection	   of	   VEGFR2-­‐inhibited	   sprout	   architectures	   revealed	   a	   near	   complete	  
loss	  of	  the	  many	  filopodia-­‐like	  protrusions	  normally	  present	   in	  the	  tip	  cells,	  with	  a	  decrease	   in	  
the	  number	  of	  protrusions	  (FIG	  17B,C).	  The	  average	  length	  of	  the	  few	  remaining	  protrusions	  was	  
not	   significantly	   different	   from	   that	   of	   the	   untreated	   sprouts.	   Surprisingly,	   we	   observed	   that	  
sprouting	   induced	   by	   the	  MVPS	   cocktail,	   while	   slowed,	   appeared	   to	   proceed	   despite	   VEGFR2	  
inhibition	  (Fig.	  3D).	  Confocal	  images	  revealed	  that	  the	  filopodia-­‐like	  protrusions	  in	  these	  sprouts	  
were	  largely	  unaffected	  by	  Semaxanib,	  whether	  added	  at	  Day	  0	  or	  Day	  3	  (FIG	  17F).	  Quantitative	  
analysis	  showed	  that	  the	  number	  of	  filopodial	  extensions	  was	  unchanged	  and	  their	   length	  was	  
unaffected	  (FIG	  17E).	  	  
	  
To	  further	  test	  the	  role	  of	  VEGF	  in	  the	  MVPS	  cocktail,	  we	  compared	  sprouting	   induced	  
by	   MPS	   versus	   MVPS	   cocktails	   (FIG	   18)	   and	   indeed	   found	   no	   significant	   difference	   between	  
these	   two	   cocktails.	   Importantly,	   these	   results	   demonstrate	   that	   the	   angiogenic	   process	  
modeled	   by	   our	   system	   can	   respond	   to	   physiologically	   relevant	   anti-­‐angiogenic	   therapeutics.	  
Moreover,	  this	  system	  offers	  insights	  into	  the	  mechanism	  by	  which	  Semaxanib	  may	  antagonize	  
angiogenesis,	  by	  arresting	  the	  formation	  of	  cellular	  protrusions	  that	  are	  critical	  to	  the	  initiation	  
and	  growth	  of	  angiogenic	  sprouts.	  Interestingly,	  in	  contexts	  containing	  factors	  that	  can	  promote	  
protrusive	   activity	   in	   a	   VEGF-­‐independent	   manner,	   angiogenic	   sprouts	   become	   refractory	   to	  
Semaxanib.	  
Figure	   18.	   Quantification	   of	   sprout	   length	  
for	   the	  MVPS	  and	  MPS	  cocktails	  at	  Day	  4.	  
MVPS	   and	  MPS	   cocktails	   were	   only	   added	  
to	   the	   source	   channel.	   Error	  bars	  are	  SEM.	  
ns	  represents	  no	  significant	  difference	  from	  
MVPS	  control	  (p≥0.05).	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S1P	  and	  MMP	  inhibition	  demonstrate	  independent	  steps	  for	  angiogenic	  invasion	  	  
To	  further	  investigate	  the	  morphogenetic	  responses	  to	  anti-­‐angiogenic	  factors,	  we	  examined	  the	  
effects	  of	  perturbing	  S1P	  signaling,	  which	  acts	  as	  a	  strong	  chemoattractant	  through	  a	  G-­‐protein	  
coupled	  receptor	  (S1PR)	  and	  is	  known	  to	  regulate	  angiogenesis	  (Lee,	  Kim	  et	  al.	  1999;	  Bayless	  
and	  Davis	  2003).	  Exposing	  cells	  to	  the	  S1PR	  inhibitor	  Fingolimod	  (LaMontagne,	  Littlewood-­‐Evans	  
et	  al.	  2006)	  resulted	  in	  abrogation	  of	  sprout	  initiation	  when	  introduced	  at	  Day	  0,	  and	  inhibited	  
further	  sprout	  extension	  when	  given	  at	  Day	  3	  (FIG	  19).	  	  
	  
Figure	   19.	   Effects	   of	   S1P	   receptor	   inhibition	   on	   angiogenic	   sprouting.	   (A,	   D)	   Plot	   of	   sprout	   length	   driven	   by	   (A)	  
HFMVS	  or	  (B)	  MVPS	  (D)	  in	  response	  to	  Fingolimod	  treatment	  over	  time.	  Arrowheads	  indicate	  initiation	  of	  Fingolimod	  
treatment	  at	  either	  Day	  0	  (Day	  0	  Fing)	  or	  Day	  3	  (Day	  3	  Fing).	   (B,E)	  Quantification	  of	  filopodia	   length	  and	  number	   in	  
sprouting	   for	   same	   inhibitor	   conditions	   versus	   no-­‐inhibitor	   control.	   (C,F)	   Representative	   confocal	  
immunofluorescence	  images	  of	  indicated	  conditions	  at	  Day	  6.	  .	  F-­‐actin	  and	  nuclei	  are	  labeled	  with	  phalloidin	  (green)	  
and	   DAPI	   (blue),	   respectively.	   Grid	   indicates	   no	   data	   acquired.	   Scale	   bars	   are	   50	   µm.	   	   Error	   bars	   are	   S.E.M.	   *	  
represents	   significant	  difference	   from	  control	   (p	  <	  0.05).	  ns	   represents	  no	  significant	  difference	   from	  control.	   In	  all	  
cases	   (inhibitor	   and	   no-­‐inhibitor	   control)	   pro-­‐angiogenic	   cocktail	   treatment	   is	   started	   at	   Day	   0.	   n	   =	   5	   samples	   for	  
sprout	  length	  quantification,	  n=3	  samples	  for	  filopodia	  quantification.	  All	  filopodia	  quantifications	  performed	  on	  data	  
from	  Day	  6	  of	  experiment.	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Interestingly,	  these	  effects	  were	  independent	  of	  which	  angiogenic	  cocktail	  (HFMVS	  or	  
MVPS)	  was	  employed	  (FIG	  19A,D).	  Quantification	  of	  the	  remaining	  sprout	  structures	  revealed	  
nearly	  complete	  loss	  in	  the	  number	  of	  filopodia-­‐like	  protrusions,	  with	  cells	  appearing	  less	  
elongated	  and	  organized	  (FIG	  19B,C,E,F).	  Given	  the	  polarizing	  effects	  of	  S1P	  on	  filopodia,	  we	  
used	  the	  system	  to	  explore	  whether	  changing	  the	  S1P	  gradient	  would	  impact	  sprouting.	  Holding	  
MCP-­‐1,	  VEGF	  and	  PMA	  constant	  in	  the	  source	  channel,	  we	  found	  that	  sprouting	  required	  S1P	  
provided	  by	  the	  source	  channel,	  regardless	  of	  whether	  S1P	  was	  present	  in	  the	  endothelialized	  
lumen.	  We	  also	  found	  that,	  while	  its	  presence	  was	  necessary,	  varying	  the	  concentration	  of	  S1P	  
by	  half	  or	  two-­‐fold	  did	  not	  appear	  to	  affect	  the	  speed	  of	  sprout	  progression	  (FIG	  20).	  	  
	  
	   Together,	  these	  data	  suggest	  that	  S1P	  signaling	  also	  regulates	  angiogenic	  sprouting,	  and	  
that	  multiple	  pathways	  in	  addition	  to	  VEGF	  signaling	  may	  contribute	  specifically	  to	  the	  
directional	  protrusions	  necessary	  for	  sprout	  extension.	  However,	  though	  necessary,	  we	  would	  
anticipate	  that	  filopodial	  protrusions	  are	  only	  one	  of	  several	  key	  cellular	  processes	  required	  for	  
sprout	  extension.	  In	  support	  of	  this,	  we	  observed	  that	  the	  broad	  spectrum	  MMP-­‐inhibitor,	  
Figure	   20.	  Quantification	   of	   sprout	   length	   for	   different	  
S1P	  gradients.	   (A)	  Plot	  of	  sprout	   length	  at	  Day	  4	   for	   the	  
MVPS	  cocktail	  in	  source	  channel	  (control	  gradient),	  MVPS	  
in	  source	  channel	  plus	  S1P	  in	  parent	  vessel	  (no	  gradient),	  
MVP	   in	   source	   channel	   plus	   S1P	   in	   parent	   channel	  
(negative	  gradient)	  and	  MVP	  in	  source	  channel	  (no	  S1P).	  
(B)	  Plot	  of	  sprout	  length	  at	  Day	  4	  for	  the	  MVPS	  cocktail	  in	  
source	   channel	   with	   different	   concentrations	   of	   S1P:	  
250nM	   (low	   gradient),	   500nM	   (control	   gradient)	   and	  
1µM	   (high	   gradient).	   *	   represents	   significant	   difference	  
from	  the	  MVPS	  (control	  gradient)	  (p<0.05).	  ns	  represents	  
no	   significant	   difference	   from	   MVPS	   (control	   gradient)	  
control.	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Marimastat	  (Brown	  1997;	  Steward	  and	  Thomas	  2000),	  also	  blocked	  sprout	  invasion	  and	  
extension	  (FIG	  21),	  but	  had	  no	  effect	  on	  directed	  filopodial	  extension.	  
	  
Figure	  21.	  Effects	  of	  MMP	  inhibition	  on	  angiogenic	  sprouting.	  (A)	  Plot	  of	  sprout	  length	  driven	  by	  MVPS	  in	  response	  to	  
Marimastat	  treatment	  over	  time.	  Pro-­‐angiogenic	  cocktail	  was	  initiated	  at	  Day	  0	  and	  Marimastat	  treatment	  was	  
initiated	  at	  either	  Day	  0	  (Day	  0	  Mar),	  Day	  3	  (Day	  3	  Mar),	  or	  never	  (No	  Inhib).	  (B)	  Representative	  confocal	  
immunofluorescence	  images	  of	  indicated	  conditions	  at	  Day	  6.	  F-­‐actin	  and	  nuclei	  are	  labeled	  with	  phalloidin	  (green)	  
and	  DAPI	  (blue),	  respectively.	  Scale	  bars	  are	  50	  µm.	  	  Error	  bars	  are	  SEM.	  *	  represents	  significant	  difference	  from	  
control	  (p	  <	  0.05).	  N	  =	  3	  samples	  for	  sprout	  length	  quantification.	  
	  
Discussion	  
Although	  central	  to	  angiogenesis,	  the	  morphogenetic	  process	  of	  endothelial	  invasion	  and	  sprout	  
extension	   has	   been	   difficult	   to	   observe	   in	   vivo	   and	  models	   of	   sprouting	   in	   vitro	   have	   largely	  
ignored	   the	  key	   initial	   conditions	   in	  which	   sprouts	  emanate	   from	  ECs	   lining	  a	  perfused	  vessel.	  
Several	   approaches	   have	   been	   developed	   recently	   in	   which	   endothelial	   cells	   seeded	   into	   a	  
channel	   within	   extracellular	  matrix	   form	   a	   primitive	   vasculature	   (Chrobak,	   Potter	   et	   al.	   2006;	  
Miller,	   Stevens	  et	  al.	  2012;	  Zheng,	  Chen	  et	  al.	  2012).	  Although	   they	  offer	  an	   in	   vitro	  model	  of	  
vessel	   biology,	   so	   far	   these	   single-­‐compartment	   microfluidic	   systems	   have	   not	   demonstrated	  
control	   over	   angiogenic	   sprouting.	   Here,	   we	   built	   on	   this	   concept	   with	   a	   device	   containing	   a	  
second	  channel	  that	  introduces	  angiogenic	  factors	  to	  trigger	  directed	  sprouting	  from	  the	  vessels.	  
Other	  designs	  have	  been	  presented	  for	  studying	  sprouting	  in	  the	  presence	  of	  flow	  (Chung,	  Sudo	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et	  al.	  2009;	  Song	  and	  Munn	  2011;	  Yeon,	  Ryu	  et	  al.	  2012).	  These	  use	  microfluidic	  channels	  with	  
square	  rather	  than	  circular	  cross-­‐sections,	  where	  3	  walls	  are	  silicone	  or	  glass	  and	  one	  sidewall	  is	  
the	  edge	  of	  an	  ECM	  matrix	  compartment	  that	  contains	  PDMS	  posts	  for	  structural	  support.	  Thus,	  
cells	  are	  exposed	  to	  surfaces	  other	  than	  the	  ECM	  itself	  both	  at	  the	  outset	  and	  during	  invasion,	  
which	   could	   impact	   and	   constrain	   cell	   migration,	   sprouting	   geometry,	   and	   multicellular	  
organization.	   	  As	   such,	   the	   simplicity	  of	   such	  devices	  make	   them	  excellent	   tools	   to	  assay	   very	  
early	   sprouting	   events,	   but	   may	   not	   be	   ideal	   for	   observing	   unconstrained	   morphogenetic	  
responses.	   In	   contrast,	   the	   system	  presented	  here	  offers	   gradient-­‐driven	  angiogenic	   sprouting	  
from	   a	   fully	   encapsulated	   endothelialized	   channel,	   thus	   allowing	   cells	   to	   emanate	   outwards	  
from	  the	  vessel	  wall	   in	  all	  directions	  without	  contacting	  artificial	  surfaces,	  and	  thus	  provides	  a	  
new	  avenue	  for	  studying	  multicellular,	  morphogenetic	  aspects	  of	  angiogenesis.	  
The	   ability	   to	   assess	   the	   3D	   multicellular	   organization	   of	   invading	   cells	   was	   a	   critical	  
feature	  that	  enabled	  us	  to	  characterize	  and	  isolate	  factors	  that	  support	  the	  many	  steps	  involved	  
in	  angiogenic	  sprouting.	  In	  our	  system,	  VEGF	  alone	  had	  negligible	  effect	  on	  sprouting	  while	  S1P	  
only	  triggered	  single	  cell	  migration.	  Instead,	  only	  in	  the	  presence	  of	  a	  more	  complex	  cocktail	  of	  
multiple	   factors	   could	   we	   observe	   robust	   multicellular	   sprout-­‐like	   invasion	   where	   a	  
morphologically	   distinct	   leading	   tip	   cell	   was	   trailed	   by	   a	   multicellular	   stalk.	   Interestingly,	   our	  
results	  suggest	  that	  different	  combinations	  of	  factors	  can	  be	  similarly	  potent.	  In	  line	  with	  these	  
findings,	   one	   study	   reported	   a	   combination	   of	   factors	   secreted	   by	   stromal	   fibroblasts	   that	  
induced	   sprouting	   (Newman,	   Nakatsu	   et	   al.	   2011),	   while	   another	   found	   a	   combination	   of	  
hematopoietic	   chemokines	   led	   to	   a	   marked	   enhancement	   in	   tubulogenesis	   and	   sprouting	  
(Stratman,	  Davis	   et	   al.	   2011).	   The	   recognition	   that	  multiple	   combinations	   of	   factors	   can	   drive	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angiogenesis,	   likely	   through	   different	  mechanisms,	   further	   underscores	   an	   important	   role	   for	  
model	  systems	  that	  allow	  for	  the	  rapid	  characterization	  of	  factor	  combinations.	  	  
With	   the	   appropriate	   stimuli	   in	   place,	   sprout	   formation	   and	   extension	   in	   our	   system	  
proceeded	  through	  a	  well-­‐defined	  progression	  that	  mirrored	  major	  steps	  of	  in	  vivo	  angiogenesis,	  
including	   directed	   tip	   cell	   invasion,	   multicellular	   stalk	   formation,	   lumen	   formation,	   and	  
neovessel	   perfusion.	   These	   steps	   are	   consistent	   with	   seminal	   observations	   of	   in	   vivo	  
angiogenesis	   showing	   the	   emergence	   of	   tip	   cells	   from	   an	   existing	   vessel,	   and	   stalk	   cells	   that	  
establish	  apical/basal	  polarity	  and	  form	  a	  lumen	  that	  excludes	  the	  tip	  cell	  (Gerhardt,	  Golding	  et	  
al.	   2003;	   Holderfield	   and	   Hughes	   2008;	   Lampugnani,	   Orsenigo	   et	   al.	   2010).	   VEGF	   has	   been	  
shown	  to	  be	   important	   in	   triggering	  such	   tip	  cells	   to	  extend	  thin,	  actin-­‐rich	  protrusions	  and	   in	  
guiding	   stalk	   cells	   to	   form	   elongated	   multi-­‐cellular	   sprouts	   (Gerhardt,	   Golding	   et	   al.	   2003;	  
Potente,	  Gerhardt	  et	   al.	   2011).	  Here,	  we	   showed	   that	  both	  VEGF	  and	  S1P	   signaling	  appear	   to	  
drive	  these	  filopodia-­‐like	  protrusions	  and	  sprouting.	  Interestingly,	  the	  requirement	  for	  VEGF	  on	  
sprouting	  depended	  on	  the	  composition	  of	  the	  angiogenic	  cocktail,	  and	  may	  explain	  why	  some	  
anti-­‐VEGF	  inhibitors	  block	  angiogenesis	  in	  some	  instances	  but	  not	  others.	  	  
Many	   distinct	   mechanisms	   have	   been	   described	   for	   in	   vivo	   lumen	   formation	   (Iruela-­‐
Arispe	  and	  Davis	  2009).	  In	  our	  system,	  we	  observed	  fully	  developed	  lumens	  formed	  by	  stalk	  cells	  
lining	  a	   tunnel	   left	  behind	   the	   leading	   tip	  cell.	   In	  other	   instances,	   the	   lumen	  was	  present	  only	  
just	  behind	  the	  tip	  cell,	  not	  yet	  extending	  contiguously	  back	  to	  the	  base	  of	  the	  stalk,	  suggesting	  
spontaneous	   lumen	   formation	   by	   the	   stalk	   cells.	   These	   observations	   are	   consistent	   with	  
mechanisms	  for	  lumenization	  observed	  in	  vivo.	  Finally,	  in	  addition	  to	  the	  simple	  coordination	  of	  
tip	  and	  stalk	  cells	  to	  form	  linear	  vessels,	  our	  system	  also	  appears	  to	  support	  higher	  order	  events	  
such	   as	   branching,	   a	   key	  mechanism	   to	   the	   patterning	   of	   sprouts	   controlled	   by	   the	   dynamic	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interconversion	   of	   stalk	   cells	   and	   filopodia-­‐containing	   tip	   cells	   (Gerhardt,	   Golding	   et	   al.	   2003;	  
Hellstrom,	  Phng	  et	  al.	  2007;	  Suchting,	  Freitas	  et	  al.	  2007;	  Carmeliet,	  De	  Smet	  et	  al.	  2009;	  Eilken	  
and	  Adams	  2010),	  as	  well	  as	  loss	  of	  filopodial	  activity	  and	  regression	  upon	  eventual	  perfusion	  of	  
the	  neovessel,	  a	  critical	  component	  of	  microvascular	  pruning	  and	  remodeling	  (le	  Noble,	  Fleury	  
et	   al.	   2005).	   The	  basis	   for	   this	   type	  of	  pruning	   could	  be	  explained	  by	   recent	   studies	   reporting	  
that	   shear	   stress	   could	   suppress	   VEGF-­‐induced	   invasion	   (Song	   and	   Munn	   2011).	   Thus,	   the	  
system	   introduced	   here	   faithfully	   recapitulates	   key	   features	   of	   in	   vivo	   angiogenesis,	   and	  
provides	   the	   ability	   to	   link	   specific	   stimuli	   to	   defined	   morphogenetic	   processes	   further	  
illustrating	  the	  power	  of	  such	  a	  model.	  
Loss-­‐of-­‐function	   in	  vivo	  models	   remain	   the	  mainstay	   for	  studying	  both	  physiologic	  and	  
pathologic	  processes,	  including	  those	  involving	  angiogenesis	  (Hasan,	  Shnyder	  et	  al.	  2004;	  Staton,	  
Reed	  et	  al.	  2009).	  However,	  organotypic	  models	  that	  are	  able	  to	  capture	  basic	  features	  of	  these	  
processes	  in	  an	  in	  vitro	  setting	  undeniably	  offer	  additional	  levels	  of	  control	  and	  analysis	  that	  are	  
critical	   to	   gaining	   mechanistic	   insights	   (Schmeichel	   and	   Bissell	   2003).	   The	   model	   system	  
presented	   here	   highlights	   that	   the	   field	   of	   angiogenesis	   has	   matured	   sufficiently	   to	   enable	  
reconstitution	  of	  the	  complex	  morphogenetic	  changes	  within	  endothelial	  cells	  as	  they	  invade	  to	  
form	  multicellular	  sprouts	  and	  newly	  perfused	  vessels.	  	  Even	  so,	  it	  represents	  merely	  a	  first	  step	  
toward	   establishing	   a	   new	   platform	   for	   investigating	   vascular	   remodeling.	   Indeed,	   the	  
introduction	  of	  additional	  cell	  types,	  including	  stromal,	  parenchymal,	  and	  circulatory	  cells,	  could	  
open	   the	   door	   to	   establishing	   a	   deeper	   understanding	   of	   how	   different	  microenvironmental,	  
genetic,	   organ-­‐specific,	   and	   pathologic	   factors	   could	   contribute	   to	   the	   different	   forms	   of	  
angiogenesis.	   This	   study	   adds	   to	   recent	   developments	   (Barrila,	   Radtke	   et	   al.	   2010;	   Huh,	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Matthews	   et	   al.	   2010)	   that	   together	   highlight	   the	   importance	   of	   engineered	   experimental	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CHAPTER	  3:	  Myosin-­mediated	  contractility	  regulates	  VE-­cadherin	  
adhesions	  during	  angiogenesis	  
Introduction	  
Cells	  migrate	  as	  collective	  groups	  in	  numerous	  developmental	  processes,	  including	  ECs	  in	  
nascent	  vessels	  during	  sprouting	  angiogenesis,	  epithelial	  cells	  in	  the	  mammary	  gland	  during	  
branching	  morphogenesis,	  and	  border	  cells	  in	  the	  Drosophila	  melanogaster	  egg	  chamber	  during	  
egg	  growth	  and	  segmentation	  (Friedl	  and	  Gilmour	  2009).	  Following	  developmental	  
morphogenesis,	  collective	  migration	  of	  poorly	  differentiated	  masses,	  elongated	  strands,	  and	  
small	  clusters	  all	  occur	  during	  cancer	  invasion	  and	  metastasis	  (Hegerfeldt,	  Tusch	  et	  al.	  2002;	  
Friedl	  and	  Gilmour	  2009).	  Multicellular	  migration	  is	  characterized	  by	  maintained	  cell-­‐cell	  
adhesions,	  an	  intercellular	  actomyosin	  cytoskeleton	  to	  generate	  traction	  and	  protrusive	  force,	  
and	  remodeling	  of	  the	  ECM	  through	  which	  the	  structure	  is	  migrating	  (Friedl	  and	  Gilmour	  2009;	  
Haeger,	  Wolf	  et	  al.	  2015).	  	  
Broad	  understandings	  of	  collective	  cell	  migration	  have	  been	  garnered	  from	  observations	  
in	  numerous	  developmental	  processes	  in	  vivo,	  including	  tracheal	  network	  branching	  and	  border	  
cell	  migration	  in	  the	  Drosophila	  melanogaster,	  and	  the	  formation	  of	  the	  instersegmental	  vessels	  
in	  the	  zebrafish	  (Affolter	  and	  Caussinus	  2008)	  (Sauteur,	  Krudewig	  et	  al.	  2014).	  Such	  tools	  allow	  
study	  of	  multicellular	  migration	  in	  the	  native	  setting	  and	  provide	  useful	  platforms	  for	  genetic	  
studies	  and	  bulk	  cellular	  responses.	  Manipulations	  of	  cytoskeletal	  and	  adhesion	  regulators	  in	  
vivo	  have	  established	  that	  the	  mechanical	  coupling	  of	  cells	  through	  cell-­‐cell	  adhesions	  is	  
required	  for	  successful	  tissue	  development	  and	  morphogenesis	  through	  collective	  migration	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(Wozniak	  and	  Chen	  2009;	  DuFort,	  Paszek	  et	  al.	  2011)	  (Rauzi,	  Verant	  et	  al.	  2008;	  Sawyer,	  Harris	  et	  
al.	  2009;	  Martin,	  Gelbart	  et	  al.	  2010;	  Rauzi,	  Lenne	  et	  al.	  2010;	  Maitre,	  Berthoumieux	  et	  al.	  2012).	  
Much	  of	  our	  understanding	  of	  the	  molecular	  regulation	  of	  cell	  migration	  has	  come	  from	  
single	  cell	  studies,	  which	  have	  highlighted	  key	  mechanisms	  of	  migration	  and	  adhesion	  likely	  at	  
play	  in	  more	  complex	  settings	  of	  multicellular	  invasion.	  During	  2D	  single	  cell	  migration	  cells	  
polarize	  their	  actin	  cytoskeleton,	  extend	  protrusions	  in	  the	  direction	  of	  migration,	  stabilize	  
protrusions	  via	  binding	  of	  the	  extracellular	  matrix	  by	  transmembrane	  receptors	  linked	  to	  the	  
actin	  cytoskeleton,	  generate	  traction	  forces	  through	  cell-­‐matrix	  adhesions	  located	  at	  the	  
migrating	  front	  of	  the	  cell,	  and	  disassemble	  adhesions	  at	  the	  rear	  of	  the	  cell	  to	  allow	  forward	  
movement	  (Etienne-­‐Manneville	  and	  Hall	  2002;	  Pollard	  and	  Borisy	  2003;	  Ridley,	  Schwartz	  et	  al.	  
2003).	  Single	  and	  two	  cell	  studies	  have	  allowed	  for	  the	  elucidation	  of	  the	  complex	  machinery	  
behind	  cell	  adhesions	  and	  force	  generation,	  and	  revealed	  requirement	  for	  the	  mechanical	  
complexing	  of	  the	  cytoskeleton	  with	  integrins	  and	  cadherins	  for	  adhesion	  strengthening	  
(Horwitz,	  Duggan	  et	  al.	  1986;	  Wang,	  Butler	  et	  al.	  1993;	  Chu,	  Thomas	  et	  al.	  2004;	  Kanchanawong,	  
Shtengel	  et	  al.	  2010).	  Despite	  some	  unique	  regulators	  (e.g.	  β-­‐catenin	  in	  cadherin	  adhesions,	  and	  
talin	  in	  integrin	  adhesions),	  numerous	  similarities	  exist	  across	  cell-­‐cell	  and	  cell-­‐matrix	  adhesion	  
maturation	  process,	  including	  the	  requirement	  for	  myosin-­‐mediated	  cytoskeletal	  contractility	  (le	  
Duc,	  Shi	  et	  al.	  2010;	  Oakes,	  Beckham	  et	  al.	  2012).	  	  
Myosin	  II,	  a	  downstream	  effector	  protein	  of	  the	  small	  GTPase	  RhoA	  (FIG	  22),	  has	  both	  
actin	  crosslinking	  and	  actin	  contracting	  activities	  and	  plays	  roles	  in	  cell	  migration	  and	  
polarization,	  in	  addition	  to	  adhesions	  (Choi,	  Vicente-­‐Manzanares	  et	  al.	  2008;	  Vicente-­‐
Manzanares,	  Ma	  et	  al.	  2009).	  Myosin	  II	  is	  comprised	  of	  two	  heavy	  chains	  (HC),	  two	  regulatory	  
light	  chains	  (RLC),	  and	  two	  essential	  light	  chains.	  Contraction	  of	  actin	  filaments	  requires	  energy,	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achieved	  via	  phosphorylation	  of	  sites	  on	  the	  RLC	  and	  HC,	  which	  drive	  myosin	  ATPase	  activity	  
(Adelstein	  and	  Eisenberg	  1980).	  Knockdown	  and	  inhibition	  studies	  of	  myosin	  in	  single	  cells	  and	  
cell	  pairs	  have	  shown	  myosin	  II	  isoforms	  slow	  protrusion	  rate,	  are	  required	  initial	  actin-­‐mediated	  
polarization	  prior	  to	  migration,	  and	  regulate	  adhesion	  strengthening	  and	  disruption	  (Conti,	  
Even-­‐Ram	  et	  al.	  2004;	  Shewan,	  Maddugoda	  et	  al.	  2005;	  Miyake,	  Inoue	  et	  al.	  2006;	  Maddugoda,	  
Crampton	  et	  al.	  2007;	  Yamada	  and	  Nelson	  2007;	  Krieg,	  Arboleda-­‐Estudillo	  et	  al.	  2008;	  Smutny,	  
Cox	  et	  al.	  2010;	  Krishnan,	  Klumpers	  et	  al.	  2011)	  (Chu,	  Thomas	  et	  al.	  2004;	  Vicente-­‐Manzanares,	  
Zareno	  et	  al.	  2007;	  Yam,	  Wilson	  et	  al.	  2007;	  Choi,	  Vicente-­‐Manzanares	  et	  al.	  2008).	  While	  
molecular	  regulators	  of	  each	  step	  within	  the	  cyclical	  process	  of	  migration	  have	  been	  thoroughly	  
defined	  for	  single	  cells,	  multicellular	  migration	  through	  matrix	  also	  encompasses	  dynamic	  
regulation	  of	  cell-­‐cell	  adhesions,	  mechanical	  linkage	  of	  cell	  cytoskeletons,	  and	  matrix	  
degradation	  (Ridley,	  Schwartz	  et	  al.	  2003;	  Haeger,	  Wolf	  et	  al.	  2015).	  	  
Most	  in	  vitro	  studies	  of	  multicellular	  migration	  have	  relied	  on	  the	  scratch	  wound	  assay,	  
which	  allows	  sheet	  and	  cell	  polarization,	  force	  generation,	  and	  mechanisms	  of	  cell–cell	  
adhesions	  to	  be	  studied	  during	  the	  movement	  of	  a	  confluent	  monolayer	  of	  cells	  with	  a	  defined	  
leading	  edge	  (Nobes	  and	  Hall	  1999;	  Poujade,	  Grasland-­‐Mongrain	  et	  al.	  2007;	  Trepat,	  Wasserman	  
et	  al.	  2009;	  Krishnan,	  Klumpers	  et	  al.	  2011).	  While	  this	  setup	  is	  removed	  from	  most	  collective	  
migration	  environments	  in	  vivo	  by	  lack	  of	  surrounding	  matrix	  and	  tissue	  architecture,	  it	  has	  
provided	  extensive	  insight	  into	  mechanisms	  of	  wound	  healing	  and	  epithelial	  adhesion	  dynamics,	  
and	  has	  been	  recently	  adapted	  to	  examine	  collective	  force	  transmission	  (Farooqui	  and	  Fenteany	  
2005;	  Trepat,	  Wasserman	  et	  al.	  2009;	  Krishnan,	  Klumpers	  et	  al.	  2011;	  Taguchi,	  Ishiuchi	  et	  al.	  
2011).	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The	  behavior	  of	  cells	  grown	  on	  planar	  substrates	  often	  varies	  greatly	  from	  those	  
cultured	  within	  3D	  matrices	  (Cukierman,	  Pankov	  et	  al.	  2001;	  Baker	  and	  Chen	  2012).	  
Dimensionality	  of	  the	  extracellular	  matrix	  can	  effect	  cell	  shape	  (Beningo,	  Dembo	  et	  al.	  2004),	  
focal	  adhesion	  assembly	  (Beningo,	  Dembo	  et	  al.	  2004),	  migration	  modes	  (Friedl	  2004),	  and	  
differentiation	  (Benya	  and	  Shaffer	  1982;	  Huebsch,	  Arany	  et	  al.	  2010;	  Khetan,	  Guvendiren	  et	  al.	  
2013).	  Cell-­‐cell	  interactions	  are	  also	  greatly	  altered	  depending	  on	  environment	  dimensionality.	  
For	  example,	  epithelial	  cells	  on	  2D	  surfaces	  form	  a	  sheet-­‐like	  monolayer	  while	  those	  cultured	  in	  
3D	  arrange	  into	  polarized	  spheroids	  with	  a	  central	  lumen,	  similar	  to	  the	  acini	  structures	  seen	  in	  
vivo	  (Emerman	  and	  Pitelka	  1977;	  Weigelt	  and	  Bissell	  2008).	  Most	  collective	  migration	  is	  a	  3D	  
process,	  and	  the	  encapsulation	  of	  multiple	  cells,	  or	  even	  tissue	  explants,	  within	  a	  3D	  matrix,	  
have	  allowed	  a	  closer	  approximation	  of	  the	  native	  environment	  while	  still	  allowing	  observation	  
and	  the	  use	  of	  powerful	  molecular	  and	  cell	  biology	  tools	  (Masson,	  Devy	  et	  al.	  2002;	  Griffith	  and	  
Swartz	  2006;	  Lee,	  Kenny	  et	  al.	  2007).	  Such	  models	  of	  3D	  invasion	  led	  to	  key	  understandings	  of	  
collective	  migration,	  including	  the	  early	  revelation	  that	  cancer	  cells	  migrate	  in	  clustered	  groups	  
of	  cells,	  and	  the	  more	  recent	  finding	  that	  this	  migration	  is	  often	  mediated	  by	  specific	  tip	  or	  
leader	  cells	  (Friedl,	  Noble	  et	  al.	  1995;	  Wolf,	  Wu	  et	  al.	  2007).	  Exciting	  advances	  in	  3D	  in	  vitro	  
structured	  tissue	  models	  are	  now	  allowing	  for	  studies	  of	  organized	  3D	  cell	  invasion	  during	  
cancer	  invasion,	  wound	  remodeling,	  and	  angiogenic	  sprouting	  (Polacheck,	  Charest	  et	  al.	  2011;	  
Legant,	  Chen	  et	  al.	  2012;	  Nguyen,	  Stapleton	  et	  al.	  2013).	  
The	  multi-­‐step	  process	  of	  angiogenesis	  requires	  the	  coordinated	  morphogenesis	  of	  
endothelial	  cells	  within	  existing	  capillary	  beds	  to	  sprout	  and	  form	  new	  interconnected	  vascular	  
conduits.	  The	  collective	  migration	  of	  invasive	  sprouting	  alone	  involves	  cooperative	  movements	  
amongst	  invading	  tip	  cells	  and	  following	  cells	  forming	  the	  multicellular	  stalk	  (Gerhardt,	  Golding	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et	  al.	  2003;	  Bentley,	  Mariggi	  et	  al.	  2009).	  Such	  movements	  require	  coordinated	  regulation	  
between	  polarized	  cell	  migration,	  cell-­‐cell	  adhesions,	  and	  cell-­‐matrix	  adhesions	  (Carmeliet	  and	  
Jain	  2011).	  While	  the	  mechanisms	  underlying	  this	  coordination	  are	  relatively	  poorly	  understood,	  
one	  key	  player	  is	  likely	  to	  be	  non-­‐muscle	  myosin	  II,	  which,	  with	  its	  actin	  crosslinking	  and	  actin	  
contracting	  activities,	  plays	  roles	  in	  cell	  migration,	  polarization	  and	  cell-­‐cell	  and	  cell-­‐matrix	  
adhesions	  (Vicente-­‐Manzanares,	  Ma	  et	  al.	  2009).	  In	  contrast	  to	  the	  consensus	  of	  its	  role	  in	  
migration	  on	  2D	  surfaces,	  the	  role	  of	  myosin	  in	  3D	  migration	  appears	  to	  be	  varied.	  	  
Within	  the	  complex	  setting	  of	  angiogenesis,	  limited	  studies	  have	  shown	  an	  unclear	  role	  
for	  myosin	  II	  in	  neovoessel	  formation.	  Most	  studies	  have	  focused	  upstream	  of	  myosin,	  instead	  
targeting	  RhoA	  and	  ROCK	  in	  experiments,	  and	  have	  found	  intriguingly	  varied	  results	  (Uchida,	  
Watanabe	  et	  al.	  2000;	  van	  Nieuw	  Amerongen,	  Koolwijk	  et	  al.	  2003;	  Hoang,	  Whelan	  et	  al.	  2004;	  
Hyvelin,	  Howell	  et	  al.	  2005;	  Mavria,	  Vercoulen	  et	  al.	  2006;	  Abraham,	  Yeo	  et	  al.	  2009;	  Kroll,	  
Epting	  et	  al.	  2009;	  Wimmer,	  Cseh	  et	  al.	  2012).	  In	  assessments	  of	  gross	  changes	  in	  VEGF-­‐,	  tumor-­‐,	  
or	  hypoxia-­‐stimulated	  angiogenesis	  in	  vivo,	  RhoA/ROCK	  signaling	  appeared	  to	  drive	  vessel	  
formation	  in	  some	  cases,	  and	  inhibit	  in	  others	  (Uchida,	  Watanabe	  et	  al.	  2000;	  Hoang,	  Whelan	  et	  
al.	  2004)}(Hyvelin,	  Howell	  et	  al.	  2005;	  Mavria,	  Vercoulen	  et	  al.	  2006).	  Investigations	  of	  
RhoA/ROCK/myosin	  II	  activity	  in	  vitro	  assessed	  ECs	  in	  assays	  merely	  associated	  with	  
angiogenesis,	  such	  as	  2D	  tube	  formation,	  scratch	  wound	  closure,	  or	  invasion	  from	  a	  bead	  
surface,	  and	  again	  found	  varied	  results	  (Abraham,	  Yeo	  et	  al.	  2009;	  Kroll,	  Epting	  et	  al.	  2009;	  
Wimmer,	  Cseh	  et	  al.	  2012).	  For	  example,	  in	  separate	  studies	  while	  ROCK	  activity	  appeared	  to	  
suppress	  invasion	  into	  a	  3D	  matrix,	  it	  increased	  2D	  migration	  and	  tube	  formation	  (Kroll,	  Epting	  
et	  al.	  2009)	  (Uchida,	  Watanabe	  et	  al.	  2000;	  van	  Nieuw	  Amerongen,	  Koolwijk	  et	  al.	  2003).	  
Upstream	  regulators	  of	  myosin	  II	  have	  numerous	  additional	  downstream	  effector	  proteins	  that	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may	  be	  at	  play,	  and	  a	  comprehensive	  evaluation	  of	  purely	  myosin-­‐mediated	  contractility	  during	  
angiogenesis	  remains	  to	  be	  conducted.	  	  
	  
Figure	   22.	   RhoA	   signaling	   pathway	   through	   ROCK	   and	  Myosin	   II.	   RhoA	   activation	   to	   the	   leads	   to	   activation	   and	  
transportation	  of	  ROCK	  to	   the	  plasma	  membrane.	  ROCK	  blocks	   the	  dephosphorylation	  of	   the	  myosin	   light	  chain	  by	  
myosin	  phosphatase.	  Consequently	  myosin	  II	  is	  activated	  and	  drives	  actomyosin	  contractility	  and	  actin	  bundling.	  This	  
activity	  has	  been	  tied	  separately	  to	  both	  pro	  and	  anti-­‐angiogenic	  responses	  in	  mice	  and	  in	  vitro.	  
	  
The	  formation	  of	  new	  vessels	  through	  angiogenic	  sprouting	  is	  a	  highly	  complex	  process	  
with	  numerous	  steps	  in	  which	  Rho/ROCK/myosin	  II	  roles	  likely	  vary.	  This	  likely	  explains	  some	  of	  
the	  variation	  between	  studies	   inhibiting	  upstream	  regulators	  of	  myosin	   II	  during	   in	  vivo	   vessel	  
formation	  and	  in	  in	  vitro	  assays.	  Here,	  we	  use	  a	  model	  that	  allows	  us	  to	  isolate	  a	  particular	  stage	  
of	   sprouting	   angiogenesis,	   sprout	   elongation,	   to	   study	   the	   isolated	   role	   of	   myosin-­‐mediated	  
contractility	   during	   this	   stage.	   Using	   our	   model,	   we	   quantitatively	   characterized	   angiogenic	  
sprout	  elongation	   in	  normal	  and	  contractility-­‐deficient	  angiogenesis	   to	  define	  the	  requirement	  
for	  myosin	  II	  during	  this	  phase	  of	  angiogenesis.	  
	  
Results	  
Inhibition	  of	  non-­‐muscle	  myosin	  II	  causes	  disassembly	  of	  adhesions	  between	  tip	  and	  stalk	  cells	  in	  a	  dose	  dependent	  manner.	  	  
The	  angiogenesis	  model	  described	  in	  Chapter	  2	  was	  used	  for	  all	  in	  vitro	  angiogenesis	  studies	  in	  
this	  chapter.	  Briefly,	  ECs	  were	  seeded	  into	  a	  cylindrical	  void	  within	  a	  3D	  collagen	  type	  1	  matrix.	  
Angiogenic	  factors	  (MVPS;	  described	  in	  pages	  58-­‐60)	  were	  applied	  in	  a	  diffusive	  gradient	  to	  the	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monolayer	  of	  ECs,	  which	  caused	  activated	  ECs	  to	  migrate	  toward	  the	  gradient	  source	  as	  
multicellular	  sprouts.	  Sprouts	  were	  comprised	  of	  a	  leading	  tip	  cell	  with	  protrusions	  extending	  in	  
the	  gradient	  direction	  followed	  by	  multiple	  stalk	  cells	  lining	  a	  narrow	  lumen.	  Cells	  maintained	  
cell-­‐cell	  contacts	  throughout	  the	  sprouting	  process.	  Within	  3	  days	  of	  cocktail	  initiation,	  
angiogenic	  sprouts	  were	  multicellular	  with	  stalks	  comprised	  of	  multiple	  ECs.	  	  
	   To	  examine	  the	  effect	  of	  inhibited	  contractility	  on	  EC	  sprouting,	  the	  gradient	  of	  
angiogenic	  factors	  was	  applied	  in	  the	  presence	  of	  blebbistatin,	  a	  small	  molecule	  inhibitor	  with	  
high	  affinity	  and	  selectivity	  toward	  myosin	  II	  that	  causes	  myosin	  to	  remain	  in	  an	  actin-­‐detached	  
state.	  Following	  five	  days	  of	  stimulation	  under	  inhibited	  contractility,	  EC	  sprouts	  were	  fixed	  and	  
stained	  for	  analysis.	  Surprisingly,	  contractility	  inhibition	  affected	  neither	  the	  speed	  nor	  the	  
cellular	  density	  of	  EC	  invasion	  from	  the	  pre-­‐patterned	  channel	  (FIG	  23A,B).	  Blebbistatin	  did,	  
however,	  affect	  the	  collectivity	  of	  migration.	  The	  invasion	  under	  inhibited	  contractility	  was	  
characterized	  by	  a	  significant	  increase	  in	  single	  cells	  as	  compared	  to	  control	  sprouting	  (FIG	  
23A,B).	  Thus,	  blebbistatin	  treatment	  caused	  a	  loss	  of	  cell-­‐cell	  contacts	  required	  for	  collective	  
angiogenic	  sprout	  invasion.	  	  
To	  determine	  if	  contact	  loss	  occurred	  during	  the	  collective	  invasion	  of	  sprout	  extension,	  
as	  opposed	  to	  prior	  to	  migration,	  contractility	  inhibition	  was	  applied	  to	  Day	  3	  multicellular	  
sprouts	  in	  which	  tip	  and	  stalk	  cells	  are	  morphologically	  defined.	  Following	  3	  days	  of	  MVPS	  
stimulation,	  a	  24-­‐hr	  treatment	  of	  (+/-­‐)	  blebbistatin	  (at	  10	  μM,	  30μM,	  or	  50μM)	  or	  vehicle	  
(dimethyl	  sulfoxide)	  control	  was	  applied.	  Devices	  were	  subsequently	  fixed	  and	  stained	  for	  
analysis.	  High-­‐resolution	  images	  allowed	  evaluation	  of	  sprout	  morphology.	  Tip	  cells	  were	  
defined	  spatially	  and	  morphologically	  by	  their	  existence	  in	  the	  front	  of	  the	  cellular	  invasion	  and	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the	  presence	  of	  long	  actin-­‐rich	  protrusions	  directed	  toward	  the	  gradient	  source.	  Remaining	  cells,	  
behind	  the	  invasion	  front	  and	  lacking	  pseudopodia,	  were	  deemed	  stalk	  cells.	  
Invasion	  following	  MVPS	  stimulation	  and	  subsequent	  Day	  3	  vehicle	  control	  treatment	  
was	  characterized	  by	  numerous	  multicellular	  structures	  with	  few	  sporadic	  unpaired	  cells	  within	  
the	  invasion	  region	  (FIG	  23C,D).	  Treatment	  with	  increasingly	  high	  concentrations	  of	  blebbistatin	  
caused	  an	  increasing	  loss	  of	  cell-­‐cell	  contacts	  between	  tip	  cells	  and	  stalk	  cells	  (FIG	  23C,D).	  An	  
insignificant	  increase	  in	  loss	  of	  stalk-­‐stalk	  contacts	  also	  occured.	  Thus,	  these	  findings	  suggest	  
myosin-­‐mediated	  actin	  contractility	  is	  not	  required	  for	  ECs	  to	  sense	  angiocrine	  gradients	  and	  
move	  towards	  them,	  but	  is	  required	  for	  the	  maintenance	  of	  leading	  cell-­‐cell	  contacts	  during	  in	  
vitro	  angiogenic	  sprout	  extension.	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Figure	  23.	   In	  vitro	  sprouting	  during	  myosin	   inhibition	  A)	  Representative	  confocal	   immunofluorescence	  
images	  of	  indicated	  conditions	  at	  Day	  5	  after	  MVPS-­‐driven	  sprouting	  under	  30	  μM	  blebbistatin	  or	  vehicle	  
control	   treatment.	   B)	   Quantifications	   of	   invasion	   density,	   distance	   and	   collectivity	   at	   Day	   5.	   C)	  
Representative	   confocal	   immunofluorescence	   images	   of	   indicated	   conditions	   at	   Day	   4	   after	   24-­‐hour	  
blebbistatin	   treatment.	   F-­‐actin	   and	   nuclei	   are	   labeled	   with	   phalloidin	   (green)	   and	   DAPI	   (blue),	  
respectively.	  D)	  Upper	  plot:	   quantification	  of	   detached	   tip	   cells	   (upper	  plot)	   and	   stalk	   cells	   (lower	  plot)	  
following	  blebbistatin	  treatment.	  Scale	  bars	  are	  100	  μm.	  N	  ≥	  5	  devices	  per	  condition.	  Error	  bars	  are	  S.E.M.	  
*	  represents	  significant	  difference	  from	  vehicle	  control	  (p	  <	  0.05).	  	  
	  
Images	  of	  sprouts	  labeled	  for	  F-­‐actin	  and	  nuclei	  allowed	  the	  assessment	  of	  contractility	  
inhibition	  during	  sprout	  extension	  on	  the	  sprout	  structures	  themselves.	  To	  evaluate	  the	  effect	  
on	  cell-­‐matrix	  interactions,	  we	  imaged	  the	  matrix	  around	  blebbistatin-­‐treated	  sprouts.	  While	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cells	  maintain	  contact	  with	  the	  collagen	  matrix	  after	  blebbistatin	  treatment,	  at	  the	  location	  of	  
lost	  cell-­‐cell	  contacts	  large,	  cell-­‐sized	  tunnels	  exist	  in	  the	  matrix	  between	  the	  two	  cells	  (FIG	  24).	  
This	  suggests	  when	  cells	  lose	  their	  cell-­‐cell	  contacts,	  stalk	  cells	  face	  pre-­‐degraded	  channels	  
ahead.	  These	  results	  demonstrated	  myosin-­‐mediated	  contractility	  was	  required	  for	  maintenance	  
of	  tip	  cell-­‐stalk	  cell	  contacts	  during	  angiogenic	  sprout	  extension.	  
	  
	  
Figure	  24.	  Structure	  of	  collagen	  matrix	  following	  blebbistatin	  treatment	  of	  an	  extending	  sprout	  A)	  Representative	  
confocal	  immunofluorescence	  image	  of	  sprouts	  conditions	  at	  Day	  3	  following	  24	  hour	  30	  μM	  blebbistatin	  treatment.	  
B)	  2x	  zoom	  of	  orange	  box	  in	  A.	  Narrowed	  z-­‐stack	  to	  show	  interactions	  of	  leading	  tip	  cell	  (white	  arrow)	  and	  following	  
cell	  (yellow	  arrow).	  C)	  2x	  zoom	  of	  pink	  box	  in	  B.	  Narrowed	  z-­‐stack	  to	  show	  channel	  between	  two	  cells.	  Collagen	  fibers	  
are	  shown	  in	  white.	  Scale	  bars	  are	  25μm.	  	  
	  
Blebbistatin	  affects	  cadherin	  organization	  during	  angiogenic	  sprout	  extension	  
The	  loss	  of	  cell-­‐cell	  contacts	  suggested	  blebbistatin	  treatment	  may	  have	  affected	  a	  change	  in	  
cell-­‐cell	  adhesions.	  In	  time-­‐lapse	  imaging	  collected	  over	  17	  hours	  following	  addition	  of	  50	  μM	  
blebbistatin	  to	  m-­‐apple	  VE-­‐cadherin	  expressing	  cells,	  the	  cadherin-­‐based	  adhesion	  between	  a	  
tip	  cell	  and	  stalk	  cell	  was	  lost	  within	  6	  hours	  of	  treatment	  initiation	  (FIG	  25).	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Figure	  25.	  VE-­‐cadherin	  dynamics	  in	  an	  extending	  sprout	  treated	  with	  blebbistatin	  A)	  Tip	  and	  stalk	  cell	  of	  an	  invading	  
sprout	  taken	  immediately	  after	  30μM	  blebbistatin	  addition.	  Cells	  transfected	  with	  mApple	  VE-­‐cadherin.	  B)	  Zoomed-­‐n	  
frames	  from	  video	  of	  mApple	  VE	  Cadherin	  ECs	  in	  a	  sprout	  treated	  with	  30μM	  blebbistatin.	  Top	  Panel:	  Hours	  0-­‐5.5	  
show	  tip-­‐stalk	  adhesion	  loss.	  Bottom	  Panel:	  Hour	  7.5	  –	  17	  show	  development	  of	  new	  protrusions	  at	  the	  lead	  end	  of	  
the	  stalk	  cell.	  C)	  Tip	  and	  stalk	  cell	  of	  an	  invading	  sprout	  taken	  17	  hrs	  after	  30μM	  blebbistatin	  addition.	  Scale	  bars	  are	  
50μm.	  White	  arrows	  designate	  cadherin-­‐adhesion	  location	  through	  initial	  site	  of	  junction	  loss.	  
	  
	   Under	  the	  same	  conditions	  described	  above	  and	  presented	  in	  Figure	  23	  we	  used	  high-­‐
resolution	  microscopy	  to	  evaluate	  VE-­‐cadherin	  localization	  in	  Day	  4	  sprouts	  treated	  with	  0,	  10,	  
30,	  and	  50	  μM	  blebbistatin.	  40X	  adhesion	  images	  were	  pooled	  for	  each	  condition	  into	  a	  
population	  and	  categorized	  as	  between	  tip	  and	  following	  stalk	  cell	  (tip-­‐stalk)	  or	  between	  
neighboring	  stalk	  cells	  (stalk-­‐stalk).	  The	  adhesions	  between	  tip	  and	  stalk	  cells	  in	  control	  in	  vitro	  
sprouts	  were	  punctate,	  and	  tortuous	  or	  discontinuous	  in	  nature.	  In	  contrast,	  stalk-­‐stalk	  
adhesions	  appeared	  generally	  smoother	  and	  more	  linear,	  particularly	  when	  running	  parallel	  to	  
direction	  of	  sprout	  migration	  (FIG	  26A).	  To	  quantify	  adhesion	  profiles,	  adhesions	  were	  
categorized	  as	  (1	  discontinuous,	  (2	  tortuous,	  or	  (3	  linear	  (FIG	  26B).	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Figure	  26.	  Effect	  of	  blebbistatin	  treatment	  on	  VE-­‐cadherin	  organization	  in	  an	  extending	  sprout	  A)	  Image	  of	  VE-­‐
cadherin	  adhesions	  in	  a	  control	  sprout	  and	  in	  10,	  30,	  50	  μM	  Blebbi-­‐treated	  sprouts.	  Blebbistatin	  was	  added	  after	  3	  
days	  of	  growth	  factor-­‐driven	  angiogenesis.	  Sprouts	  were	  fixed	  24	  hours	  later.	  Scale	  bars	  are	  50μm.	  B)	  Representative	  
images	  of	  cataloged	  adhesion	  types.	  C)	  Cataloging	  of	  adhesion	  types	  for	  both	  tip-­‐stalk	  and	  stalk-­‐stalk	  adhesions	  in	  
control	  	  sprouts.	  D)	  Cataloging	  of	  adhesion	  types	  for	  stalk-­‐stalk	  adhesions	  in	  control	  and	  blebbistatin-­‐treated	  sprouts.	  
Cadherin	  adhesions	  were	  evaluated	  as	  populations	  for	  each	  blebbistatin	  condition.	  N	  >	  3	  devices	  per	  condition.	  
	  
With	  increasing	  blebbistatin	  treatment	  concentration,	  the	  population	  profile	  of	  tip-­‐stalk	  
adhesions,	  which	  was	  largely	  punctate	  and	  discontinuous	  in	  untreated	  sprouts,	  shifted	  to	  an	  
even	  more	  discontinuous	  profile.	  Stalk	  cell	  adhesions,	  which	  were	  smooth	  and	  linear	  in	  
untreated	  sprouts,	  shifted	  to	  a	  more	  discontinuous	  adhesion	  profile.	  Thus,	  bebbistatin	  
treatment	  during	  in	  vitro	  sprout	  extension	  affected	  cadherin	  organization	  at	  cell-­‐cell	  junctions.	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Decreased	  contractility	  affects	  junction	  activity	  in	  an	  angiogenesis	  simulation	  model	  
Recently,	   Bentley	   et	   al.	   built	   on	   cell-­‐cell	   adhesion	   and	   signaling	   network	   models	   to	   include	  
receptor	  level	  dynamics,	  particle	  diffusion,	  and	  multicellular	  remodeling	  in	  a	  model	  of	  sprouting	  
angiogenesis	  (Bentley,	  Franco	  et	  al.	  2014).	  This	  hybrid	  model	  included	  a	  3D	  multicellular	  spatial	  
model	  simulating	  a	  sprout	  comprised	  of	  cells	  with	  Notch/VEGF	  signaling	  and	  filopodia	  dynamics.	  
This	   component	  was	   a	   previously	   validated	  Notch	   tip	   cell	   selection	   spring	  model	   from	   earlier	  
work	   by	   the	   same	   group	   (Bentley,	   Gerhardt	   et	   al.	   2008;	   Bentley,	   Mariggi	   et	   al.	   2009).	   A	  
junctional	   remodeling	   component	   of	   the	   2014	   model,	   which	   allowed	   cell	   rearrangement	   via	  
junctional	   dynamics,	   was	   based	   on	   the	   cellular	   Potts	   model.	   Combinations	   of	   the	   spring	   and	  
Potts	  models	  allowed	  investigation	  of	  force	  and	  signaling-­‐mediated	  junctional	  dynamics.	  Model	  
simulations	  paired	  with	  in	  vitro	  and	  in	  vivo	  experiments	  revealed	  a	  regulatory	  role	  for	  Notch	  and	  
cell	   contractility	   in	   junction	   dynamics	   during	   sprouting	   angiogenesis	   and	   cell-­‐cell	  
rearrangements.	  
This	  model	  was	  capable	  of	  evaluating	  two	  separate,	  though	  linked,	  mechanisms	  of	  
sprout	  progression	  and	  cell-­‐cell	  interactions.	  The	  first	  mechanism	  (M1)	  was	  defined	  by	  
differential	  adhesion	  strengths	  within	  the	  sprout.	  This	  was	  modeled	  through	  VEGFR-­‐2	  levels,	  as	  
VEGFR-­‐2	  has	  been	  shown	  to	  drive	  cadherin	  activity	  through	  endocytosis	  (Gavard	  and	  Gutkind	  
2006).	  As	  a	  basis	  of	  understanding,	  adhesion	  activity	  itself	  powers	  cell	  rearrangements	  in	  2D	  
studies	  of	  epithelial	  cells	  (Foty	  and	  Steinberg	  2005).	  The	  second	  mechanism	  (M2)	  evaluated	  the	  
effects	  of	  cortical	  actin	  protrusions	  formed	  at	  cell-­‐cell	  adhesions,	  permitting	  free	  VEGFR-­‐2-­‐
independent	  polarized	  movements	  of	  the	  junctions.	  	  
The	  model	  sprout	  included	  10	  unique	  cells,	  with	  nine	  cells	  in	  the	  sprout	  stalk	  (2	  cells	  per	  
cross	  section)	  and	  one	  cell	  designated	  as	  a	  tip	  cell.	  The	  cell	  membrane	  and	  actin	  skeleton	  of	  each	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cell	  were	  spatially	  represented	  by	  a	  linked	  mesh	  surface,	  consisting	  of	  1um2	  elements	  (called	  
MemAgents)	  connected	  by	  springs	  that	  follow	  Hooke’s	  law.	  Each	  MemAgent	  interacted	  with	  26	  
of	  its	  nearest	  neighbors,	  which	  may	  be	  MemAgents	  within	  the	  same	  cell,	  or	  if	  the	  agent	  was	  
located	  at	  a	  cell-­‐cell	  junction,	  with	  MemAgents	  of	  the	  adjacent	  cell.	  Each	  MemAgent	  interaction	  
resulted	  in	  an	  evaluation	  of	  relative	  adhesive	  free	  energy	  	  (regulated	  by	  VEGFR-­‐2	  expression;	  
M1)	  within	  the	  context	  of	  satisfying	  the	  constraints	  of	  polarized	  protrusion	  formation	  (inhibited	  
by	  notch	  expression;	  M2).	  Junction	  activity	  was	  mediated	  by	  actin	  cortex	  dynamics,	  which	  was	  
directly	  mediated	  by	  notch	  (M2:	  high	  DLL4	  expression	  =	  high	  protrusions	  =	  high	  junction	  
activity),	  while	  adhesion	  strength	  was	  mediated	  by	  VEGFR-­‐2	  signaling	  (M1:	  high	  VEGFR-­‐2	  =	  high	  
VE-­‐cadherin	  endocytosis	  =	  weak	  adhesions).	  Over	  time	  and	  averages	  of	  MemAgent	  interactions,	  
cells	  with	  weaker,	  more	  active	  adhesions	  moved	  past	  cells	  with	  stronger,	  less	  active	  adhesions.	  	  
In	  their	  recent	  publication,	  Bentley	  et	  al.	  examined	  the	  effect	  of	  differential	  adhesion	  
activity	  and	  protrusion	  formation	  in	  the	  sprout	  under	  numerous	  perturbations	  (including	  VEGFR-­‐
2+/-­‐	  and	  VEGFR-­‐1+/-­‐	  chimeric	  sprouting)	  and	  matched	  results	  with	  in	  vitro	  sprouting	  under	  the	  
same	  conditions.	  Matching	  of	  in	  vitro	  and	  in	  silco	  data	  suggested	  sprout	  dynamics	  were	  
mediated	  by	  differential	  levels	  of	  polarized	  (in	  the	  direction	  of	  sprout	  migration)	  protrusion	  
activity	  (M2)	  and	  differential	  levels	  of	  adhesion	  activity	  (M1)	  in	  cells.	  The	  model	  dynamics	  were	  
based	  on	  in	  vitro	  dynamics	  of	  cell	  rearrangement	  and	  notch	  signaling	  patterns,	  and	  simulations	  
were	  set	  to	  model	  approximately	  125	  hours	  of	  cell-­‐cell	  dynamics	  in	  a	  sprout.	  The	  study	  reported	  
the	  following	  findings:	  	  
1. Differential	  adhesions	  within	  a	  sprout	  and	  differential	  levels	  of	  polarized	  protrusions	  
were	  required	  for	  cell-­‐cell	  rearrangements	  in	  sprouts.	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2. These	  differential	  M1	  and	  M2	  profiles	  propelled	  cells	  with	  polarized	  protrusions	  and	  
weak	  adhesions	  forward	  in	  the	  sprout	  toward	  the	  tip.	  	  
	  
This	  model,	  with	  its	  consideration	  of	  notch-­‐mediated	  signaling	  and	  adhesion	  strength,	  
presented	  a	  starting	  point	  examination	  of	  the	  myosin-­‐mediated	  effects	  on	  cell	  rearrangements	  
and	  junction	  dynamics.	  While	  the	  model	  hypothesis	  included	  protrusion	  activity	  at	  cell-­‐cell	  
adhesions	  as	  a	  function	  of	  contractility,	  it	  did	  not	  capture	  all	  potential	  effects	  of	  such	  
protrusions	  (Vicente-­‐Manzanares,	  Zareno	  et	  al.	  2007).	  For	  example,	  protrusions	  in	  contractility-­‐
deficient	  cells	  are	  a	  result	  of	  increased	  Rac-­‐1	  signaling,	  which	  is	  strongly	  associated	  with	  both	  
disruption	  and	  tightening	  of	  adhesions	  depending	  on	  signaling	  duration	  (van	  Wetering,	  van	  Buul	  
et	  al.	  2002)	  (Waschke,	  Baumgartner	  et	  al.	  2004;	  Perez-­‐Moreno	  and	  Fuchs	  2006;	  Fischer,	  Gardel	  
et	  al.	  2009).	  Rac-­‐1	  regulation	  of	  VE-­‐cadherin	  adhesions	  was	  not	  incorporated	  into	  the	  model.	  
The	  model	  also	  did	  not	  consider	  other	  potential	  effects	  of	  decreasing	  contractility,	  including	  the	  
well-­‐established	  requirement	  for	  contractility	  during	  formation	  of	  new	  cadherin	  complexes	  
(Shewan,	  Maddugoda	  et	  al.	  2005).	  	  
This	  model	  was	  adapted	  by	  Bert	  Cruys	  (co-­‐advised	  by	  Dr.	  Katie	  Bentley)	  to	  provide	  
insight	  into	  our	  in	  vitro	  model	  findings	  of	  contractility-­‐mediated	  adhesion	  dynamics	  during	  
sprout	  extension	  (Figures	  25	  and	  26).	  Increasing	  the	  relative	  effect	  of	  M2	  (increasing	  polarized	  
protrusions	  at	  cell-­‐cell	  adhesions)	  was	  used	  to	  model	  the	  effect	  of	  inhibiting	  contractility.	  Thus,	  
within	  this	  model,	  we	  were	  simply	  capturing	  the	  potential	  effects	  of	  contractility	  inhibition	  on	  
protrusion-­‐mediated	  cell	  motility	  within	  the	  sprout.	  Further	  potential	  adaptations	  of	  the	  model	  
to	  more	  comprehensively	  model	  contractility	  modulation	  and	  VE-­‐cadherin	  dynamics	  are	  
discussed	  under	  “Chapter	  4:	  Collective	  Migration,	  Future	  investigations.”	  Our	  outputs	  were:	  cell	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rearrangement	  rate	  (hours	  between	  a	  rearrangement	  event),	  tip	  cell	  overtake	  (in	  the	  case	  of	  
heterogeneous	  cell	  populations),	  and	  pVEGFR-­‐2	  adhesion	  strength	  profile.	  	  
Simulation	  1:	  Blebbistatin	  treatment	  of	  cells	  in	  a	  WT	  sprout	  
A	  simulation	  examined	  the	  effects	  of	  increasing	  the	  relative	  M2	  effect	  within	  a	  wildtype	  (WT)	  
sprout	  on	  cell	  rearrangement	  and	  adhesion	  strength	  profiles.	  Simulations	  were	  run	  under	  two	  
separate	  scenarios	  for	  M1/M2	  interaction;	  in	  the	  first	  scenario,	  protrusion	  activity	  affects	  
adhesion	  strength.	  This	  was	  modeled	  as	  VEGFR-­‐2	  independent,	  such	  that	  pVEGFR-­‐2	  profiles	  do	  
not	  show	  adhesion	  weakening,	  and	  in	  the	  second	  scenario	  protrusion	  activity	  was	  not	  linked	  to	  
adhesion	  strength	  in	  anyway.	  The	  simulation	  results	  (which	  average	  of	  50	  simulation	  runs)	  
showed	  increased	  blebbistatin	  treatment	  drove	  an	  increase	  in	  the	  cell	  rearrangements	  within	  
the	  sprout	  (FIG	  27).	  This	  is	  presented	  in	  data	  as	  “hours	  between	  a	  rearrangement	  event.”	  Thus	  
higher	  rates,	  suggest	  lower	  cell-­‐cell	  rearrangement	  events.	  Such	  increased	  cell	  shuffling	  was	  
observed	  in	  both	  in	  silico	  and	  in	  vivo	  models	  of	  inhibited	  notch	  signaling,	  as	  well	  as	  in	  silico	  in	  a	  
simulation	  of	  all	  weakly	  adhesive	  adhesions.	  Predicted	  VEGFR-­‐2	  mediated	  adhesion	  strength	  
profiles	  were	  not	  affected	  by	  blebbistatin-­‐treatment	  (FIG	  28).	  As	  M2	  is	  not	  modeled	  to	  affect	  
VEGFR-­‐2,	  any	  changes	  would	  be	  through	  unpredicted	  feedback	  loops.	  Simulation	  1	  suggests	  
blebbistatin	  treatment	  is	  predicted	  to	  increase	  cell	  motility	  within	  the	  model	  sprout.	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Figure	   27.	   Simulated	   results	   of	   blebbistatin	   treatment	   of	   a	   homogeneous	   wild	   type	   sprout.	   Left	   plot:	   Effect	   of	  
increasingly	  high	  doses	  of	  blebbistatin	  on	  cell	  rearrangement	  rates	  in	  the	  sprout.	  Right	  plot:	  Effect	  of	  blebbistatin	  on	  
tip	  cell	  designation.	  Cells	  are	  randomly	  designated	  as	  green	  or	  red	  in	  the	  homogeneous	  WT	  sprout,	  so	  random	  tip	  cell	  
contribution	   (50%)	   is	   expected.	   Solid	   bars	   represent	   scenario	   1:	   No	   M1/M2	   interaction.	   Textured	   bars	   represent	  
scenario:	  M2	  affects	  M1.	  	  	  
	  
As	  reported	  in	  Bentley	  2014,	  DAPT	  (inhibition	  of	  notch	  signaling)	  treatment	  of	  the	  WT	  
sprout	  shifted	  adhesion	  profiles	  to	  weak,	  active	  adhesions.	  The	  sinusoidal	  pattern	  of	  pVEGFR-­‐2	  is	  
also	  lost	  as	  sinusoidal	  NOTCH	  signaling	  is	  disrupted	  under	  DAPT.	  Thus,	  while	  DAPT	  treatment	  in	  
this	  model	  regulates	  both	  VEGFR-­‐2	  mediated	  strength,	  and	  protrusion	  activity,	  blebbistatin	  
treatment	  in	  the	  model	  only	  regulate	  protrusion	  activity.	  Model	  simulations	  show	  additive	  
effects	  of	  DAPT	  treatment	  and	  blebbistatin	  treatment	  did	  not	  shift	  the	  pVEGF-­‐R2	  adhesion	  
profile	  as	  expected	  (FIG	  28).	  High	  blebbistatin	  treatment	  in	  combination	  with	  DAPT	  treatment,	  
both	  of	  which	  are	  modeled	  to	  increase	  cell	  migration,	  yielded	  a	  cell	  rearrangement	  rate	  of	  
approximately	  2.8	  h.	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Figure	  28.	  pVEGFR-­‐2	  mediated	  adhesion	  strength	  profiles	  over	  125	  hours.	  Upper	   left	  plot:	  No-­‐treatment	  adhesion	  
strengths	   (green	   and	   red	   cells	   are	   two	   identical	   WT	   populations).	   Upper	   Right	   plot:	   Mixed	   population	   adhesion	  
strengths.	  Blebbistatin	  cells	  are	  shown	  in	  green,	  WT	  cells	  are	  shown	  in	  red.	  Scenario	  M2	  does	  affect	  M1.	  Lower	  left	  
plot:	  DAPT-­‐treatment	   adhesion	   strengths	   (green	  and	   red	   cells	   are	   two	   identical	  WT	  populations).	   Lower	   right	   Plot:	  
DAPT-­‐	  and	  blebbistatin-­‐treated	  adhesion	  strengths	   (green	  and	  red	  cells	  are	  two	   identical	  populations).	  Black	   line	  at	  
200	  units	  represents	  distinction	  between	  strong	  (below)	  and	  weak	  (above)	  adhesion	  strength.	  
	  
Simulation	  2:	  Blebbistatin	  treatment	  isolated	  to	  individual	  cells	  within	  a	  sprout	  
In	  a	  separate	  simulation,	  cells	  were	  deemed	  either	  WT	  or	  mutant	  “blebbistatin-­‐treated”.	  A	  50:50	  
mix	  of	  cells	  were	  simulated	  in	  a	  sprout	  (random	  initial	  positioning	  throughout	  the	  sprout).	  
Simulation	  results	  showed	  the	  average	  occurrences	  of	  cell-­‐cell	  rearrangements	  in	  the	  sprout	  
increased	  with	  increasing	  blebbistatin	  treatment	  in	  the	  mutant	  cells	  (FIG	  29).	  While	  the	  trend	  of	  
increasing	  shuffling	  was	  consistent	  across	  Simulation	  1	  and	  Simulation	  2,	  the	  numerical	  
decreases	  in	  rearrangement	  rate	  with	  increasing	  blebbistatin	  treatment	  were	  smaller	  in	  this	  
second	  simulation.	  This	  is	  predicted	  as	  only	  half	  the	  cells	  in	  the	  sprout	  were	  experiencing	  
decreased	  contractility.	  
At	  the	  end	  of	  simulation,	  results	  showed	  blebbistatin	  cells	  were	  in	  the	  tip	  cell	  position	  
more	  often	  than	  were	  WT	  cells	  (FIG	  29).	  In	  the	  condition	  of	  highest	  blebbistatin	  treatment,	  tip	  
cells	  were	  almost	  exclusively	  blebbistatin	  cells.	  This	  same	  phenotype	  of	  cells	  localizing	  to	  the	  
sprout	  front	  was	  predicted	  in	  Bentley	  et	  al.	  2014	  for	  cells	  exhibiting	  weakly	  adhesive	  adhesions	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within	  a	  sprout	  of	  differential	  adhesion	  types.	  This	  result	  and	  the	  cell-­‐cell	  rearrangement	  rate	  
results,	  hypothesize	  the	  increased	  formation	  of	  polarized	  protrusion	  induced	  by	  blebbistatin	  
treatment	  is	  key	  in	  propelling	  these	  blebbistatin-­‐treated	  cells	  towards	  the	  tip	  of	  the	  sprout.	  
Thus,	  blebbistatin	  treatment	  in	  this	  model	  caused	  cells	  to	  experience	  a	  more	  dynamic	  cell-­‐cell	  
interface.	  	  
	  
Figure	   29.	   Simulated	   results	   of	   a	   WT:blebbistatin	   (blebbi)	   sprout.	   Left	   plot:	   Effect	   of	   increasingly	   high	   doses	   of	  
blebbistatin	  in	  the	  blebbi	  mutant	  cells	  (50%	  of	  population)	  on	  total	  cell	  rearrangement	  rates	  in	  the	  sprout.	  Right	  plot:	  
Effect	  of	  blebbistatin	   in	   the	  blebbi	  mutant	   cells	  on	   tip	   cell	   designation.	  Blebbistatin	  mutant	   cells	   are	  designated	  as	  
green	   and	  WT	   cells	   are	   designated	   as	   red	   in	   the	   heterogeneous	   WT	   sprout.	   Solid	   bars	   represent	   scenario	   1:	   No	  
M1/M2	  interaction.	  Textured	  bars	  represent	  scenario:	  M2	  affects	  M1.	  	  	  
	  
When	  adhesion	  types	  of	  the	  two	  cell	  types	  were	  evaluated,	  blebbistatin-­‐treated	  cells	  
appeared	  to	  have	  adhesion	  profiles	  very	  slightly	  shifted	  toward	  higher	  VEGFR-­‐2	  adhesion	  
strength	  (FIG	  28).	  This	  is	  intriguing	  because	  no	  shift	  in	  activity	  profiles	  was	  observed	  in	  the	  broad	  
blebbistatin	  treatment	  of	  Simulation	  1.	  This	  may	  suggest	  the	  model	  predicts	  decreased	  myosin-­‐
mediated	  contractility	  only	  affects	  VEGFR-­‐2	  mediated	  endocytosis	  of	  VE-­‐cadherin	  at	  adhesions	  
between	  cells	  of	  different	  internal	  contractility	  levels.	  When	  WT:blebbistatin	  sprouts	  were	  
treated	  with	  DAPT,	  high	  blebbistatin	  plus	  DAPT	  yielded	  cell-­‐rearrangement	  rates	  of	  2.8	  hrs,	  and	  
green	  cell	  concentration	  to	  tip	  position	  of	  50%.	  Thus,	  it	  appears,	  while	  contractility	  regulates	  cell	  
dynamics	  within	  the	  model,	  these	  effects	  are	  lost	  when	  all	  adhesions	  in	  the	  sprout	  are	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weakened.	  This	  suggests	  that	  within	  this	  model	  blebbistatin-­‐induced	  cell	  motility	  is	  insignificant	  
in	  comparison	  with	  DAPT-­‐induced	  weakening	  through	  increased	  VE-­‐cadherin	  endocytosis.	  	  
Simulation	  3:	  Blebbistatin	  treatment	  of	  VEGFR-­‐2+/-­‐and	  WT	  cells	  in	  a	  sprout	  
Cells	  with	  half	  the	  WT	  level	  of	  VEGFR-­‐2	  signaling	  were	  included	  in	  a	  sprout	  at	  a	  ratio	  of	  1:1	  with	  
WT	  cells	  to	  model	  a	  setting	  of	  differential	  adhesions	  (FIG	  31).	  Bentley	  et	  al.	  2014,	  found	  
differential	  adhesions	  were	  required	  to	  model	  in	  vivo	  like	  cell	  rearrangements.	  VEGFR-­‐2+/-­‐	  cells	  
are	  modeled	  to	  have	  increased	  cell	  adhesion	  strength	  as	  a	  consequence	  of	  reduced	  VE-­‐cadherin	  
endocytosis.	  Simulation	  of	  blebbistatin	  treatment	  in	  the	  heterogeneous	  sprouts	  predicted	  an	  
increase	  in	  cell-­‐cell	  rearrangement	  events,	  consistent	  with	  the	  trend	  of	  the	  previous	  two	  
simulations	  (FIG	  30).	  	  
	  
Figure	   30.	   Simulated	   results	   of	   blebbistatin	   treatment	  of	   a	  WT:VEGFR-­‐2+/-­‐	   sprout.	   Left	   plot:	   Effect	   of	   increasingly	  
high	   doses	   of	   blebbistatin	   on	   cell	   rearrangement	   rates	   in	   the	   sprout.	   Right	   plot:	   Effect	   of	   blebbistatin	   on	   tip	   cell	  
designation.	   Blebbistatin-­‐treated	   cells	   are	   designated	   as	   green	   and	   WT	   cells	   are	   designated	   as	   red.	   Solid	   bars	  
represent	  scenario	  1:	  No	  M1/M2	  interaction.	  Textured	  bars	  represent	  scenario:	  M2	  affects	  M1.	   	  
	  
The	  predicted	  relative	  scale	  of	  cell	  rearrangement	  effect	  was	  greater	  than	  in	  the	  two	  
previous	  simulations.	  In	  the	  case	  of	  no	  blebbistatin,	  the	  VEGFR-­‐2+/-­‐-­‐:WT	  sprouts	  had	  greater	  cell	  
rearrangements	  than	  a	  WT:WT	  sprout,	  as	  predicted	  from	  simulated	  rearrangement	  results	  in	  a	  
sprout	  with	  differential	  adhesions	  from	  Bentley	  et	  al.	  2014.	  Highest	  blebbistatin	  treatment	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reduced	  the	  rate	  of	  cell	  rearrangement	  by	  approximately	  40%,	  this	  compares	  to	  a	  reduction	  in	  
rate	  of	  only	  20%	  in	  the	  case	  of	  highest	  blebbistatin	  treatment	  in	  the	  WT	  sprout.	  Thus,	  this	  model	  
hypothesizes	  increases	  in	  junction	  protrusion	  activity	  via	  blebbistatin	  differentially	  increase	  cell	  
rearrangements	  in	  sprouts	  of	  heterogeneous	  adhesions	  strengths	  as	  compared	  to	  sprouts	  of	  
uniform	  adhesion	  strength.	  Blebbistatin	  treatment,	  which	  increases	  protrusions	  in	  all	  cells,	  is	  not	  
predicted	  to	  effect	  tip	  cell	  position,	  which	  was	  generally	  dominated	  by	  the	  cells	  with	  weaker	  
assigned	  adhesion.	  At	  high	  blebbistatin	  treatment,	  under	  the	  scenario	  that	  M2	  affects	  M1,	  we	  
see	  strong	  adhesions	  are	  suddenly	  predicted	  to	  dominate	  the	  tip	  cell	  position	  (FIG	  31).	  	  
Figure	   31.	   pVEGFR-­‐2	   mediated	   adhesion	   strength	   profiles	   over	   125	   hours.	   Left	   plot:	   No-­‐treatment	   of	   mixed	  
population	   adhesion	   strengths.	   VEGFR-­‐2+/-­‐	   cells	   are	   shown	   in	   green,	   WT	   cells	   are	   shown	   in	   red.	   Right	   plot:	  
Blebbistatin-­‐treatment	   of	  mixed	   population	   adhesion	   strengths.	   VEGFR-­‐2+/-­‐	   cells	   are	   shown	   in	   green,	  WT	   cells	   are	  
shown	   in	   red.	   Black	   line	   at	   200	   units	   represents	   distinction	   between	   strong	   (below)	   and	   weak	   (above)	   adhesion	  
strength.	  
	  
A	  subsequent	  simulation	  examined	  model	  predictions	  of	  cell	  rearrangement	  and	  tip	  cell	  
contribution	  if	  VEGFR-­‐2+/-­‐	  and	  blebbistatin	  treatment	  were	  applied	  within	  the	  same	  cell.	  No	  clear	  
difference	  in	  overtaking	  rate	  changes	  were	  predicted	  between	  broad	  blebbistatin	  treatment	  
(FIG	  30)	  or	  targeted	  VEGFR-­‐2+/-­‐	  blebbistatin	  treatment	  (FIG	  32).	  Thus	  rearrangements	  in	  the	  
heterogeneous	  sprout	  may	  be	  mostly	  driven	  by	  protrusion	  activity	  within	  the	  strongly	  adhesive	  
WT	  cells.	  Blebbistatin	  treatment	  of	  VEGFR-­‐2+/-­‐	  cells	  was	  predicted	  to	  completely	  reverse	  their	  
absence	  in	  the	  tip	  cell	  position.	  This	  suggests	  protrusive	  activity	  dominated	  adhesion	  strength	  in	  
this	  model	  of	  heterogeneous	  adhesion	  strengths.	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Figure	  32.	  Simulated	  results	  of	  targeted	  blebbistatin-­‐treatment	  of	  VEGFR-­‐2+/-­‐	  cells	   in	  a	  WT:VEGFR-­‐2+/-­‐	  sprout.	  Left	  
plot:	  Effect	  of	   increasingly	  high	  doses	  of	  blebbistatin	  on	  cell	  rearrangement	  rates	   in	  the	  sprout.	  Right	  plot:	  Effect	  of	  
blebbistatin	  on	  tip	  cell	  designation.	  Blebbistatin-­‐treated	  cells	  are	  designated	  as	  green	  and	  WT	  cells	  are	  designated	  as	  
red	  in	  the	  heterogeneous	  WT	  sprout.	  Solid	  bars	  represent	  scenario	  1:	  No	  M1/M2	  interaction.	  Textured	  bars	  represent	  
scenario:	  M2	  affects	  M1.	  
	  
The	  results	  of	  our	  blebbistatin	  treatment	  during	  in	  vitro	  sprout	  extension	  were	  likely	  a	  
consequence	  of	  numerous	  effects	  of	  myosin	  inhibition.	  This	  model	  evaluated	  myosin	  inhibition	  
simply	  as	  an	  activator	  of	  cell	  protrusions.	  With	  this	  in	  mind,	  the	  simulation	  had	  limited	  utility	  in	  
aiding	  a	  collective	  understanding	  of	  adhesion	  dynamics	  as	  a	  direct	  and	  indirect	  result	  of	  myosin	  
II	  inhibition.	  Adjustments	  to	  the	  model	  to	  expand	  the	  scope	  of	  the	  model	  are	  discussed	  in	  
Chapter	  4.	  Our	  treatment	  with	  blebbistatin	  showed	  a	  shift	  in	  adhesion	  phenotype	  to	  a	  more	  
discontinuous	  VE-­‐cadherin	  state,	  which	  Bentley	  et	  al.	  2014	  demonstrate	  are	  associated	  with	  a	  
more	  active	  cell.	  Thus,	  this	  in	  silico	  model	  may	  have	  captured	  an	  increased	  cell	  motility	  effect	  
that	  was	  supported	  by	  our	  evaluations	  of	  in	  vitro	  adhesion	  organization.	  
	  
Stabilization	  of	  the	  VE-­Cadherin	  α-­catenin	  complex	  decreases	  blebbistatin-­mediated	  
adhesion	  disassembly	  
Cells	  transfected	  with	  shRNA	  against	  VE-­‐cadherin	  (shVE)	  were	  seeded	  into	  devices	  and	  exposed	  
to	  an	  MVPS	  gradient	  for	  4	  days.	  Invasion	  of	  shVE	  cells	  was	  reduced	  compared	  control	  sprouting,	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and	  was	  characterized	  by	  single	  cell	  migration,	  and	  no	  collective	  migration	  events	  (Fig	  33).	  This	  
confirmed	  VE-­‐cadherin	  is	  required	  for	  multicellular	  migration	  during	  angiogenesis	  (Carmeliet,	  
Lampugnani	  et	  al.	  1999).	  
	  
Blebbistatin	  appeared	  to	  affect	  junction	  strength	  and	  activity,	  but	  the	  mechanism	  of	  
action	  remained	  unclear.	  The	  disorganization	  of	  VE-­‐cadherin	  in	  response	  to	  blebbistatin	  is	  likely	  
a	  consequence	  one	  or	  both	  of	  two	  potential	  scenarios,	  contractility	  inhibition	  causes	  1)	  a	  
reduction	  of	  VE-­‐cadherin	  at	  the	  junction,	  or	  2)	  a	  loss	  of	  VE-­‐cadherin	  function.	  Cells	  from	  3	  
devices	  per	  condition	  (0,	  10,	  30,	  50	  μM	  blebbistatin)	  were	  collected	  at	  Day	  4,	  lysed,	  and	  pooled	  
for	  real-­‐time	  polymerase	  chain	  reaction	  (PCR).	  Blebbistatin	  treatment	  did	  not	  significantly	  affect	  
VE-­‐cadherin	  expression	  in	  cells	  within	  24	  hours	  (Fig	  34).	  	  
Figure	   33.	   Promotion	   of	   in	   vitro	   sprouting	   in	  
ECs	  with	  silenced	  CDH5	  (VE-­‐cadherin)	  gene	  A)	  
Representative	   confocal	   immunofluorescence	  
images	   of	   indicated	   conditions	   at	   Day	   4	   of	  
sprouting	   under	   MVPS	   cocktail.	   F-­‐actin	   and	  
nuclei	   are	   labeled	  with	   phalloidin	   (green)	   and	  
DAPI	  (blue),	  respectively.	  Scale	  bar	  is	  50μm.	  B)	  
Upper	  plot:	  quantification	  of	  single	  cells	  (upper	  
plot)	  and	  total	  invaded	  cells	  (lower	  plot)	  at	  Day	  
4.	  N	   =	   3	   devices	   per	   condition.	   Error	   bars	   are	  
S.E.M.	  *	  (p<	  0.05)	  and	  **	  (p	  <	  0.005)	  represent	  
significant	  difference	  from	  control.	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Figure	  35.	  Western	  blot	  of	  for	  VE-­‐cadherin.	  Cell	  lysates	  collected	  from	  GFP	  expressing	  control	  cells	  and	  VEC	  cells.	  VE-­‐
cadherin	  bands	  were	  located	  at	  approximately	  120	  kDa.	  	  
	  
We	  overexpressed	  VE-­‐cadherin	  in	  ECs	  (VEC)	  and	  then	  re-­‐ran	  our	  experiment	  in	  which	  
MVPS-­‐driven	  sprouts	  were	  treated	  with	  blebbistatin	  or	  vehicle	  control	  at	  Day	  3	  and	  evaluated	  at	  
Day	  4	  (FIG	  35,	  36).	  General	  sprout	  morphology	  and	  cadherin	  organization	  profiles	  appeared	  
unaffected	  in	  VE-­‐cad	  sprouts	  not	  treated	  with	  blebbistatin	  in	  an	  initial	  experiment,	  but	  in	  a	  
secondary	  round	  with	  slightly	  different	  device	  preparation	  (discussed	  in	  following	  pages),	  
numerous	  single	  cells	  were	  present	  in	  both	  the	  blebbistatin	  and	  control	  conditions.	  Treatment	  
with	  blebbistatin	  resulted	  in	  a	  nonsignificant	  loss	  of	  adhesions	  and	  a	  shift	  in	  cadherin	  
organization	  profiles.	  Non-­‐significance	  is	  believed	  to	  be	  a	  result	  of	  increased	  single	  cells	  in	  the	  
control	  VEC,	  as	  compared	  to	  the	  non-­‐infected.	  Experiments	  will	  be	  repeated	  to	  confirm	  if	  
adhesion	  loss	  is	  significant.	  If	  adhesion	  loss	  is	  not	  significant,	  it	  appears	  VEC	  partially	  rescues	  
blebbistatin	  effect,	  suggesting	  blebbistatin	  treatment	  may	  be	  either	  weakening	  or	  decreasing	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the	  presence	  of	  VE-­‐cadherin	  at	  the	  adhesion,	  and	  over	  expression	  makes	  up	  for	  this	  effect.	  If	  
adhesion	  loss	  is	  in	  fact	  significant	  as	  seen	  in	  initial	  experiments,	  results	  suggest,	  while	  VE	  
cadherin	  is	  required	  for	  multicellular	  sprouting,	  an	  overexpression	  of	  the	  cadherin,	  and	  likely	  
consequential	  increase	  of	  VE-­‐cadherin	  at	  the	  junctions,	  does	  not	  prevent	  the	  loss	  of	  adhesions	  
following	  contractility	  inhibition.	  
	  
Figure	   36.	   Effect	   of	   blebbistatin	   on	   VEC	   sprouts	   A)	   Representative	   confocal	   immunofluorescence	   images	   of	   VEC	  
sprouts	  under	  indicated	  conditions	  at	  Day	  4	  following	  24-­‐hour	  blebbistatin	  or	  vehicle	  treatment.	  Color	  images:	  F-­‐actin	  
and	   nuclei	   are	   labeled	  with	   phalloidin	   (green)	   and	   DAPI	   (blue),	   respectively.	   Grayscale	   images:	   High	  magnification	  
images	  of	  tip-­‐stalk	  (upper	  panels)	  and	  stalk-­‐stalk	  (lower	  panels)	  cadherin	  adhesion.	  VE-­‐cadherin	  and	  nuclei	  are	  shown	  
in	  white.	  Scale	  bars	  are	  25μm.	  B)	  Upper	  plot:	  quantification	  of	  detached	  tip	  cells	   (upper	  plot)	  and	  stalk	  cells	   (lower	  
plot)	   following	   blebbistatin	   treatment.	   N	   =	   4	   devices	   per	   condition.	   Error	   bars	   are	   S.E.M.	   *	   represents	   significant	  
difference	   from	  vehicle	  control	   (p	  <	  0.05).	  C)	  Cataloging	  of	  adhesion	  types	   for	  both	   tip-­‐stalk	   (upper	  plot)	  and	  stalk-­‐
stalk	   (lower	   plot)	   adhesions	   in	   control	   and	   blebbistatin-­‐treated	   sprouts.	   Cadherin	   adhesions	   were	   evaluated	   as	  
populations	  for	  each	  condition.	  	  
	  
While	  not	  necessary	  for	  initial	  adhesion	  formation,	  interaction	  between	  the	  actin	  
cytoskeleton	  and	  cadherin	  complex	  is	  necessary	  for	  adhesion	  strengthening	  and	  force	  
transmission	  (Chu,	  Thomas	  et	  al.	  2004)(Thomas,	  Boscher	  et	  al.	  2013).	  This	  binding	  of	  α-­‐catenin	  
to	  VE-­‐cadherin	  and	  actin	  binding	  proteins	  requires	  force-­‐dependent	  conformational	  changes	  in	  
α-­‐catenin	  (Yonemura,	  Wada	  et	  al.	  2010).	  Other	  work,	  including	  from	  our	  lab	  has	  shown	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inhibiting	  actin	  contractility,	  and	  consequently	  the	  ability	  to	  exert	  dynamic	  tension,	  causes	  
destabilization	  of	  cadherin	  adhesions	  (Liu,	  Tan	  et	  al.	  2010).	  Thus,	  blocking	  contractility	  of	  the	  
cytoskeleton,	  causing	  a	  drop	  in	  tension	  across	  the	  cell,	  may	  inhibit	  the	  ability	  of	  actin	  fibers	  and	  
cadherins	  to	  complex.	  In	  the	  case	  of	  already	  discontinuous	  adhesion	  between	  two	  migrating	  
cells,	  which	  require	  rapid	  turnover	  of	  cadherins,	  the	  inability	  to	  form	  new	  adhesion	  complexes	  
would	  likely	  cause	  cells	  to	  lose	  contact	  with	  each	  other.	  In	  organized	  adhesions	  that	  experience	  
reduced	  adhesion	  turnover,	  the	  effects	  of	  blocking	  new	  complex	  formation	  may	  be	  more	  dilute.	  
This	  supports	  this	  study’s	  results	  that	  blebbistatin	  treatment	  causes	  breaking	  of	  the	  
discontinuous	  tip-­‐stalk	  adhesion	  more	  often	  than	  the	  organized	  stalk-­‐stalk	  adhesions.	  	  
We	  hypothesized	  that	  by	  blocking	  contractility	  during	  adhesion	  remodeling	  would	  
abrogate	  the	  cells’	  ability	  to	  stabilize	  or	  strengthen	  their	  junctions	  through	  connection	  with	  the	  
actin	  cytoskeleton,	  which	  in	  turn	  led	  to	  the	  loss	  of	  multicellularity.	  
	  
Figure	  37.	   Schematic	   showing	  VE-­‐cadherin,	  α-­‐catenin,	   and	   fusion	  protein	  VEC-­‐α-­‐C.	  Truncated	  VE-­‐cadherin	   (amino	  
acids	   1-­‐709)	   lacks	   both	   the	   α-­‐catenin	   and	   β-­‐catenin	   binding	   domains	   of	   full	   VE-­‐cadherin.	   Truncated	   α-­‐catenin	   is	  
lacking	  the	  β-­‐catenin	  binding	  domain	  of	  the	  full	  α-­‐catenin.	  
	  
Previous	  studies	  have	  examined	  cadherin	  adhesions	  using	  constructs	  that	  remove	  the	  
tension	  dependence	  of	  the	  VE-­‐cadherin	  binding	  of	  α-­‐catenin.	  The	  Vestweber	  group	  developed	  a	  
fusion	  protein	  (VEC-­‐α-­‐C)	  that	  makes	  the	  VE-­‐cadherin	  complex	  tension-­‐insensitive	  by	  fusing	  the	  
C-­‐terminal	  of	  the	  VE-­‐cadherin	  to	  the	  N-­‐terminal	  of	  α-­‐catenin	  (FIG	  37).	  Cells	  expressing	  VEC-­‐α-­‐C	  
	   92	  
have	  tighter	  cell-­‐cell	  junctions,	  and	  reduced	  (latrunculin-­‐A	  dependent)	  FRAP	  response	  (Schulte,	  
Kuppers	  et	  al.	  2011).	  VEC-­‐α-­‐C	  expression	  doesn’t	  to	  effect	  cytoskeletal	  arrangement,	  cadherin	  
endocytosis,	  or	  VEGFR2	  signaling	  (Schulte,	  Kuppers	  et	  al.	  2011).	  	  
	  
Figure	  38.	  Western	  blot	  of	  for	  α-­‐catenin.	  Cell	  lysates	  collected	  from	  GFP	  expressing	  control	  cells	  and	  VEC-­‐α-­‐C	  cells.	  A	  
band	  at	  approximately	  200kDa	  signified	  presence	  of	  the	  VEC-­‐α-­‐C	  fusion	  protein.	  The	  endogenous	  α-­‐catenin	  band	  was	  
located	  at	  approximately	  100kDa.	  
	  
	   We	  expressed	  VEC-­‐α-­‐C	  in	  ECs	  (Fig	  38)	  and	  re-­‐ran	  our	  experiment	  in	  which	  MVPS-­‐driven	  
sprouts	  were	  treated	  with	  blebbistatin	  at	  Day	  3	  and	  evaluated	  at	  Day	  4.	  Again,	  general	  sprout	  
morphology	  and	  cadherin	  activity	  profiles	  appeared	  unaffected	  in	  VEC-­‐α-­‐C	  sprouts	  not	  treated	  
with	  blebbistatin.	  Treatment	  of	  the	  VEC-­‐α-­‐C	  sprouts	  with	  blebbistatin	  drove	  a	  shift	  in	  adhesion	  
population	  profiles	  to	  a	  more	  discontinuous	  profile,	  as	  in	  VE-­‐cad	  and	  non-­‐infected	  sprouts.	  
Interestingly,	  despite	  the	  organizational	  shift,	  no	  increased	  loss	  in	  cell-­‐cell	  contact	  was	  observed	  
in	  VEC-­‐α-­‐C	  sprouts	  (FIG	  39).	  This	  supports	  our	  hypothesis	  that	  in	  a	  discontinuous	  adhesion	  
contractility	  inhibition	  caused	  adhesion	  disassembly	  by	  affecting	  the	  ability	  of	  VE-­‐cadherin	  and	  
α-­‐catenin	  to	  complex	  with	  each	  other,	  and	  consequently	  with	  the	  actin	  cytoskeleton.	  We	  
hypothesize	  our	  in	  vitro	  findings	  have	  provided	  novel	  insights	  inherent	  to	  the	  broad	  
angiogenesis	  process,	  and	  aimed	  to	  confirm	  our	  findings	  in	  an	  in	  vivo	  model	  of	  angiogenesis.	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Figure	   39.	   Effect	   of	   blebbistatin	   treatment	   on	   VEC-­‐α-­‐C	   sprouts	   A)	   Representative	   confocal	   immunofluorescence	  
images	  of	  VEC-­‐α-­‐C	  sprouts	  under	   indicated	  conditions	  at	  Day	  4	  following	  24-­‐hour	  blebbistatin	  or	  vehicle	  treatment.	  
Color	   images:	  F-­‐actin	  and	  nuclei	  are	  labeled	  with	  phalloidin	  (green)	  and	  DAPI	  (blue),	  respectively.	  Grayscale	   images:	  
High	  magnification	   images	  of	   tip-­‐stalk	   (upper	  panels)	  and	  stalk-­‐stalk	   (lower	  panels)	   cadherin	  adhesion.	  VE-­‐cadherin	  
and	  nuclei	  are	  shown	  in	  white.	  Scale	  bars	  are	  25μm.	  B)	  Upper	  plot:	  quantification	  of	  detached	  tip	  cells	  (upper	  plot)	  
and	   stalk	   cells	   (lower	   plot)	   following	   blebbistatin	   treatment.	   N	   =	   4	   devices	   per	   condition.	   Error	   bars	   are	   S.E.M.	   *	  
represents	   significant	   difference	   from	   vehicle	   control	   (p	   <	   0.05).	   C)	   Cataloging	   of	   adhesion	   types	   for	   both	   tip-­‐stalk	  
(upper	   plot)	   and	   stalk-­‐stalk	   (lower	   plot)	   adhesions	   in	   control	   and	   blebbistatin-­‐treated	   sprouts.	   Cadherin	   adhesions	  
were	  evaluated	  as	  populations	  for	  each	  condition.	  
	  
Blebbistatin	  induces	  loss	  of	  cell-­‐cell	  contacts	  in	  vivo,	  and	  is	  rescued	  by	  VEC-­‐α-­‐C	  	  
One	  model	  of	  angiogenesis	  where	  one	  can	  observe	  the	  invading	  front	  of	  multicellular	  sprouts	  is	  
in	  the	  developing	  mouse	  retina.	  For	  lentivirus	  in	  vivo	  transduction,	  postnatal	  Day	  3	  aged	  mouse	  
pups	  were	  given	  an	  intraperitoneal	  (IP)	  viral	  doses	  of	  1	  ×	  107	  I.U.	  in	  a	  final	  volume	  of	  50μl.	  Pups	  
at	  postnatal	  day	  5	  (P5)	  were	  subsequently	  given	  IP	  injections	  of	  blebbistatin	  (180	  mg/kg	  
assuming	  4g	  pup	  weight	  at	  P5)	  or	  vehicle	  control.	  Mice	  were	  sacrificed	  6	  hours	  later	  and	  retinas	  
were	  harvested	  for	  analysis.	  We	  separately	  injected	  mice	  with	  cells	  with	  GFP-­‐control	  or	  VEC-­‐α-­‐C	  
virus.	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Retinas	  of	  mice	  infected	  with	  GFP	  exhibited	  normal	  morphology	  when	  treated	  with	  vehicle	  (FIG	  
40A).	  Images	  of	  GFP-­‐retinas	  6	  hours	  post-­‐blebbistatin	  treatment	  revealed	  numerous	  VE-­‐
cadherin	  positive	  detached	  single	  cells	  were	  present	  at	  the	  leading	  edge	  of	  the	  retina.	  In	  VEC-­‐α-­‐
C	  infected	  mice	  treated	  with	  blebbistatin,	  the	  number	  of	  detached	  ECs	  was	  significantly	  reduced	  
as	  compared	  to	  GFP-­‐treated	  mice	  (FIG	  40B).	  	  
	  
Figure	   40.	   Effect	   of	   blebbistatin	   treatment	   of	   GFP	   and	   VEC-­‐Α-­‐C	   transfected	   mouse	   retinas	   A)	   Representative	  
immufluorescence	   images	  of	  mouse	   retinas	  stained	  with	   Isolectin	  B4	   (green;	  upper	  panes)	  and	  VE-­‐cadherin	   (white;	  
lower	  panes).	  Scale	  bar	   is	  50μm.	  B)	  Left	  Plot:	  Quantification	  of	  number	  of	  single	  detached	  ECs	   in	  mouse	  retinas.	  **	  
indicates	  significant	  difference	  from	  GFP	  +	  Blebbistatin	  control	  (p	  <	  0.005).	  N	  >	  4	  retinas	  for	  each	  condition.	  Right	  Plot:	  
Categorization	  of	  VE-­‐cadherin	  adhesion	  organization	  in	  the	  mouse	  retina.	  
	  
Blebbistatin-­‐treated	  of	  GFP-­‐mouse	  retinas	  displayed	  more	  discontinuous	  cadherin	  
adhesions	  than	  the	  vehicle-­‐treated	  GFP-­‐mouse	  retinas	  (FIG	  40B).	  The	  blebbistatin-­‐treated	  VEC-­‐
α-­‐C-­‐mouse	  retinas	  displayed	  a	  stark	  difference	  in	  adhesion	  organization	  as	  compared	  to	  both	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the	  vehicle-­‐	  and	  blebbistatin-­‐treated	  GFP-­‐mouse	  retinas.	  These	  results	  confirm	  in	  vitro	  findings	  
that	  myosin-­‐mediated	  contractility	  is	  required	  for	  sprout	  extension.	  In	  the	  absence	  of	  
actomyosin	  contractility	  cells	  fail	  to	  form	  the	  critical	  VE-­‐cadherin	  complex	  required	  for	  adhesion	  
strengthening	  and	  maintained	  cell-­‐cell	  contacts	  during	  migration.	  
	  
Discussion	  
We	  have	  shown	  contractility	  is	  required	  for	  multicellular	  invasion	  during	  angiogenic	  sprout	  
extension	  through	  use	  of	  a	  biomimetic	  in	  vitro	  sprouting	  model,	  supported	  by	  an	  in	  silico	  model	  
of	  cell	  rearrangements	  during	  sprouting	  and	  an	  in	  vivo	  retinal	  model	  of	  angiogenesis.	  We	  used	  
quantification	  metrics	  to	  define	  adhesion	  types	  within	  in	  vitro	  sprouts	  (tip-­‐stalk	  or	  stalk-­‐stalk)	  by	  
distinct	  cadherin	  organization	  profiles.	  	  
	  
Tip-­stalk	  adhesions	  are	  more	  discontinuous	  than	  stalk-­stalk	  adhesions	  
We	  observed	  the	  cadherin	  adhesions	  between	  tip	  and	  stalk	  cell	  are	  phenotypically	  more	  
punctate	  and	  discontinuous	  than	  the	  adhesions	  between	  neighboring	  stalk	  cells,	  which	  are	  
characterized	  by	  a	  population	  of	  adhesions	  with	  majority	  clear	  linear	  junctions	  and	  minority	  
zigzagged,	  less	  localized	  (referred	  to	  as	  “tortuous”	  in	  text)	  adhesions.	  Numerous	  studies	  of	  cells	  
on	  2D	  surfaces	  have	  attributed	  such	  linear	  adhesions	  to	  a	  stable	  or	  quiescent	  adhesion	  
characteristic	  of	  cells	  sitting	  in	  a	  monolayer,	  while	  punctate	  adhesions	  are	  characteristic	  of	  a	  
dynamic	  cell-­‐cell	  interface	  between	  two	  migrating	  cells	  (Kametani	  and	  Takeichi	  2007;	  Taguchi,	  
Ishiuchi	  et	  al.	  2011;	  Peglion,	  Llense	  et	  al.	  2014).	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From	  this	  simple	  correlation	  of	  morphology	  with	  activity,	  once	  would	  conclude	  the	  
junction	  between	  the	  tip	  cell	  and	  stalk	  cell	  is	  a	  dynamic	  interface,	  and	  stalk-­‐stalk	  adhesions	  are	  
generally	  characteristic	  of	  more	  stable,	  less	  migratory	  cells.	  It	  is	  possible	  stalk	  cells	  play	  a	  
relatively	  quiescent	  role	  in	  the	  extending	  sprout,	  simply	  maintaining	  stable	  connections,	  while	  
only	  occasionally	  migrating	  and	  remodeling	  their	  adhesions	  to	  maintain	  connections	  with	  the	  
invading	  sprout	  tip.	  Meanwhile	  dynamic	  tip	  cells	  consistently	  actively	  degrade	  and	  migrate	  
through	  a	  three	  dimensional	  matrix,	  requiring	  a	  dynamic	  adhesion	  at	  their	  rear	  to	  keep	  up	  with	  
the	  movement.	  Alternatively,	  the	  stalk	  may	  be	  composed	  of	  two	  populations	  of	  cells,	  the	  
minority	  population	  being	  migratory,	  characterized	  by	  “tortuous”	  adhesions,	  and	  the	  majority	  
population	  being	  still,	  characterized	  by	  linear	  adhesions.	  This	  theory	  is	  well	  supported	  by	  results	  
from	  Bentley	  et	  al.,	  which	  reports	  DLL4-­‐high	  cells	  within	  the	  stalk	  are	  actively	  migrating	  in	  
attempts	  to	  replace	  the	  tip	  cells,	  while	  DLL4-­‐low	  cells	  have	  stable	  adhesions	  and	  do	  not	  actively	  
migrate	  (Bentley,	  Franco	  et	  al.	  2014).	  	  
While	  variations	  in	  stalk-­‐stalk	  adhesion	  profiles	  may	  be	  a	  consequence	  of	  patchwork	  
Notch-­‐DLL4	  signaling,	  it	  is	  unlikely	  Notch-­‐DLLR	  fully	  drive	  adhesion	  profiles.	  Blebbistatin-­‐
treatment	  particularly	  drives	  loss	  of	  cell-­‐cell	  contacts	  at	  the	  tip-­‐stalk	  adhesion,	  which	  is	  
characteristically	  more	  disorganized	  that	  stalk-­‐stalk	  adhesions.	  Notch-­‐signaling	  protein	  
expression	  levels	  associated	  with	  tip	  cells	  have	  also	  been	  shown	  to	  affect	  an	  adhesion	  
phenotype.	  Gavard	  et	  al.	  found	  activation	  of	  VEGF-­‐R2	  caused	  rapid	  endocytosis	  of	  VE-­‐cadherin,	  
and	  in	  their	  separate	  study	  Bentley	  et	  al.	  found	  active	  patches	  of	  VE-­‐cadherin	  adhesions	  
correlate	  with	  DLL4	  staining	  in	  the	  mouse	  retina	  (Gavard	  and	  Gutkind	  2006;	  Bentley,	  Franco	  et	  
al.	  2014).	  Both	  DLL4	  and	  VEGF-­‐R2	  are	  highly	  expressed	  and	  active	  in	  tip	  cells,	  likely	  playing	  a	  role	  
in	  the	  high	  cytoplasmic	  staining	  and	  discontinuous	  adhesions	  we	  observe	  in	  the	  in	  vitro	  sprouts.	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While	  it	  is	  suggested	  DLL4	  and	  VEGR-­‐2	  expression	  is	  expressed	  as	  patchwork	  throughout	  a	  
sprout	  (to	  allow	  cell-­‐cell	  rearrangements),	  it	  is	  likely	  our	  targeted	  loss	  of	  cell-­‐cell	  contacts	  
between	  tip	  and	  stalk	  is	  a	  consequence	  of	  an	  increased	  likelihood	  of	  DLL4/VEGFR-­‐2	  expressing	  
near	  the	  front	  of	  extending	  sprouts.	  	  
Interestingly,	  studies	  of	  2D	  sheets	  of	  cells	  suggest	  cell	  and	  junction	  arrangement,	  rather	  
than	  angiogenic	  signaling,	  may	  drive	  adhesion	  organization	  within	  structured	  cell	  migration.	  It	  
was	  recently	  discovered	  discontinuous	  adherens	  junctions	  are	  not	  simply	  a	  result	  of	  a	  cell’s	  
migratory	  activity,	  but	  may	  also	  be	  a	  consequence	  of	  a	  polarized	  cell	  with	  asymmetric	  cadherin	  
adhesions	  (Peglion,	  Llense	  et	  al.	  2014).	  In	  agreement	  with	  Peglion	  et	  al.’s	  finding,	  a	  separate	  
study	  by	  Taguchi	  et	  al.	  imaged	  adhesions	  in	  epithelial	  sheets	  of	  migrating	  cells	  and	  noted	  active	  
adhesions	  in	  the	  leading	  edge	  cells,	  but	  linear	  inactive	  adhesions	  between	  cells	  as	  little	  as	  one	  
cell	  length	  back	  from	  the	  leading	  edge	  (Taguchi,	  Ishiuchi	  et	  al.	  2011).	  Thus,	  the	  characteristically	  
punctate	  adhesions	  at	  the	  tip-­‐stalk	  adhesions	  may	  be	  a	  result	  of	  the	  polarized,	  asymmetric	  tip	  
cell	  phenotype.	  Conversely,	  stalk	  cells	  essentially	  exist	  within	  a	  curved	  monolayer	  and	  are	  fully	  
encircled	  by	  cell-­‐cell	  adhesions	  between	  their	  apical	  and	  basal	  surfaces,	  which	  may	  additionally	  
explain	  the	  linearity	  of	  their	  adhesions.	  
Providing	  clues	  to	  VE-­‐cadherin	  dynamics	  with	  some	  punctate	  adhesions,	  Kametani	  et	  al.	  
found,	  in	  a	  migrating	  sheet	  of	  epithelial	  cells,	  the	  junctions	  running	  perpendicular	  to	  the	  
direction	  of	  migration	  were	  the	  only	  junctions	  undergoing	  active	  apical	  to	  basal	  turnover	  of	  
cadherin	  clusters	  (Kametani	  and	  Takeichi	  2007).	  It	  is	  at	  these	  junctions	  following	  cells	  are	  
believed	  to	  be	  forming	  forward	  protrusions	  during	  migration.	  In	  invading	  angiogenesis,	  stalk	  
cells	  and	  tip	  cells	  are	  elongated	  along	  the	  axis	  of	  migration,	  with	  the	  majority	  of	  stalk-­‐stalk	  
adhesions	  running	  parallel	  to	  migration	  direction	  and	  the	  majority	  of	  tip-­‐stalk	  adhesions	  running	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perpendicular	  to	  the	  same	  axis.	  Peglion	  et	  al.	  and	  Kametani	  et	  al.’s	  findings	  suggest	  adhesion	  
orientation	  and	  symmetry	  within	  a	  migrating	  sprout	  may	  also	  dictate	  VE-­‐cadherin	  organization	  
and	  activity.	  	  
	  
Dynamic	  adhesions	  in	  angiogenic	  sprouts	  require	  myosin-­mediated	  contractility	  
Our	  experiments	  with	  blebbistatin	  suggest	  discontinuous	  cadherin	  adhesions	  require	  myosin-­‐
mediated	  contractility	  to	  maintain	  adhesions	  during	  dynamic	  cell	  migration.	  Myosin-­‐2	  has	  
previously	  been	  shown	  as	  necessary	  for	  localization	  of	  E-­‐cadherin	  to	  cell-­‐cell	  contacts.	  When	  
cells	  were	  treated	  with	  ROCK	  inhibitor,	  Y-­‐27632,	  E-­‐cadherin	  scattered	  from	  the	  junction,	  as	  did	  
myosin	  isoform	  IIA.	  When	  fluorescence	  recovery	  after	  photobleaching	  (FRAP)	  analysis	  was	  
performed,	  Y-­‐27632-­‐treated	  cells	  were	  slower	  to	  recover	  their	  junctions,	  suggesting	  actin	  
contractility	  is	  necessary	  for	  the	  formation	  of	  new	  adhesion	  clusters	  (Shewan,	  Maddugoda	  et	  al.	  
2005).	  Following	  initial	  adhesion,	  adhesion	  strengthening	  requires	  stabilization	  of	  the	  cadherin	  
complex	  through	  links	  with	  the	  actin	  cytoskeleton	  (Chu,	  Thomas	  et	  al.	  2004).	  Stalk	  cells	  often	  
maintained	  their	  cell-­‐cell	  contacts	  even	  at	  doses	  that	  caused	  the	  vast	  majority	  of	  tip-­‐stalk	  
junctions	  to	  disassemble.	  Interestingly,	  blebbistatin	  appears	  to	  shift	  the	  profile	  of	  the	  stalk-­‐stalk	  
adhesions	  to	  a	  more	  discontinuous	  phenotype.	  This	  is	  supported	  by	  findings	  by	  Taguchi	  et	  al.,	  
which	  showed	  inner	  adhesions	  of	  a	  2D	  migrating	  epithelial	  sheet	  were	  converted	  into	  
peripheral-­‐like	  active	  junctions	  when	  ROCK	  was	  inhibited	  with	  Y-­‐27632	  (Taguchi,	  Ishiuchi	  et	  al.	  
2011).	  	  
Previous	  studies	  have	  used	  numerous	  approaches	  to	  explore	  the	  linkage	  between	  
cytoskeleton	  and	  cadherin	  by	  deleting	  various	  domains	  or	  proteins	  within	  the	  actin-­‐binding	  
complex,	  or	  by	  artificially	  fusing	  of	  the	  cadherin	  complex	  together	  (Carmeliet,	  Lampugnani	  et	  al.	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1999;	  Chu,	  Thomas	  et	  al.	  2004;	  Nelson,	  Pirone	  et	  al.	  2004).	  Here,	  we	  employed	  the	  VEC-­‐α-­‐C	  
fusion	  protein	  to	  investigate	  the	  role	  of	  contractility	  on	  the	  formation	  of	  the	  cadherin	  complex	  
required	  for	  adhesion	  strengthening.	  Cells	  expressing	  VEC-­‐α-­‐C	  exhibit	  tighter	  cell-­‐cell	  junctions,	  
and	  reduced	  (latrunculin-­‐A	  dependent)	  FRAP	  response,	  suggesting	  an	  increased	  association	  of	  
VE-­‐cadherin	  with	  the	  actin	  cytoskeleton	  (Schulte,	  Kuppers	  et	  al.	  2011).	  VEC-­‐α-­‐C	  expression	  does	  
not	  effect	  cytoskeletal	  arrangement,	  cadherin	  endocytosis,	  or	  VEGFR2	  signaling	  (Schulte,	  
Kuppers	  et	  al.	  2011).	  We	  show	  cells	  expressing	  VEC-­‐α-­‐C	  no	  longer	  responded	  to	  a	  loss	  in	  
contractility	  with	  a	  loss	  of	  	  contact	  between	  tip	  cell	  and	  stalk	  cell	  during	  sprouting	  extension.	  
Interestingly,	  we	  do	  still	  see	  a	  shift	  in	  stalk-­‐stalk	  adhesion	  organization	  to	  a	  less	  organized	  
profile.	  It	  follows	  that	  blebbistatin	  treatment	  inhibited	  the	  ability	  of	  the	  VE-­‐cadherin/α-­‐catenin	  
complex	  to	  form	  in	  normal	  cells,	  and	  that	  this	  complex	  is	  required	  for	  the	  maintenance	  of	  tip-­‐
stalk	  adhesions	  during	  multicellular	  sprout	  extension.	  	  
	  
Collective	  migration	  is	  regulated	  by	  actomyosin	  contractility	  	  
In	  3D	  collective	  cell	  migration,	  cells	  at	  the	  leading	  front	  of	  migration	  carry	  the	  large	  
responsibility	  of	  both	  directing	  migration	  and	  degrading	  matrix	  (Ruhrberg,	  Gerhardt	  et	  al.	  2002;	  
Khalil	  and	  Friedl	  2010).	  While	  early	  studies	  suggested	  leader	  cells	  exert	  more	  Rho-­‐dependent	  
force	  to	  pull	  along	  migration,	  recent	  results	  in	  a	  2D	  sheet	  of	  migration	  cells	  suggest	  force	  
distributions	  vary	  along	  the	  migration	  direction	  (Omelchenko,	  Vasiliev	  et	  al.	  2003;	  Trepat,	  
Wasserman	  et	  al.	  2009).	  While	  follower	  cells	  may	  contribute	  forces	  (via	  pushing	  or	  pulling)	  to	  
collective	  migration,	  lead	  cells	  dictate	  patterning	  of	  the	  invasion.	  Thus,	  our	  results	  showing	  that	  
contractility	  regulates	  tip-­‐stalk	  contact	  maintenance,	  also	  provides	  the	  important	  finding	  that	  
contractility	  regulates	  patterning	  and	  invasion	  of	  collective	  migration.	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In	  the	  experimental	  set	  up,	  myosin	  is	  inhibited	  over	  a	  period	  of	  24	  hours	  before	  samples	  
are	  fixed	  and	  analyzed.	  Thus,	  we	  only	  inhibit	  contractility	  in	  the	  elongating	  sprout	  once,	  
resulting	  in	  contact	  losses	  between	  current	  tip	  and	  stalk	  cells.	  Live	  imaging	  suggests	  after	  the	  
adhesion	  breaks,	  the	  following	  stalk	  cell	  begins	  to	  extend	  long	  protrusions	  thus	  taking	  over	  as	  
the	  new	  tip	  cell	  (FIG	  25).	  In	  relation	  to	  studies	  showing	  cells	  within	  a	  sprout	  dynamically	  
compete	  for	  tip	  cell	  position,	  this	  is	  not	  surprising	  (Jakobsson,	  Franco	  et	  al.	  2010).	  As	  the	  new	  tip	  
cell	  adapts	  to	  its	  shifted	  role,	  cadherin	  adhesions	  linking	  it	  to	  neighbor	  cells	  should	  take	  on	  the	  
punctate,	  discontinuous	  phenotype	  we	  see	  between	  tip	  and	  stalk	  cells	  in	  our	  in	  vitro	  sprout	  
extension.	  This	  would	  suggest,	  under	  a	  situation	  of	  continuously	  blocked	  contractility,	  repeat	  
cycles	  of	  tip-­‐stalk	  cell	  breaking	  would	  occur,	  resulting	  in	  eventual	  complete	  loss	  of	  collective	  cell	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Chapter	  4:	  Conclusions	  and	  future	  directions	  
The	  development	  of	  our	  novel	  biomimetic	  angiogenesis	  assay	  has	  allowed	  for	  exciting	  new	  
explorations	  of	  sprout	  morphology	  and	  progression.	  With	  this	  assay,	  we	  were	  able	  to	  
quantitatively	  define	  for	  the	  first	  time	  clear	  differences	  between	  tip-­‐stalk	  adhesions	  and	  stalk-­‐
stalk	  adhesions	  both	  in	  their	  appearance	  and	  response	  to	  perturbations	  in	  contractility.	  We	  used	  
our	  angiogenesis	  model	  to	  show	  dynamic	  adhesion	  maintenance	  during	  angiogenesis	  requires	  
myosin-­‐mediated	  contractility.	  
	  
Angiogenesis	  model:	  Impact	  on	  the	  field	  
In	  April	  2013	  the	  work	  of	  Chapter	  2	  was	  published	  in	  the	  Proceedings	  of	  the	  National	  Academy	  
of	  Sciences	  with	  Duc-­‐Huy	  Nguyen	  and	  I	  sharing	  first	  authorship.	  Over	  50	  other	  publications	  in	  
the	  fields	  of	  organ-­‐on-­‐a-­‐chip	  style	  engineering,	  vascular	  biology,	  cancer	  biology,	  and	  beyond	  
have	  cited	  this	  work.	  This	  work	  defined	  a	  set	  of	  factors	  that,	  when	  applied	  in	  gradient,	  could	  
elicit	  multicellular	  organized	  angiogenic	  sprouting	  that	  closely	  resembled	  native	  angiogenesis	  in	  
terms	  of	  a)	  invasion	  into	  a	  3D	  matrix,	  b)	  clear	  morphological	  definition	  of	  a	  leading	  tip	  cell,	  c)	  a	  
stalk	  comprised	  of	  multiple	  stalk	  cells	  lining	  a	  lumen	  the	  display	  correct	  apical	  basal	  polarization	  
and	  maintain	  cell-­‐cell	  contacts,	  and	  d)	  formation	  of	  flow-­‐supporting	  nascent	  vascular	  network.	  
The	  model	  has	  been	  widely	  adopted	  for	  use	  both	  within	  the	  Chen	  research	  lab	  and	  with	  external	  
collaborators.	  It	  has	  proved	  to	  be	  a	  widely	  diverse	  tool	  with	  researchers	  often	  modifying	  aspects	  
to	  fit	  their	  studies	  of	  cancer	  angiogenesis,	  fat	  vasculature	  growth,	  cancer	  metastasis,	  blood	  
vessel	  clotting	  and	  permeability,	  and	  immune	  cell	  trafficking.	  This	  biomimetic	  model	  has	  also	  
proved	  useful	  in	  its	  original	  form	  to	  study	  specific	  aspects	  of	  the	  angiogenic	  sprouting	  process,	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including	  investigations	  of	  angiogenic	  branching	  regulation	  by	  Rho	  GTPases,	  and	  my	  own	  work	  
on	  the	  interplay	  of	  cell	  adhesions	  and	  contractility.	  
While	  this	  model	  is	  a	  versatile	  tool,	  multiple	  limitations	  to	  utility	  exist	  in	  its	  current	  form	  
as	  a	  model	  of	  sprouting	  angiogenesis	  and	  nascent	  network	  formation.	  A)	  While	  the	  simplicity	  of	  
an	  EC-­‐only	  system	  provides	  obvious	  benefits,	  it	  also	  limits	  the	  ability	  to	  assess	  effects	  of	  other	  
cells	  (e.g.	  mural	  cells,	  inflammatory	  cells,	  or	  tumor	  cells)	  on	  angiogenesis.	  Incorporation	  of	  other	  
cell	  types	  into	  the	  system	  would	  alleviate	  this	  limitation.	  B)	  A	  significant	  caveat	  of	  the	  sprouting	  
angiogenesis	  in	  our	  system	  is	  the	  requirement	  of	  a	  the	  non-­‐endogenous	  small	  molecule	  PMA,	  
which	  is	  acts	  as	  an	  analogue	  for	  the	  PKC	  activator,	  	  diacylglycerol.	  While	  our	  sprouts	  do	  model	  
numerous	  aspects	  of	  in	  vivo	  angiogenesis,	  the	  reliance	  on	  an	  artificial	  modulator	  suggests	  our	  in	  
vitro	  sprouts	  may	  include	  artifacts	  that	  may	  not	  accurately	  represent	  the	  cellular	  environment	  in	  
vivo.	  Thus,	  removal	  of	  PMA	  from	  the	  system	  may	  improve	  the	  correlation	  between	  in	  vitro	  and	  
in	  vivo	  findings.	  C)	  Flow	  in	  our	  system	  is	  maintained	  by	  a	  rocker,	  resulting	  in	  a	  cyclic,	  back	  and	  
forth	  flow.	  Cells	  show	  responses	  to	  shear	  stress	  via	  alignment	  of	  their	  actin	  fibers.	  However,	  the	  
ability	  to	  manipulate	  flow	  regimes	  in	  the	  device	  would	  greatly	  enhance	  the	  utility	  of	  the	  device	  
to	  study	  the	  effects	  of	  flow	  (interstitial	  or	  shear)	  on	  sprout	  initiation	  and	  elongation	  as	  well	  as	  
during	  network	  remodeling.	  This	  would	  require	  the	  feasible	  integration	  of	  a	  pump	  system.	  
	  
Angiogenesis	  model:	  Future	  advancements	  and	  applications	  
The	  widespread	  adoption	  of	  the	  angiogenesis	  model	  has	  highlighted	  its	  utility,	  but	  also	  the	  need	  
for	  advancements	  in	  device	  fabrication	  and	  refinement	  of	  the	  angiogenic	  cocktail.	  These	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advancements,	  and	  numerous	  potential	  explorations	  with	  the	  angiogenesis	  tool	  are	  discussed	  in	  
the	  following	  sections.	  	  
	  
Manufacturing	  overhaul	  
Manufacturing	  of	  the	  angiogenesis	  model	  is	  somewhat	  time	  consuming	  and	  often	  takes	  multiple	  
rounds	  before	  researchers	  are	  capable	  of	  reliably	  and	  independently	  producing	  the	  device.	  We	  
at	  the	  Chen	  lab	  are	  interested	  in	  staying	  at	  the	  forefront	  of	  both	  the	  engineering	  and	  biology	  
fields.	  While	  our	  angiogenesis	  model	  served	  both	  of	  these	  areas	  three	  years	  ago,	  we	  now	  look	  to	  
advance	  the	  model	  to	  increase	  device	  reliability	  and	  decrease	  production	  time.	  Streamlining	  of	  
the	  device	  will	  likely	  take	  place	  over	  the	  coming	  years.	  	  
	  
Refinement	  of	  sprouting	  cocktail	  
We	  use	  a	  cocktail	  of	  MCP-­‐1,	  VEGF,	  S1P,	  and	  PMA	  in	  gradient	  to	  promote	  3D	  angiogenesis	  in	  our	  
model.	  While	  the	  sprouts	  and	  neovessels	  formed	  under	  these	  factors	  provide	  an	  excellent	  
correlative	  to	  in	  vivo	  angiogenesis,	  we	  hope	  to	  further	  refine	  this	  cocktail	  to	  more	  accurately	  
represent	  in	  vivo	  stimulators	  of	  angiogenesis.	  While	  PMA	  has	  been	  implicated	  in	  angiogenic	  
responses	  in	  vivo,	  and	  promotes	  multicellularity	  of	  cell	  invasion	  in	  our	  device,	  it	  is	  a	  small	  
molecule	  drug	  not	  produced	  endogenously	  (Morris,	  Hida	  et	  al.	  1988).	  PMA	  is	  an	  activator	  of	  the	  
protein	  kinase	  C	  signaling,	  similar	  in	  activity	  to	  the	  natural	  PCK	  activator,	  diacylglycerol.	  Thus,	  in	  
future	  studies	  we	  hope	  to	  investigate	  endogenously	  produced	  PKC	  activators	  for	  replacement	  of	  
PMA.	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Further	  studies	  with	  the	  angiogenesis	  tool	  
As	  mentioned	  above,	  numerous	  researchers	  are	  currently	  using	  the	  design	  of	  our	  angiogenesis	  
model	  to	  answer	  their	  own	  questions	  in	  fields	  ranging	  cancer	  biology	  to	  hemodynamics.	  We	  
expect	  this	  tool	  to	  remain	  relevant	  and	  useful	  in	  both	  biology	  and	  engineering	  for	  years	  to	  come	  
assuming	  its	  constant	  adaptation	  to	  the	  latest	  manufacturing	  and	  imaging	  techniques.	  	  
Expand	  our	  system	  to	  study	  tip	  cell	  selection,	  anastamosis,	  or	  network	  pruning	  
While	  we	  have	  largely	  used	  this	  model	  to	  explore	  sprout	  extension,	  numerous	  avenues	  of	  study	  exist	  at	  the	  sprout	  initiation	  stage,	  as	  well	  as	  network	  formation	  stage.	  The	  angiogenesis	  device	  provides	  a	  model	  that	  includes	  numerous	  elements	  known	  to	  affect	  cell-­‐signaling	  changes,	  while	  also	  allowing	  high-­‐resolution	  live	  imaging	  and	  use	  of	  the	  latest	  cell	  and	  molecular	  biology	  tools.	  
Much	  remains	  to	  be	  understood	  about	  the	  signaling	  networks	  at	  play	  during	  tip	  cell	  selection	  and	  sprout	  initiation	  (Carmeliet,	  De	  Smet	  et	  al.	  2009).	  The	  angiogenesis	  device	  provides	  an	  avenue	  to	  examine	  sprouting	  initiation	  in	  a	  biomimetic	  system	  that	  includes	  numerous	  factors	  known	  to	  affect	  cell	  signaling	  including	  shear	  stress,	  and	  basement	  membrane	  (Iozzo,	  Zoeller	  et	  al.	  2009;	  Conway,	  Breckenridge	  et	  al.	  2013).	  Alternatively,	  the	  angiogenesis	  tool	  provides	  an	  excellent	  avenue	  to	  monitor	  anastamosis	  events	  and	  the	  formation	  of	  a	  nascent	  vascular	  network.	  We	  have	  only	  begun	  to	  understand	  the	  basic	  mechanisms	  behind	  sprout	  and	  network	  fusion,	  and	  a	  tool	  that	  provides	  live	  imaging	  of	  molecularly	  manipulatable	  EC-­‐EC	  interactions	  during	  anastamosis	  could	  be	  used	  to	  elucidate	  the	  role	  of	  vital	  particular	  signaling	  pathways	  and	  morphological	  changes	  (Cheng,	  Liao	  et	  al.	  2011).	  Interestingly,	  during	  imaging	  of	  network	  formations	  in	  the	  angiogenesis	  device,	  it	  was	  noted	  numerous	  neovessels	  appeared	  to	  have	  been	  pinched	  closed,	  and	  in	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some	  cases	  were	  fully	  separated	  with	  two	  blunt	  ends	  meeting	  in	  the	  middle.	  This	  phenotype	  is	  suggestive	  of	  the	  process	  of	  vascular	  pruning.	  With	  the	  shift	  toward	  vessel	  normalization	  therapies	  in	  cancer,	  the	  understanding	  of	  network	  pruning	  mechanisms	  has	  become	  an	  important	  focus.	  Better	  understanding	  of	  sprout	  initiation,	  nascent	  network	  formation,	  and	  vessel	  pruning,	  may	  aid	  in	  eliciting	  therapeutic	  targets	  for	  potential	  inhibition	  or	  normalization	  of	  vascular	  events	  in	  human	  patients.	  
Screen	  pro-­	  and	  anti-­angiogenic	  therapies	  in	  the	  angiogenesis	  device	  
The	  angiogenesis	  device	  presents	  an	  attractive	  means	  to	  test	  the	  effects	  of	  angiogenic	  therapies.	  Once	  manufacturing	  is	  streamlined	  (a	  current	  undertaking	  in	  the	  Chen	  Lab),	  devices	  will	  provide	  a	  high	  through	  put	  option	  for	  evaluating	  drug	  effects	  on	  sprout	  initiation,	  sprout	  extension	  and	  network	  formation	  in	  a	  biomimetic	  angiogenesis	  assay.	  Interestingly,	  our	  device	  promotes	  sprouting	  angiogenesis	  that	  appears	  to	  function	  independent	  of	  VEGF-­‐gradient	  (FIG	  18).	  As	  human	  tumors	  are	  capable	  of	  promoting	  angiogenesis	  through	  means	  other	  than	  VEGF,	  perhaps	  particularly	  in	  adaptation	  to	  anti-­‐VEGF	  therapy,	  the	  MVPS	  cocktail	  may	  serve	  as	  in	  important	  environment	  to	  investigate	  regulation	  of	  VEGF-­‐independent	  angiogenic	  sprouting.	  Use	  of	  the	  biomimetic	  model	  will	  provide	  advantages	  over	  animal	  models,	  as	  human	  cells	  are	  easily	  employed,	  and	  advantages	  over	  traditional	  angiogenesis	  assays	  in	  the	  ability	  to	  assess	  morphological	  effects	  of	  the	  drug	  and	  to	  evaluate	  the	  drug	  in	  a	  biomimetic	  environment.	  Alternative	  3D	  models	  of	  angiogenesis	  are	  currently	  advancing	  in	  this	  area	  (Vinci,	  Gowan	  et	  al.	  2012).	  	  
Use	  device	  to	  study	  angiogenesis	  of	  organ-­specific	  ECs	  
It	  has	  been	  shown	  that	  liver-­‐specific	  endothelial	  cells,	  termed	  liver	  sinusoidal	  endothelial	  cells	  
(SECs),	  drive	  regeneration	  of	  injured	  organs	  through	  paracrine	  signaling	  and,	  later,	  proliferative	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angiogenesis(Ding,	  Nolan	  et	  al.	  2010).	  These	  SECs	  exhibit	  different	  expression	  profiles	  from	  
nearby	  ECs	  that	  remain	  quiescent	  during	  the	  vascularization	  of	  the	  damaged	  organ	  tissue.	  The	  
observable	  differences	  between	  the	  vascular	  networks	  of	  different	  organs	  have	  been	  thoroughly	  
recognized,	  but	  not	  fully	  explained.	  It	  has	  now	  been	  shown	  that	  endocrine	  gland-­‐derived-­‐VEGF	  
(EG-­‐VEGF)	  drives	  an	  angiogenic	  response	  from	  particular	  EC	  types	  (adrenal	  cortical	  ECs),	  but	  not	  
from	  other	  ECs	  (LeCouter,	  Lin	  et	  al.	  2002)	  This	  provides	  evidence	  of	  potential	  EC-­‐specific	  factors	  
that	  drive	  organ-­‐specific	  angiogenesis,	  and	  suggest	  reasons	  why	  basic	  angiogenic	  therapies	  (e.g.	  
bFGF,	  VEGF)	  may	  be	  less	  effective	  in	  some	  organs	  than	  others	  (LeCouter,	  Lin	  et	  al.	  2002).	  	  
Adoption	  of	  the	  angiogenesis	  device	  to	  study	  organ-­‐specific	  ECs	  may	  reveal	  how	  
variations	  in	  expression	  profiles	  respond	  differently	  to	  angiogenic	  cocktail	  factors	  differently	  in	  
the	  MVPS	  or	  other	  cocktail.	  Initial	  studies	  within	  the	  Chen	  Lab	  have	  shown	  different	  sprouting	  
phenotypes	  exist	  between	  EC	  types	  (mouse	  lung,	  human	  microvascular,	  human	  dermal	  and	  
human	  hemangioma)	  used	  in	  the	  angiogenesis	  device.	  Thus,	  the	  angiogenesis	  device	  may	  be	  
employed	  to	  discover	  angiogenesis	  inhibition	  or	  promotion	  strategies	  tailored	  to	  the	  EC	  type.	  
Examine	  tumor-­associated	  ECs	  in	  the	  angiogenesis	  device	  to	  understand	  key	  drivers	  of	  
aberrant	  phenotype	  
Tumor	  vasculature	  is	  characteristically	  different	  from	  normal	  vascular	  in	  terms	  of	  increased	  
vessel	  density,	  tortuousity	  and	  leakiness	  (Carmeliet	  and	  Jain	  2000).	  The	  tumor	  vasculature	  
phenotype	  is	  likely	  driven	  by	  tumor-­‐associated	  ECs	  that	  differ	  from	  normal	  ECs	  as	  well	  as	  the	  
unique	  chemical	  and	  physical	  environment	  under	  which	  the	  vessels	  form	  (Hida,	  Hida	  et	  al.	  2004;	  
Butler,	  Kobayashi	  et	  al.	  2010).	  Hemangiomas	  are	  masses	  of	  disregulated	  angiogenesis	  that	  occur	  
at	  infancy	  and	  after	  approximately	  8	  months	  of	  growth,	  regress	  until	  absent	  (Boye,	  Yu	  et	  al.	  
2001).	  These	  masses	  are	  marked	  by	  characteristic	  tumor	  vasculature.	  ECs	  isolated	  from	  these	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tumors	  are	  clonal	  and	  genetically	  different	  from	  regular	  ECs	  (Jinnin,	  Medici	  et	  al.	  2008).	  They	  are	  
marked	  by	  low	  expression	  of	  VEGFR1	  expression.	  
The	  biomimetic	  angiogenic	  device	  is	  an	  ideal	  system	  in	  which	  to	  study	  in	  regular	  and	  
tumor	  angiogenesis	  in	  the	  context	  of	  the	  ECs	  themselves.	  While	  genetic	  differences	  seen	  
between	  the	  cell	  types	  likely	  effect	  cell	  activity,	  it	  isn’t	  yet	  clear	  that	  this	  alone	  regulates	  the	  
tumor	  vasculature	  phenotype.	  Thus	  one	  can	  explore	  what	  may	  drive	  tumor–associated	  and	  
normal	  endothelial	  cells	  to	  produce	  different	  vascular	  networks	  under	  the	  same	  conditions.	  For	  
instance,	  studies	  have	  shown	  disregulated	  angiogenesis	  in	  cavernous	  cerebral	  malformations	  is	  
a	  result	  of	  aberrantly	  high	  levels	  of	  RhoA	  activity	  in	  the	  tumor	  associated	  ECs(Whitehead,	  Chan	  
et	  al.	  2009).	  By	  blocking	  ROCK	  activity,	  it	  was	  shown	  that	  the	  vasculature	  was	  normalized	  and	  
the	  effect	  of	  the	  gene	  CCM2	  that	  drives	  the	  malformations	  was	  blocked.	  A	  separate	  study	  of	  
tumor	  associated	  ECs	  showed	  these	  cells	  display	  higher	  levels	  of	  ROCK	  activity	  and	  angiogenic	  
potential	  in	  vitro,	  and	  again,	  when	  ROCK	  activity	  is	  blocked,	  these	  cells	  behave	  like	  normal	  ECs	  
(Ghosh,	  Thodeti	  et	  al.	  2008).	  Finally,	  a	  study	  showed	  that	  exposure	  of	  normal	  vasculature	  to	  
constitutively	  active	  RhoA	  resulted	  in	  vasculature	  more	  reminiscent	  of	  that	  found	  at	  a	  tumor	  
(Hoang,	  Whelan	  et	  al.	  2004).	  
In	  early	  experiments,	  we	  drove	  sprouting	  of	  normal	  and	  hemangioma	  ECs	  to	  examine	  
different	  angiogenic	  responses	  in	  vitro.	  Initial	  results	  suggested	  invasion	  phenotypes	  varied	  
across	  cell	  types.	  A	  deeper	  exploration	  into	  the	  drivers	  behind	  hemangioma	  angiogenesis	  could	  
provide	  valuable	  insight	  into	  potential	  therapeutic	  targets	  to	  normalize	  the	  tumor	  vasculature.	  
The	  literature	  described	  above	  suggest	  it	  would	  be	  interesting	  to	  inhibit	  ROCK	  signaling	  while	  
promoting	  hemangioma	  angiogenesis	  to	  determine	  if	  lowering	  ROCK	  activity	  in	  the	  cells	  reduced	  
the	  tumor	  EC	  phenotype.	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Collective	  migration	  study:	  Impact	  on	  the	  field	  	  
We	  have	  demonstrated	  myosin-­‐mediated	  contractility	  is	  required	  for	  multicellular	  migration	  
during	  angiogenic	  sprouting.	  For	  the	  first	  time	  we	  know	  of	  we	  have	  quantitatively	  defined	  
differences	  between	  tip-­‐stalk	  and	  stalk-­‐stalk	  cadherin	  adhesions,	  through	  both	  phenotype	  and	  
response	  to	  changes	  in	  cell	  contractility.	  This	  provides	  insight	  both	  into	  adhesion	  biology,	  
suggesting	  adhesion	  activities	  are	  differentially	  regulated	  by	  contractility,	  and	  angiogenesis	  
sprouting	  regulation,	  providing	  a	  new	  understanding	  of	  VE-­‐cadherin	  dynamics	  during	  blood	  
vessel	  formation.	  These	  findings	  were	  made	  possible	  through	  the	  application	  of	  genetic	  and	  
pharmacologic	  manipulations	  within	  our	  novel	  system	  unique	  in	  its	  biomimetic	  design.	  
The	  major	  limitation	  of	  this	  study	  lies	  in	  the	  heavy	  usage	  of	  blebbistatin	  to	  evaluate	  the	  
role	  of	  myosin-­‐mediated	  contractility.	  This	  inhibitor	  preferentially	  binds	  to	  the	  ATPase	  
intermediate	  and	  interferes	  with	  phosphate	  release,	  thus	  inhibiting	  myosin’s	  ATP-­‐mediated	  
activity.	  Blebbistatin	  does	  not	  effect	  binding	  of	  myosin	  to	  actin	  or	  ATP-­‐induced	  actomyosin	  
dissociation	  (Kovacs,	  Toth	  et	  al.	  2004).	  While	  blebbistatin	  is	  a	  widely	  used	  and	  well-­‐characterized	  
inhibitor	  of	  myosin	  II	  activity,	  there	  is	  the	  possibility	  the	  effects	  we	  see	  are	  a	  result	  of	  a	  
blebbistatin	  artifact	  rather	  than	  an	  inhibition	  of	  actomyosin	  contractility.	  Further	  advancements	  
of	  this	  study	  should	  consider	  other	  methods	  for	  inhibiting	  myosin	  activity	  such	  as	  eliminating	  or	  
reducing	  myosin	  via	  CRISPR	  or	  shRNA	  technology,	  respectively.	  Targeting	  upstream	  of	  myosin	  
with	  the	  ROCK	  inhibitor,	  Y-­‐27632,	  or	  shRNA	  technology	  would	  also	  provide	  mechanistic	  insight.	  
Initial	  investigations	  with	  shROCk,	  CRISPR	  myosin	  IIA,	  and	  Y-­‐27632	  have	  all	  shown	  similar	  loss-­‐of-­‐
contacts	  or	  lack-­‐of-­‐contacts	  phenotypes	  to	  blebbistatin	  treatment.	  Full	  confirmation	  of	  at	  least	  
one	  of	  these	  phenotypes	  with	  3	  or	  more	  devices	  per	  condition	  is	  would	  aid	  confirmation	  of	  the	  
blebbistatin-­‐mediated	  contractility	  findings. 
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Collective	  migration	  study:	  Future	  investigations	  
I	  aim	  to	  submit	  the	  work	  presented	  in	  Chapter	  3	  for	  publication	  within	  the	  next	  month.	  I	  will	  
share	  authorship	  with	  Tea	  Mirabella	  who	  has	  provided	  the	  in	  vivo	  work	  presented	  in	  Figure	  40.	  
While	  we	  have	  highlighted	  the	  link	  between	  dynamic	  adhesions	  and	  myosin-­‐mediated	  
contractility,	  many	  questions	  remain.	  Final	  experiments	  will	  be	  completed	  within	  the	  following	  
weeks.	  Future	  studies	  in	  our	  lab	  or	  outside,	  will	  likely	  shed	  light	  on	  what	  drives	  the	  difference	  
between	  stalk	  and	  tip	  cell-­‐cell	  adhesions,	  and	  through	  what	  mechanism	  contractility	  regulates	  
the	  difference	  between	  and	  maintenance	  of	  these	  adhesions.	  
	  
Parse	  out	  the	  role	  of	  specific	  myosin	  isoforms	  in	  regulating	  junction	  organization	  
We	  have	  used	  blebbistatin	  to	  inhibit	  non-­‐muscle	  myosin	  II	  ATPase	  activity.	  Non-­‐muscle	  myosin	  II	  
exists	  in	  three	  isoforms,	  as	  determined	  by	  the	  non-­‐muscle	  myosin	  heavy	  chains	  (NMHC)	  II,	  	  
NMHC	  IIA,	  IIB,	  and	  IIC.	  While	  these	  isoforms	  share	  a	  high	  degree	  of	  homology	  they	  are	  
differentially	  localized	  in	  some	  regions	  of	  the	  cell	  and	  have	  some	  different	  functional	  outputs	  
(Maupin,	  Phillips	  et	  al.	  1994).	  For	  example,	  myosin	  IIA	  assembles	  actomyosin	  bundles	  in	  
protrusions	  while	  myosin	  IIB	  incorporates	  into	  actin	  bundles	  at	  segregated	  locations	  to	  define	  
the	  rear	  of	  the	  cell	  (Vicente-­‐Manzanares,	  Koach	  et	  al.	  2008).	  Myosin	  IIA	  has	  the	  highest	  rate	  of	  
actin-­‐binding-­‐mediated	  ATPase	  activity	  and	  seems	  to	  be	  involved	  in	  the	  most	  dynamic	  actin	  
rearrangements,	  as	  it	  is	  located	  in	  dynamic	  actin	  filaments	  at	  cell	  protrusions,	  while	  also	  
mediating	  cell-­‐retraction	  and	  microtubule	  organization	  (Chrzanowska-­‐Wodnicka	  and	  Burridge	  
1996).	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We	  attribute	  the	  effects	  seen	  following	  blebbistatin	  treatment	  to	  an	  inhibition	  of	  
actomyosin	  contractility	  because	  myosin-­‐mediation	  of	  actin	  contractility	  is	  a	  major	  function	  of	  
the	  motor	  protein.	  However,	  it	  is	  possible	  blebbistatin	  effects	  are	  a	  result	  of	  inhibited	  actin	  
crosslinking,	  which	  is	  also	  regulated	  by	  the	  myosin	  II.	  Further	  investigations	  of	  the	  myosin	  
isoforms	  could	  help	  narrow	  down	  the	  potential	  actin-­‐mediated	  dynamics	  that	  are	  truly	  at	  play	  in	  
blocking	  the	  binding	  of	  VE-­‐cadherin	  and	  α-­‐catenin	  for	  junction	  strengthening.	  	  
	  
Further	  exploration	  of	  contractility	  effects	  on	  the	  adhesion	  complex.	  	  	  
We	  have	  only	  just	  begun	  to	  probe	  the	  potential	  affects	  of	  myosin	  inhibition	  on	  the	  complicated	  
molecular	  components	  of	  the	  VE-­‐cadherin	  and	  actin	  interactions.	  Much	  debate	  remains	  around	  
the	  regulators	  of	  the	  connection	  between	  actin	  and	  VE-­‐cadherin,	  including	  the	  molecules	  play	  
and	  the	  drivers	  of	  their	  binding	  affinity	  and	  activity	  (Yonemura	  2011).	  The	  understanding	  of	  α-­‐
catenin-­‐mediation	  of	  cadherin	  complex	  formation	  with	  the	  actin	  cytoskeleton	  is	  particularly	  
contentious.	  While	  it	  was	  previously	  believed	  α-­‐catenin	  directly	  bound	  actin	  and	  beta	  catenin	  to	  
bridge	  the	  complex,	  in	  a	  2005	  study	  it	  was	  revealed	  α-­‐catenin	  was	  incapable	  of	  simultaneously	  
binding	  both	  β-­‐catenin	  and	  actin	  (Drees,	  Pokutta	  et	  al.	  2005).	  Studies	  have	  since	  shown	  that	  
binding	  of	  α-­‐catenin	  is	  dependent	  on	  a	  tension-­‐driven	  conformational	  change	  in	  the	  protein	  that	  
allows	  new	  binding	  site	  access	  (Yonemura,	  Wada	  et	  al.	  2010).	  Strengthening	  of	  the	  cadherin	  
adhesion	  complex	  appears	  to	  rely	  on	  myosin-­‐II	  mediated	  vinculin	  recruitment	  to	  the	  site	  of	  a	  
tension	  bearing	  α-­‐catenin	  spanning	  actin	  and	  beta	  catenin	  (le	  Duc,	  Shi	  et	  al.	  2010).	  This	  would	  
suggest	  myosin	  II	  inhibition	  would	  block	  adhesion	  strengthening	  as	  a	  consequence	  of	  reduced	  
vinculin	  recruitment	  to	  adhesions.	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Interestingly,	  the	  rescue	  of	  the	  blebbistatin-­‐induced	  loss	  of	  cell-­‐contacts	  by	  VEC-­‐α-­‐C	  
suggests	  contractility	  is	  required	  to	  form	  the	  connections	  between	  α-­‐catenin.	  We	  see	  that	  
despite	  VEC-­‐α-­‐C	  expression,	  myosin	  inhibition	  still	  drives	  a	  shift	  to	  disorganization	  of	  the	  
adhesion.	  It	  is	  possible	  this	  may	  be	  a	  result	  of	  reduced	  vinculin	  recruitment	  to	  additionally	  
stabilize	  the	  adhesion.	  Thus	  a	  model	  may	  emerge	  whereby	  myosin	  inhibition	  reduces	  cadherin	  
organization	  in	  a	  vinculin-­‐dependent	  manner,	  and	  also	  blocks	  the	  tension-­‐induced	  spreading	  of	  
alpha	  catenin.	  Thus,	  while	  the	  first	  mechanism	  is	  not	  rescued	  via	  VEC-­‐α-­‐C	  expression,	  the	  second	  
mechanism,	  which	  forces	  the	  α-­‐catenin	  VE-­‐cadherin	  interaction	  is	  rescued.	  Our	  VEC-­‐α-­‐C	  rescue	  
finding	  doesn’t	  specifically	  clarify	  what	  aspect	  of	  normal	  complex	  formation	  between	  VE-­‐
cadherin,	  β-­‐catenin	  and	  α-­‐catenin	  is	  disrupted	  by	  a	  drop	  in	  myosin.	  For	  example,	  it	  is	  possible	  
the	  blocking	  of	  complex	  formation	  by	  myosin	  inhibition	  is	  a	  result	  of	  a	  change	  in	  β-­‐catenin	  
binding	  of	  in	  α-­‐catenin	  or	  VE-­‐cadherin.	  Further	  clarification	  to	  myosin’s	  effect	  on	  adhesions	  and	  
cell	  contacts	  during	  3D	  migration	  would	  be	  mediated	  by	  a)	  observing	  myosin	  II	  effects	  on	  
vinculin	  localization	  within	  the	  sprout,	  b)	  driving	  sprouting	  in	  vinculin	  deficient	  cells	  to	  
determine	  if	  adhesions	  are	  maintained,	  c)	  testing	  blebbistatin	  effect	  on	  sprout	  extension	  in	  
sprouts	  composed	  of	  ECs	  expressing	  alternative	  fusion	  proteins	  (such	  as	  VEC-­‐β-­‐C).	  
	  
Advancements	  of	  the	  in	  silico	  model	  to	  more	  accurately	  predict	  aspects	  of	  adhesion	  
dynamics	  and	  contractility.	  	  
Relationships	  between	  contractility,	  adhesions,	  and	  sprout	  formation	  are	  examined	  in	  this	  
thesis,	  and	  numerous	  other	  published	  studies.	  The	  inclusion	  of	  multiple	  complex	  key	  
relationships	  in	  the	  in	  silico	  model	  may	  improve	  the	  model’s	  ability	  to	  hypothesize	  adhesion	  and	  
cell	  dynamics.	  It	  would	  be	  particularly	  interesting	  to	  model	  regulation	  of	  adhesions	  through	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RhoA	  GTPase	  signaling.	  After	  such	  feedback	  relationships	  are	  included	  into	  the	  model,	  further	  
refinement	  to	  include	  regulators	  of	  adhesions	  stabilization,	  such	  as	  β-­‐catenin,	  α-­‐catenin,	  and	  
p120-­‐catenin	  could	  potentially	  provide	  interesting	  predictive	  results	  of	  GTPase	  regulation	  of	  the	  
formation	  of	  the	  adhesion	  complex.	  Initial	  adaptations	  may	  include	  simple	  ON/OFF	  feedback	  
relationships	  between	  RhoGTPases	  and	  adhesions:	  
Differential	  of	  Rac-­‐1	  and	  RhoA	  affects	  cadherin	  adhesions	  through	  multiple	  mechanisms:	  
When	  contractility	  is	  inhibited,	  Rac-­‐1	  is	  activated,	  which	  drives	  protrusions	  at	  the	  front	  of	  cells	  
through	  stimulation	  of	  actin	  polymerization	  and	  integrin	  adhesion	  complexes,	  is	  also	  necessary	  
for	  cadherin	  cluster	  formation,	  junction	  stability	  and	  barrier	  function	  (Waschke,	  Baumgartner	  et	  
al.	  2004;	  Perez-­‐Moreno	  and	  Fuchs	  2006).	  Surprisingly,	  other	  studies	  have	  shown	  that	  expression	  
of	  constitutively	  active	  (CA)	  Rac-­‐1	  in	  ECs	  leads	  to	  reactive-­‐oxygen-­‐species-­‐mediated	  junction	  
disruption	  through	  β-­‐catenin	  phosphorylation	  by	  tyrosine	  kinase	  Protein	  Proline-­‐rich	  tyrosine	  
kinase	  2	  (Pyk2)(van	  Wetering,	  van	  Buul	  et	  al.	  2002).	  Both	  Rac-­‐1	  also	  regulates	  cell	  polarization,	  is	  
required	  for	  cadherin	  endocytosis,	  and	  controls	  cadherin-­‐mediated	  adhesion	  via	  IQGAP1	  	  
(Kuroda,	  Fukata	  et	  al.	  1998;	  Izumi,	  Sakisaka	  et	  al.	  2004;	  Gavard	  and	  Gutkind	  2006).	  RhoA	  
signaling,	  which	  drives	  actin	  crosslinking	  and	  actomyosin	  contraction	  through	  MLC	  
phosphorylation,	  is	  required	  for	  adhesion	  stabilization	  and	  formation	  of	  actin	  bundles	  at	  
cadherin	  adhesions	  but	  has	  also	  been	  shown	  to	  increase	  junction	  permeability	  (Braga,	  Machesky	  
et	  al.	  1997;	  Abraham,	  Yeo	  et	  al.	  2009).	  	  
Cross	  talk	  between	  RhoA,	  Rac-­‐1	  and	  cadherin	  adhesions:	  A	  feedback	  loop:	  VE-­‐cadherin	  
signaling	  has	  been	  to	  affect	  RhoA	  and	  Rac-­‐1	  activity.	  In	  epithelial	  cells,	  increased	  E-­‐cadherin	  (via	  
a	  calcium	  switch)	  led	  to	  a	  rapid	  increase	  in	  Rac-­‐1,	  followed	  by	  a	  delayed	  increase	  hours	  later	  in	  
RhoA	  (Noren,	  Niessen	  et	  al.	  2001).	  When	  VE-­‐cadherin	  was	  expressed	  in	  VE-­‐cadherin-­‐deficient	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ECs,	  Rac-­‐1	  signaling	  was	  augmented	  via	  increased	  expression	  of	  the	  Rac-­‐specific	  GEF,	  Tiam1	  
(Corada,	  Zanetta	  et	  al.	  2002).	  RhoA	  and	  Rac-­‐1	  have	  been	  shown	  to	  effect	  signaling	  activity	  of	  
each	  other.	  For	  example,	  Rac-­‐1	  inhibition	  leads	  to	  RhoA	  activation,	  which	  causes	  EC	  barrier	  
function	  to	  decrease	  (Seebach,	  Madler	  et	  al.	  2005).	  
VEGF-­‐regulation	  of	  RhoGTPases:	  VEGF	  signaling	  is	  known	  to	  modulate	  both	  RhoA	  and	  
Rac-­‐1	  signaling,	  and	  has	  multiple	  effects	  on	  cadherins,	  including	  increased	  adhesion	  
permeability	  via	  Src	  kinase	  phosphorylation	  of	  VE-­‐cadherin	  and	  increased	  β-­‐arrestin-­‐mediated	  
endocytosis	  of	  VE-­‐cadherin	  (Gavard	  and	  Gutkind	  2006;	  Wallez,	  Cand	  et	  al.	  2007).	  VEGFR-­‐2	  
mediated	  VE-­‐cadherin	  endocytosis	  is	  currently	  included	  in	  the	  model.	  Expansion	  of	  the	  model	  to	  
include	  VEGF	  modulation	  of	  Rho	  GTPase	  would	  be	  highly	  relevant,	  as	  VEGF	  activation	  of	  VEGFR-­‐
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Chapter	  5:	  Methods	  
Angiogenesis	  model	  methods	  (Chapter	  2)	  
Methods	  summary	  
Our	  model	  consists	  of	  a	  bilayer	  PDMS	  mold	  adhered	  to	  a	  glass	  coverslip.	  Rat	  tail	  Collagen	  Type	  I	  
is	  polymerized	  in	  the	  center	  cavity	  of	  the	  device	  around	  two	  400µm-­‐diameter	  needles.	  Needle	  
extraction	  leaves	  two	  cylindrical	  channels	  in	  the	  matrix.	  Endothelial	  cells	  are	  seeded	  into	  one	  
channel	  and	  allowed	  to	  form	  a	  confluent	  monolayer	  along	  the	  wall	  of	  the	  cylindrical	  void.	  
Devices	  are	  placed	  on	  a	  platform	  rocker	  to	  generate	  gravity-­‐driven	  flow	  through	  both	  channels.	  
Pro-­‐angiogenic	  factors	  are	  added	  to	  the	  opposite	  channel	  to	  induce	  sprouting.	  This	  process	  is	  
captured	  with	  brightfield	  or	  confocal	  microscopy.	  In	  inhibitor	  experiments,	  inhibitors	  were	  
added	  to	  the	  system	  concurrently	  with	  angiogenic	  factors	  at	  day	  0	  or	  three	  days	  after	  sprouting	  
was	  initiated.	  In	  all	  cases,	  angiogenic	  factors	  or	  inhibitors	  were	  refreshed	  daily.	  	  
	  
Detailed	  methods	  
Device	  Fabrication.	  The	  device	  housing	  is	  fabricated	  from	  two	  patterned	  layers	  of	  
poly(dimethylsiloxane)	  (PDMS;	  Sylgard	  184;	  Dow-­‐Corning)	  bonded	  to	  each	  other	  and	  sealed	  
against	  a	  glass	  substrate	  (Fig.	  S7).	  The	  two	  PDMS	  layers	  were	  cast	  or	  double-­‐cast	  from	  templates	  
originally	  generated	  using	  standard	  photolithography	  of	  SU-­‐8	  on	  silicon	  wafers.	  Dimensions	  of	  
important	  features	  in	  both	  layers	  are	  shown	  in	  Fig.	  1A.	  To	  assemble	  the	  device,	  the	  bottom	  layer	  
was	  first	  sealed	  to	  a	  glass	  coverslip.	  The	  top	  and	  bottom	  layers	  were	  then	  treated	  with	  oxygen	  
plasma,	  bonded	  together,	  and	  cured	  at	  110°C	  overnight.	  Assembled	  devices	  then	  were	  treated	  
with	  oxygen	  plasma,	  immersed	  in	  0.1	  mg/ml	  poly-­‐L-­‐lysine	  (Sigma)	  for	  1	  hr,	  1%	  glutaraldehyde	  
	   115	  
(Sigma)	  for	  1.5	  hr,	  washed	  several	  times	  with	  ddH2O,	  sterilized	  with	  UV	  light	  for	  15	  min,	  and	  
soaked	  in	  70%	  ethanol	  for	  1	  hr.	  To	  mold	  cylindrical	  channels,	  two	  400	  µm	  diameter	  acupuncture	  
needles	  (Hwato)	  were	  inserted	  into	  parallel	  grooves	  at	  the	  top	  of	  the	  bottom	  layer	  (Fig.	  S7)	  and	  
through	  the	  middle	  rectangular	  chamber	  approximately	  200µm	  above	  the	  glass	  coverslip	  
surface.	  Rat	  tail	  collagen	  type	  I	  (2.5	  mg/ml;	  BD	  Biosciences)	  was	  prepared	  per	  the	  
manufacturer’s	  protocol	  and	  pipetted	  into	  the	  middle	  chamber	  and	  allowed	  to	  polymerize	  at	  
37oC	  for	  30	  min.	  Excess	  collagen	  was	  subsequently	  aspirated	  from	  the	  fluid	  reservoirs	  feeding	  
from	  the	  middle	  chamber.	  Devices	  were	  then	  covered	  with	  EGM-­‐2	  (Lonza)	  before	  the	  needles	  
were	  extracted	  as	  previously	  described	  (Chrobak,	  Potter	  et	  al.	  2006).	  	  
	   	  
Cell	  Culture	  and	  Seeding	  in	  Devices.	  Human	  umbilical	  vein	  endothelial	  cells	  (HUVECs)	  
(Lonza)	  and	  human	  microvascular	  endothelial	  cells	  (HMVECs)	  (Lonza)	  were	  cultured	  in	  EGM-­‐2	  
and	  EGM-­‐2MV,	  respectively.	  While	  all	  experiments	  shown	  were	  conducted	  with	  HUVECs,	  
HMVECs	  also	  sprouted	  in	  response	  to	  angiogenic	  cocktails.	  ECs	  were	  concentrated	  at	  107	  
cells/ml	  and	  seeded	  into	  one	  of	  the	  two	  channels.	  The	  device	  was	  inverted	  to	  allow	  ECs	  to	  
adhere	  to	  the	  top	  surface	  of	  the	  channel	  for	  10	  min,	  and	  then	  flipped	  upright	  to	  allow	  cells	  to	  
adhere	  to	  the	  bottom	  surface	  of	  the	  channel	  for	  another	  10	  min.	  Cells	  that	  adhered	  in	  the	  fluid	  
reservoirs	  were	  scraped	  off	  with	  a	  pipette	  tip,	  and	  unattached	  cells	  in	  the	  channel	  were	  
thoroughly	  flushed	  out	  with	  phosphate-­‐buffered	  saline	  (PBS).	  Media	  was	  immediately	  added	  
thereafter	  and	  the	  devices	  were	  placed	  on	  a	  platform	  rocker	  (BenchRocker,	  BR2000).	  Cells	  were	  
cultured	  in	  channels	  for	  1-­‐2	  days	  before	  angiogenic	  factors	  were	  introduced.	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Immunofluorescence	  Staining.	  For	  immunofluorescence	  staining,	  cells	  in	  the	  devices	  
were	  fixed	  in	  situ	  with	  3.7%	  formaldehyde	  for	  45	  min.	  For	  CD31	  labeling,	  cells	  were	  
permeabilized	  with	  0.1%	  Triton-­‐X	  for	  30	  minutes,	  blocked	  in	  3%	  BSA	  overnight	  at	  4oC,	  washed	  3	  
times	  with	  PBS	  and	  incubated	  with	  mouse	  monoclonal	  antibody	  against	  human	  CD31	  (1:200,	  
Dako).	  For	  laminin,	  collagen	  IV	  and	  podocalyxin	  labeling,	  samples	  were	  blocked	  with	  3%	  BSA	  
overnight	  at	  4oC,	  washed	  3	  times	  with	  PBS	  and	  incubated	  at	  4oC	  overnight	  with	  rabbit	  polyclonal	  
antibody	  against	  laminin	  (1:100,	  Chemicon),	  mouse	  polyclonal	  antibody	  against	  collagen	  IV	  
(1:50,	  Dako),	  and	  goat	  polyclonal	  anti-­‐human	  podocalyxin	  (1:100,	  R&D),	  respectively.	  Before	  
secondary	  antibody	  incubation,	  the	  devices	  were	  washed	  overnight	  with	  PBS	  at	  4oC.	  All	  
secondary	  antibodies	  (Invitrogen)	  were	  used	  at	  1:500	  dilution.	  Cell	  nuclei	  were	  labeled	  with	  
DAPI	  (1:500,	  Sigma).	  F-­‐actin	  was	  labeled	  with	  Alexa	  Fluor	  488-­‐conjugated	  Phalloidin	  (1:100,	  
Sigma).	  	  
	  
Image	  Acquisition	  and	  Processing.	  Brightfield	  images	  of	  sprouts	  were	  acquired	  with	  a	  
Nikon	  TE200	  epifluorescence	  microscope	  (Nikon	  Instruments,	  Inc.)	  using	  a	  10x	  objective.	  
Confocal	  immunofluorescence	  images	  were	  acquired	  with	  either	  a	  10x	  air	  objective	  or	  an	  LD	  C-­‐
Apochromat	  40x,	  1.1	  numerical	  aperture	  (N.A.)	  water	  immersion	  objective	  attached	  to	  either	  an	  
Axiovert	  200M	  inverted	  microscope	  (Zeiss)	  equipped	  with	  a	  CSU10	  spinning	  disk	  confocal	  scan	  
head	  (Yokogawa	  Electric	  Corporation)	  and	  an	  Evolve	  EMCCD	  camera	  (Photometrics),	  or	  an	  
Olympus	  IX	  81	  microscope	  (Olympus	  America,	  Inc.)	  equipped	  with	  an	  CSU-­‐X1	  spinning	  disk	  
confocal	  scan	  head	  (Yokogawa	  Electric	  Corporation)	  and	  an	  Andor	  iXon3	  897	  EMCCD	  camera	  
(Andor	  Technology).	  ImageJ	  was	  used	  to	  merge	  channels,	  perform	  z-­‐projection	  for	  all	  confocal	  
stacks,	  and	  generate	  longitudinal	  and	  transverse	  cross-­‐sections.	  Custom	  MATLAB	  scripts	  and	  
ImageJ	  were	  used	  to	  stitch	  images	  together.	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Treatment	  with	  Pro-­‐	  and	  Anti-­‐angiogenic	  Factors.	  In	  screening	  experiments,	  the	  
endothelialized	  parent	  vessel	  was	  perfused	  with	  culture	  media	  while	  the	  source	  channel	  was	  
perfused	  with	  media	  enriched	  with	  angiogenic	  factors.	  Angiogenic	  factors	  include	  vascular	  
endothelial	  growth	  factor	  (VEGF),	  monocyte	  chemotactic	  protein-­‐1	  (MCP-­‐1),	  hepatocyte	  growth	  
factor	  (HGF),	  and	  basic	  fibroblast	  growth	  factor	  (bFGF),	  all	  purchased	  from	  R&D	  Systems.	  
Sphingosine-­‐1-­‐phosphate	  (S1P)	  and	  phorbol	  myristate	  acetate	  (PMA)	  were	  purchased	  from	  
Cayman	  Chemical	  and	  Sigma,	  respectively.	  VEGF,	  MCP-­‐1,	  bFGF,	  HGF,	  and	  PMA	  were	  all	  used	  at	  
75ng/mL.	  S1P	  was	  used	  at	  500nM	  unless	  otherwise	  indicated.	  Inhibitors	  targeting	  VEGFR2	  (10	  
µM	  Semaxanib,	  Cayman	  Chemical)	  or	  S1P	  receptors	  (100	  nM	  Fingolimod,	  Selleck	  Chemicals)	  
were	  administered	  into	  both	  channels.	  MMP	  inhibitor	  (0.6	  μM	  Marimastat,	  Tocris	  Bioscience)	  
was	  administered	  into	  the	  source	  channel.	  Media	  in	  both	  channels	  were	  refreshed	  daily.	  	  	  
	  
Bead	  Perfusion	  of	  Microvessels.	  After	  neovessels	  bridged	  the	  two	  preformed	  channels	  
in	  the	  device,	  a	  solution	  of	  CellTracker	  CM-­‐DiI	  (Invitrogen)	  was	  delivered	  into	  the	  parent	  vessel	  
to	  label	  cells	  in	  situ.	  Fluorescent	  beads	  (Polysciences)	  of	  3	  μm	  diameter	  were	  suspended	  in	  PBS	  
and	  perfused	  into	  the	  parent	  vessel	  at	  a	  flow	  rate	  of	  5	  µL/min.	  Images	  were	  acquired	  at	  40	  
frames/sec	  using	  an	  Eclipse	  TE2000	  equipped	  with	  an	  Evolve	  EMCCD	  camera.	  	  
	  
Quantification	  of	  Sprout	  Length	  and	  Sprout	  Density.	  Custom	  MATLAB	  code	  was	  written	  
to	  measure	  the	  individual	  distances	  from	  the	  leading	  protrusions	  of	  tip	  cells	  to	  the	  wall	  of	  the	  
parent	  vessel.	  Tip	  cells	  were	  additionally	  quantified	  as	  either	  attached	  to	  stalk	  cells	  extending	  
from	  the	  endothelialized	  channel	  or	  as	  isolated	  single	  cells	  (Fig.	  S2).	  Sprouting	  metrics	  were	  
quantified	  for	  the	  screening	  experiment	  (N	  =	  2	  samples	  per	  condition),	  the	  VEGFR2	  and	  S1P	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inhibitor	  experiment	  (N	  =	  5	  samples	  per	  condition),	  and	  the	  MMPs	  inhibitor	  experiment	  (N	  =	  3	  
samples	  per	  condition).	  
	  
Filopodia	  Quantification	  and	  Analysis.	  Projections	  from	  z-­‐resolved	  confocal	  stacks,	  
which	  were	  taken	  with	  a	  25x	  objective,	  Axiovert	  200M	  inverted	  microscope	  (Zeiss),	  and	  spinning	  
disk	  confocal	  scan	  head,	  were	  used	  to	  analyze	  filopodia	  length	  and	  number.	  A	  custom	  MATLAB	  
code	  was	  used	  to	  determine	  the	  distance	  from	  the	  tips	  of	  filopodia	  to	  the	  nearest	  edge	  of	  the	  
cell	  body	  and	  to	  count	  the	  number	  of	  filopodia.	  The	  number	  and	  length	  of	  filopodia	  were	  
averaged	  over	  the	  number	  of	  cells	  across	  3	  samples	  per	  condition.	  
	  
Characterization	  of	  Gradient.	  20kDa	  fluorescein	  isothiocyanate-­‐dextran	  (Sigma)	  was	  perfused	  
into	  the	  source	  channel	  and	  the	  fluorescence	  signal	  across	  the	  interstitial	  space	  between	  the	  
parent	  endothelialized	  vessel	  and	  the	  source	  channel	  was	  recorded	  for	  1	  hour	  using	  an	  Axiovert	  
200M	  inverted	  microscope	  equipped	  with	  an	  40x	  water	  immersion	  objective,	  CSU10	  spinning	  
disk	  confocal	  scan	  head,	  and	  an	  Evolve	  EMCCD	  camera.	  Intensity	  was	  normalized	  to	  maximum	  
intensity	  and	  plotted	  over	  the	  distance	  between	  the	  source	  and	  sink	  channels.	  
	  
Statistical	  Analysis.	  Sample	  populations	  were	  compared	  using	  unpaired,	  two-­‐tailed	  
Student’s	  t-­‐test.	  P	  <	  0.05	  was	  the	  threshold	  for	  statistical	  significance.	  Data	  points	  on	  the	  graphs	  
represent	  mean	  values	  and	  error	  bars	  depict	  SEM.	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Collective	  migration	  study	  methods	  (Chapter	  3)	  
Methods	  summary	  
The	  3D	  angiogenesis	  device	  was	  employed	  to	  study	  sprout	  elongation	  in	  the	  absence	  and	  
presence	  of	  a	  contractility	  inhibitor.	  ECs	  were	  infected	  with	  various	  lentiviral	  constructs	  and	  
employed	  in	  the	  sprouting	  assay.	  A	  mouse	  retinal	  angiogenesis	  model	  was	  used	  to	  validate	  
results.	  An	  in	  silico	  model	  was	  used	  to	  predict	  the	  effect	  of	  blebbistatin-­‐induced	  protrusions	  on	  
cell	  dynamics.	  Details	  of	  device	  fabrication,	  cell	  culture	  and	  seeding	  in	  devices,	  
immunofluorescence	  staining,	  image	  acquisition	  and	  processing,	  and	  treatment	  with	  pro-­‐
angiogenic	  factors	  is	  included	  in	  the	  first	  section	  of	  Chapter	  5	  “Angiogenesis	  Model	  Methods	  
(Chapter	  2).”	  In	  silico	  experiments	  were	  conducted	  as	  described	  previously	  published	  (Bentley,	  
Gerhardt	  et	  al.	  2008;	  Bentley,	  Franco	  et	  al.	  2014).	  
	  
Detailed	  methods	  
Blebbistatin	  treatment	  of	  in	  vitro	  sprouts	  in	  device.	  Cells	  were	  cultured	  in	  the	  device	  under	  
MVPS	  gradient	  for	  3	  days.	  During	  this	  period,	  media	  in	  the	  cell	  channel	  and	  cocktail	  in	  the	  source	  
channel	  were	  refreshed	  daily,	  and	  back-­‐and-­‐forth	  flow	  was	  maintained	  via	  the	  platform	  rocker.	  
After	  3	  days	  of	  sprouting,	  blebbistatin	  or	  vehicle	  control	  was	  added	  to	  cell	  media	  and	  MVPS	  
cocktail	  and	  used	  to	  refresh	  the	  device.	  Blebbistatin	  concentrations	  in	  device	  were	  10,	  30,	  50	  
μM,	  and	  vehicle	  control	  was	  DMSO	  (added	  at	  amount	  used	  for	  50	  μM	  blebbistatin	  treatment).	  
Devices	  were	  fixed	  in	  warm	  3%	  paraformaldehyde	  for	  25	  min	  at	  37°C,	  subsequently	  rinsed	  three	  
times	  with	  PBS	  before	  permeabilization	  with	  0.1%	  Triton-­‐X	  for	  20	  min.	  For	  VE-­‐cadherin	  staining,	  
devices	  were	  blocked	  with	  3%	  BSA	  in	  PBS	  overnight,	  then	  treated	  with	  1:100	  mouse	  anti-­‐human	  
VE-­‐cadherin	  antibody	  (sc-­‐9989;	  Santa	  Cruz)	  in	  3%	  BSA	  in	  PBS	  overnight,	  rinsed	  for	  6	  hours,	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treated	  with	  1:500	  donkey	  anti-­‐mouse	  secondary	  (alexafluor	  568	  A10037;	  Life	  Technologies).	  
Dapi	  and	  phalloidin	  staining	  was	  completed	  as	  described	  above	  in	  the	  section	  
“Immunofluorescence	  Staining.”	  	  
	  
Quantification	  of	  cell-­‐cell	  contacts.	  For	  each	  device,	  40X	  3D	  image	  stacks	  were	  collected	  
at	  three	  locations	  equidistance	  from	  each	  other	  along	  the	  channel	  (FIG	  41).	  Image	  collections	  
were	  centered	  on	  the	  midpoint	  of	  the	  channel	  in	  the	  z,	  or	  vertical,	  direction.	  Individual	  image	  
stacks	  contained	  100	  images,	  taken	  at	  2µm	  increments	  in	  the	  z	  direction.	  	  
	  
Figure	  41.	  Illustration	  of	  40X	  imaging	  regions	  of	  each	  device	  for	  cell-­‐cell	  contact	  evaluation.	  Orange	  dashed	  boxes	  
represent	  areas	  imaged.	  The	  width	  of	  each	  image	  capture	  is	  approximately	  150µm.	  Length	  of	  image	  capture	  is	  
variable	  depending	  on	  length	  of	  sprout,	  but	  is	  often	  between	  3	  to	  5	  frames	  which	  are	  stitched	  together	  during	  post-­‐
acquisition	  processing.	  	  
Quantification	  was	  completed	  by	  scrolling	  through	  each	  200µm	  depth	  set	  after	  images	  
were	  stitched	  together	  to	  capture	  full	  invasion	  length.	  Numerical	  data	  was	  collected	  on	  a)	  
number	  of	  tip	  cells,	  b)	  number	  of	  detached	  tip	  cells,	  c)	  number	  of	  stalk	  cells,	  d)	  number	  of	  
detached	  stalk	  cells.	  Tip	  cells	  were	  defined	  morphologically	  by	  their	  existence	  in	  the	  leading	  half	  
of	  the	  cellular	  invasion	  distance	  (defined	  from	  the	  front	  of	  leading	  cells	  back	  to	  the	  near	  edge	  of	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the	  cell	  channel),	  and	  the	  presence	  of	  multiple,	  long	  actin-­‐rich	  protrusions	  directed	  toward	  the	  
gradient	  source.	  Remaining	  cells	  were	  deemed	  stalk	  cells,	  which	  were	  generally	  located	  in	  the	  
back	  half	  of	  the	  invasion	  and	  lacked	  actin-­‐rich	  protrusions.	  
	  
Quantification	  of	  cadherin	  adhesions.	  In	  devices	  and	  retinas	  labeled	  with	  VE-­‐cadherin,	  
adhesions	  were	  categorized	  as	  a)	  discontinuous,	  b)	  in	  between,	  c)	  organized.	  In	  the	  devices,	  
adhesions	  were	  also	  categorized	  as	  a)	  tip-­‐stalk,	  or	  b)	  stalk-­‐stalk	  based	  on	  morphological	  analysis	  
described	  above.	  Categorizations	  were	  made	  from	  compressed	  stacks	  (z-­‐projection	  images)	  40X	  
images.	  	  
	  
Cloning	  and	  Lentiviral	  preparation.	  For	  shCDH5	  and	  scramble	  cloning,	  the	  two	  
complementary	  oligos	  (CDH5:CATAGCATTGGATACTCCATCCGCA	  and	  
scramble:GCGTCTCGAGGCAACAAGATGAAGAGCACCAA)	  were	  mixed	  at	  a	  1:1	  ratio	  to	  a	  final	  
concentration	  of	  50μM	  and	  annealed	  as	  follows:	  95°C	  for	  30	  sec,	  72°C	  for	  2	  min,	  37°C	  for	  2	  min	  
and	  25°C	  for	  2	  min.	  The	  oligos	  were	  cloned	  in	  pLVTHM	  (Addgene:12247)	  between	  MluI	  and	  ClaI	  
cutting	  sites.	  The	  shROCK1	  and	  scramble	  were	  cloned	  into	  shLVDP	  and	  have	  been	  reported	  
elsewhere	  (Alimperti,	  Lei	  et	  al.	  2012).	  
The	  VEC	  construct	  was	  PCR	  amplified	  using	  pShuttle-­‐VE	  and	  pShuttle-­‐VEΔ	  (Nelson,	  
Pirone	  et	  al.	  2004).	  The	  VEC-­‐α-­‐C	  was	  PCR	  amplified	  using	  pENTR2B	  hVEC-­‐aC-­‐GFP	  (kindly	  
provided	  by	  Dr.	  V.	  Kueppers	  (Max-­‐Planck-­‐Institute	  of	  Molecular	  Biomedicine))	  (Schulte,	  Kuppers	  
et	  al.	  2011).	  	  The	  VEC	  and	  VEC-­‐α-­‐C	  were	  subcloned	  between	  NheI	  and	  AgeI	  into	  the	  pCSCG	  
(Addgene:	  12154)	  lentiviral	  vector	  downstream	  of	  the	  cytomegalovirus	  (CMV)	  promoter	  and	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followed	  by	  the	  internal	  ribosome	  entry	  site	  (IRES)	  and	  enhanced	  green	  fluorescent	  protein	  
(EGFP).	  To	  this	  end,	  they	  were	  PCR	  amplified	  using	  as	  template	  with	  primers	  subsequently	  listed.	  
VEC	  forward	  primer	  sequence:	  ACAACAAGCTAGCCCACCATGCAGAGG	  
VEC	  reverse	  primer	  sequence:	  ACAACAAACCGGTCTAATACAGCAGCTCCTCC	  
VEC-­‐α-­‐C	  forward	  primer	  sequence:	  ACAACAAGCTAGCATGCAGAGGCTCATGAT	  
VEC-­‐α-­‐C	  forward	  primer	  sequence:	  ACAACAACTCGAGGATGCTGTCCATGGCTTT	  
	  
All	  cloning	  products	  were	  confirmed	  by	  sequencing	  with	  Quintara	  Biosciences	   (Albany,	  
CA,	  USA)	  using	  the	  primers	  subsequently	  listed.	  	  
CDH5	  portion	  forward	  primer	  sequence:	  TGGGCTCTCTGTTTGTTGAG	  
CDH5	  portion	  reverse	  primer	  sequence:	  GTAGGAAGTGGACCTTGGTATG	  
Fusion	  portion	  forward	  primer	  sequence:	  GTTCACCTTCTGCGAGGATATG	  	  
Fusion	  portion	  reverse	  primer	  sequence:	  G	  GAGGACACAGTGCTTCTAACTG	  
CTNNA1	  portion	  forward	  primer	  sequence:	  GCACTGTGTCCTCAGGTTATC	  
CTNNA1	  portion	  reverse	  primer	  sequence:	  G	  CATCCAGCTTGCTCTTCTCTT	  
	  
For	  lentivirus	  production,	  293T/17	  cells	  were	  transfected	  with	  three	  plasmids:	  lentiviral	  
vector	  (16.8μg),	  psPAX2	  (Addgene:	  12260)	  (15μg)	  and	  pMD2.G	  (Addgene:	  12259)	  (5μg)	  using	  the	  
standard	  calcium	  phosphate	  precipitation	  method.	  Virus	  was	  harvested	  24hr	  post	  transfection,	  
filtered	   through	   a	   0.45µm	   filter	   (Millipore,	   Bedford,	  MA),	   pelleted	   by	   PEG-­‐it	   solution	   (System	  
Biosciences)	  and	  resuspended	  in	  fresh	  medium.	  For	  titration	  of	  lentiviral	  vectors,	  293T/17	  cells	  
were	   infected	   with	   serial	   dilution	   of	   viruses	   and	   the	   number	   of	   infection	   units	   (I.U.)	   per	  
microliter	  were	   estimated	   by	   using	   the	   formula:	   (%	   GFP	   positive	   cells/100)	   x	   (initially	   seeded	  
number	  of	  cells	  per	  well	  )	  x	  (dilution	  factor).	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Lentivirus	  infection	  of	  HUVECs.	  HUVECs	  were	  grown	  on	  0.1%	  gelatin-­‐	  coated	  petri	  
dishes	  in	  EGM-­‐2	  medium	  until	  a	  confluence	  of	  60%	  was	  reached.	  After	  washing	  cells	  in	  PBS,	  an	  
infection	  at	  10	  MOI	  of	  lentivirus	  was	  conducted	  in	  transduction	  medium,	  containing	  50%	  
OptiMEM®,	  50%	  EGM-­‐2	  and	  8μg/ml	  	  final	  concentration	  of	  Polybrene.	  The	  transduction	  was	  
carried	  on	  O.N.	  at	  37°C,	  after	  which	  the	  virus	  medium	  was	  removed	  and	  replaced	  with	  EGM-­‐2.	  
Before	  seeding	  HUVECs	  in	  devices,	  as	  a	  checkpoint	  for	  efficiency	  of	  the	  virus	  integration	  and	  
expression	  in	  HUVECs,	  	  the	  genomic	  DNA	  and	  the	  mRNA	  were	  extracted	  with	  QIAamp	  DNA	  Mini	  
Kit	  and	  RNeasy	  Mini	  Kit	  (QIAGEN)	  respectively.	  The	  content	  of	  vector-­‐derived	  GFP	  integrated	  
into	  the	  HUVEC	  genome	  was	  quantified	  by	  plotting	  Ct	  values	  from	  Real	  Time	  PCR	  (QuantiTect	  
SYBR	  Green	  PCR	  Kit,	  Qiagen)	  to	  a	  standard	  curve	  of	  500	  bp	  long	  GFP	  nucleotide	  sequence.	  The	  
total	  expression	  level	  of	  CDH5	  gene	  was	  quantified	  by	  Real	  Time	  PCR	  after	  cDNA	  synthesis	  with	  
qScript™	  cDNA	  SuperMix,	  Quanta	  Bioscience.	  We	  set	  80%	  decrease	  in	  CDH5	  mRNA	  level	  as	  
benchmark	  of	  efficient	  silencing	  when	  Sh-­‐lentivirus	  was	  used,	  and	  not	  less	  than	  70%	  increase	  in	  
mRNA	  level	  as	  mark	  of	  CMV	  promoter-­‐driven	  expression	  of	  CDH5	  gene.	  
For	  VEC	  and	  VEC-­‐α-­‐C	  verification	  and	  quantification	  in	  infected	  HUVECs,	  cells	  were	  lysed	  
in	  Ripa	  Buffer	  with	  Protease and Phosphatase Inhibitor cocktail	  from	  Thermoscientific	  Inc,	  βME-­‐
denatured	  protein	  lysates	  were	  run	  on	  Nupage 4-12% Bis-tris gel (Life Technologies)	  and	  
Western	  Blots	  performed	  by	  standard	  procedures.	  Membranes	  were	  stained	  with	  mouse	  
monoclonal	  anti-­‐human	  VE-­‐Cadherin	  antibody	  (F-­‐8	  clone,	  Santa	  Cruz)	  and	  rat	  monoclonal	  anti-­‐
mouse	  VE-­‐Cadherin	  antibody (BV13	  clone,	  eBioscience),	  followed	  by	  HPR-­‐conjugated	  secondary	  
antibodies	  from	  Sigma	  and	  Cell	  Signaling.	  Signal	  was	  developed	  with	  Thermo	  Scientific	  Pierce	  
ECL	  Kit	  and	  bands	  quantified	  with	  Image	  J	  according	  to	  standard	  procedures.	  Transfected	  cells	  
were	  seeded	  in	  devices	  two	  days	  post	  infection.	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Mouse	  Retina	  Studies.	  Mice	  were	  housed	  in	  accordance	  with	  the	  Institutional	  Animal	  
Care	  and	  Use	  Committee	  at	  Boston	  University	  and	  the	  National	  Institutes	  of	  Health	  guidelines.	  
C57Black6	  mice	  from	  Taconic	  were	  used	  for	  breading	  purposes.	  Pups	  at	  postnatal	  day	  5	  (P5)	  
were	  i.p.	  injected	  with	  either	  5μl	  of	  Vehicle	  (DMSO)	  or	  Blebbistatin	  (50mM),	  diluted	  in	  Optimem	  	  
for	  a	  total	  50μl	  injection	  volume.	  For	  lentivirus	  in	  vivo	  transduction,	  P3	  aged	  pups	  were	  given	  an	  
i.p.	  dose	  of	  1	  ×	  107	  I.U.	  in	  a	  final	  volume	  of	  50μl.	  Six	  hours	  after	  Blebbistatin	  injection,	  pups	  were	  
euthanized	  and	  retinas	  dissected	  after	  fixation	  in	  PFA	  4%.	  Retinas	  were	  then	  processed	  for	  1h	  in	  
3%	  BSA	  and	  0.5%	  Triton	  X100.	  Reagents	  used	  for	  retina	  staining:	  rat	  anti-­‐mouse	  VE-­‐Cadherin	  
antibody	  (clone	  11D4.1,	  1:50,	  BD	  Bioscience),	  anti-­‐rat	  IgG	  Cy3	  (1:300,	  Jackson's	  Lab	  ),	  anti-­‐rat	  
IgG	  Alexa568	  (1:300,	  Invitrogen),	  	  isolectins	  B4	  (Vectorlabs),	  DAPI	  (Sigma).	  Retinas	  were	  whole	  
mounted,	  and	  images	  were	  acquired	  with	  an	  LD	  C-­‐Apochromat	  40×,	  1.1	  N.A.	  water-­‐immersion	  
objective	  attached	  to	  	  an	  Axiovert	  200M	  inverted	  microscope	  (Zeiss)	  equipped	  with	  a	  CSU10	  
spinning	  disk	  confocal	  scan	  head	  (Yokogawa	  Electric	  Corp.)	  and	  an	  Evolve	  EMCCD	  camera	  
(Photometrics).	  
	  
Statistical	  Analysis.	  Sample	  populations	  were	  compared	  using	  unpaired,	  two-­‐tailed	  
Student’s	  t-­‐test.	  P	  <	  0.05	  was	  the	  threshold	  for	  statistical	  significance	  unless	  otherwise	  noted.	  
Data	  points	  on	  the	  graphs	  represent	  mean	  values	  and	  error	  bars	  depict	  SEM.	  N	  =	  number	  of	  
sprouting	  device	  for	  in	  vitro	  sprout	  analysis.	  N	  =	  number	  of	  retina	  for	  in	  vivo	  sprout	  analysis.	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ABBREVIATIONS INDEX 
	  
Frequently	  used	  abbreviations	  are	  listed	  below	  
	  
AJ:	  Adherens	  Junction	  
EC:	  Endothelial	  Cell	  
FRAP:	  Fluorescence	  Recovery	  After	  Photobleaching	  
FRET:	  Förster	  Resonance	  Energy	  Transfer	  
GF:	  Growth	  Factors*	  
GFP:	  Green	  Fluorescent	  Protein	  
ECM:	  Extracellular	  Matrix	  
MCP-­‐1:	  Monocyte	  chemottractant	  protein-­‐1	  
MVPS:	  Angiogenic	  factor	  cocktail	  consisting	  of	  MCP-­‐1,	  VEGF,	  S1P,	  PMA	  
PCR:	  Polymerase	  Chain	  Reaction	  
PMA:	  Phorbol	  12-­‐myristate	  13-­‐acetate	  
S1P:	  sphingosine-­‐1-­‐phosphate	  
SEC:	  Sinusoidal	  EC	  
TJ:	  Tight	  Junction	  	  
VE-­‐Cadherin:	  Vascular	  Endothelial	  Cadherin	  
VEC:	  ECs	  with	  overexpression	  of	  VE-­‐cadherin	  
VEC-­‐α-­‐C:	  ECs	  expressing	  the	  fusion	  protein	  VE-­‐cadherin	  linked	  to	  α-­‐catenin	  
VEGF:	  Vascular	  Endothelial	  Growth	  Factor	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